
<html lang="en"     class="pb-page"  data-request-id="e0d9d643-580c-463b-8b75-7daaf40d4059"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/jm900563e;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2009.52.issue-21;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Antagonists of the Calcium Receptor. 2. Amino Alcohol-Based Parathyroid Hormone Secretagogues" /></meta><meta name="dc.Creator" content="Robert W.  Marquis" /></meta><meta name="dc.Creator" content="Amparo M.  Lago" /></meta><meta name="dc.Creator" content="James F.  Callahan" /></meta><meta name="dc.Creator" content="Attiq  Rahman" /></meta><meta name="dc.Creator" content="Xiaoyang  Dong" /></meta><meta name="dc.Creator" content="George B.  Stroup" /></meta><meta name="dc.Creator" content="Sandra  Hoffman" /></meta><meta name="dc.Creator" content="Maxine  Gowen" /></meta><meta name="dc.Creator" content="Eric G.  DelMar" /></meta><meta name="dc.Creator" content="Bradford C.  Van Wagenen" /></meta><meta name="dc.Creator" content="Sarah  Logan" /></meta><meta name="dc.Creator" content="Scott  Shimizu" /></meta><meta name="dc.Creator" content="John  Fox" /></meta><meta name="dc.Creator" content="Edward F.  Nemeth" /></meta><meta name="dc.Creator" content="Theresa  Roethke" /></meta><meta name="dc.Creator" content="Brian R.  Smith" /></meta><meta name="dc.Creator" content="Keith W.  Ward" /></meta><meta name="dc.Creator" content="Pradip  Bhatnagar" /></meta><meta name="dc.Description" content="When administered as a single agent to rats, the previously reported calcium receptor antagonist 3 elicited a sustained elevation of plasma PTH resulting in no increase in overall bone mineral dens..." /></meta><meta name="Description" content="When administered as a single agent to rats, the previously reported calcium receptor antagonist 3 elicited a sustained elevation of plasma PTH resulting in no increase in overall bone mineral dens..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 12, 2009" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm900563e" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2009 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm900563e" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm900563e" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm900563e" /></link>
        
    
    

<title>Antagonists of the Calcium Receptor. 2. Amino Alcohol-Based Parathyroid Hormone Secretagogues | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm900563e" /></meta><meta property="og:title" content="Antagonists of the Calcium Receptor. 2. Amino Alcohol-Based Parathyroid Hormone Secretagogues" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/large/jm-2009-00563e_0003.jpeg" /></meta><meta property="og:description" content="When administered as a single agent to rats, the previously reported calcium receptor antagonist 3 elicited a sustained elevation of plasma PTH resulting in no increase in overall bone mineral density. The lack of a bone building effect for analogue 3 was attributed to the large volume of distribution (Vdss(rat) = 11 L/kg), producing a protracted plasma PTH profile. Incorporation of a carboxylic acid functionality into the amino alcohol template led to the identification of 12 with a lower volume of distribution (Vdss(12) = 1.18 L/kg) and a shorter half-life. The zwitterionic nature of antagonist 12 necessitated the utility of an ester prodrug approach to increase overall permeability. Antagonist 12 elicited a rapid and transient increase in circulating levels of PTH following oral dosing of the ester prodrug 11 in the dog. The magnitude and duration of the increases in plasma levels of PTH would be expected to stimulate new bone formation." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm900563e"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm900563e">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm900563e&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm900563e&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm900563e&amp;href=/doi/10.1021/jm900563e" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2009</span><span class="cit-fg-volume">, 52</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 6599-6605</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/52/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm900561s" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm9007938" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Antagonists of the Calcium Receptor. 2. Amino Alcohol-Based Parathyroid Hormone Secretagogues</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+W.++Marquis">Robert W. Marquis</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amparo+M.++Lago">Amparo M. Lago</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+F.++Callahan">James F. Callahan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Attiq++Rahman">Attiq Rahman</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaoyang++Dong">Xiaoyang Dong</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=George+B.++Stroup">George B. Stroup</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sandra++Hoffman">Sandra Hoffman</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maxine++Gowen">Maxine Gowen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric+G.++DelMar">Eric G. DelMar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bradford+C.++Van+Wagenen">Bradford C. Van Wagenen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sarah++Logan">Sarah Logan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scott++Shimizu">Scott Shimizu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Fox">John Fox</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Edward+F.++Nemeth">Edward F. Nemeth</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Theresa++Roethke">Theresa Roethke</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian+R.++Smith">Brian R. Smith</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Keith+W.++Ward">Keith W. Ward</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pradip++Bhatnagar">Pradip Bhatnagar</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="affa"><span class="aff-symbol">†</span> <span class="aff-text">Departments of Medicinal Chemistry</span></div><div class="aff-info" id="affb"><span class="aff-symbol">‡</span> <span class="aff-text">Bone and Cartilage Biology</span></div><div class="aff-info" id="affd"><span class="aff-symbol">∥</span> <span class="aff-text">Drug Metabolism and Pharmacokinetics</span></div><div class="aff-info" id="gsk"><span class="aff-text">GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span></div><div class="aff-info" id="affe"><span class="aff-symbol">⊥</span> <span class="aff-text">NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: 1-610-917-7368. Fax: 1-610-917-4206. E-mail <a href="/cdn-cgi/l/email-protection#beecd1dcdbccca90e990f3dfcccfcbd7cdfed9cdd590ddd1d3"><span class="__cf_email__" data-cfemail="085a676a6d7a7c265f2645697a797d617b486f7b63266b6765">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm900563e&amp;href=/doi/10.1021%2Fjm900563e" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2009</span></span><span class="cit-volume">, 52</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 6599–6605</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 12, 2009</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>6 May 2009</li><li><span class="item_label"><b>Published</b> online</span>12 October 2009</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 November 2009</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm900563e" title="DOI URL">https://doi.org/10.1021/jm900563e</a></div><div class="article_header-article-copyright"><strong>Copyright © 2009 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6599%26pageCount%3D7%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRobert%2BW.%2BMarquis%252C%2BAmparo%2BM.%2BLago%252C%2BJames%2BF.%2BCallahan%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D52%26issueNum%3D21%26contentID%3Djm900563e%26title%3DAntagonists%2Bof%2Bthe%2BCalcium%2BReceptor.%2B2.%2BAmino%2BAlcohol-Based%2BParathyroid%2BHormone%2BSecretagogues%26numPages%3D7%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6605%26publicationDate%3DNovember%2B2009">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm900563e"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1263</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">21</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm900563e" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Antagonists of the Calcium Receptor. 2. Amino Alcohol-Based Parathyroid Hormone Secretagogues&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;W. Marquis&quot;},{&quot;first_name&quot;:&quot;Amparo&quot;,&quot;last_name&quot;:&quot;M. Lago&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;F. Callahan&quot;},{&quot;first_name&quot;:&quot;Attiq&quot;,&quot;last_name&quot;:&quot;Rahman&quot;},{&quot;first_name&quot;:&quot;Xiaoyang&quot;,&quot;last_name&quot;:&quot;Dong&quot;},{&quot;first_name&quot;:&quot;George&quot;,&quot;last_name&quot;:&quot;B. Stroup&quot;},{&quot;first_name&quot;:&quot;Sandra&quot;,&quot;last_name&quot;:&quot;Hoffman&quot;},{&quot;first_name&quot;:&quot;Maxine&quot;,&quot;last_name&quot;:&quot;Gowen&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;G. DelMar&quot;},{&quot;first_name&quot;:&quot;Bradford&quot;,&quot;last_name&quot;:&quot;C. Van Wagenen&quot;},{&quot;first_name&quot;:&quot;Sarah&quot;,&quot;last_name&quot;:&quot;Logan&quot;},{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;Shimizu&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Fox&quot;},{&quot;first_name&quot;:&quot;Edward&quot;,&quot;last_name&quot;:&quot;F. Nemeth&quot;},{&quot;first_name&quot;:&quot;Theresa&quot;,&quot;last_name&quot;:&quot;Roethke&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;R. Smith&quot;},{&quot;first_name&quot;:&quot;Keith&quot;,&quot;last_name&quot;:&quot;W. Ward&quot;},{&quot;first_name&quot;:&quot;Pradip&quot;,&quot;last_name&quot;:&quot;Bhatnagar&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;52&quot;,&quot;pages&quot;:&quot;6599-6605&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm900563e&quot;},&quot;abstract&quot;:&quot;When administered as a single agent to rats, the previously reported calcium receptor antagonist 3 elicited a sustained elevation of plasma PTH resulting in no increase in overall bone mineral density. The lack of a bone building effect for analogue 3 was attributed to the large volume of distribution (Vdss(rat) = 11 L/kg), producing a protracted plasma PTH profile. Incorporation of a carboxylic acid functionality into the amino alcohol template led to the identification of 12 with a lower volume of distribution (Vdss(12) = 1.18 L/kg) and a shorter half-life. The zwitterionic nature of antagonist 12 necessitated the utility of an ester prodrug approach to increase overall permeability. Antagonist 12 elicited a rapid and transient increase in circulating levels of PTH following oral dosing of the ester prodrug 11 in the dog. The magnitude and duration of the increases in plasma levels of PTH would be expected to stimulate new bone formation.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900563e&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900563e" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900563e&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900563e" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900563e&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900563e" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm900563e&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900563e&amp;href=/doi/10.1021/jm900563e" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm900563e" /></input><a href="/doi/pdf/10.1021/jm900563e" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (842 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm900563e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm900563e%26sid%3Dliteratum%253Aachs%26pmid%3D19821575%26genre%3Darticle%26aulast%3DMarquis%26date%3D2009%26atitle%3DAntagonists%2Bof%2Bthe%2BCalcium%2BReceptor.%2B2.%2BAmino%2BAlcohol-Based%2BParathyroid%2BHormone%2BSecretagogues%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D52%26issue%3D21%26spage%3D6599%26epage%3D6605%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=291411" title="Pharmacokinetics">Pharmacokinetics</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/52/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/medium/jm-2009-00563e_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/large/jm-2009-00563e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900563e&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">When administered as a single agent to rats, the previously reported calcium receptor antagonist <b>3</b> elicited a sustained elevation of plasma PTH resulting in no increase in overall bone mineral density. The lack of a bone building effect for analogue <b>3</b> was attributed to the large volume of distribution (<i>V</i><sub>dss</sub>(rat) = 11 L/kg), producing a protracted plasma PTH profile. Incorporation of a carboxylic acid functionality into the amino alcohol template led to the identification of <b>12</b> with a lower volume of distribution (V<sub>dss</sub>(<b>12</b>) = 1.18 L/kg) and a shorter half-life. The zwitterionic nature of antagonist <b>12</b> necessitated the utility of an ester prodrug approach to increase overall permeability. Antagonist <b>12</b> elicited a rapid and transient increase in circulating levels of PTH following oral dosing of the ester prodrug <b>11</b> in the dog. The magnitude and duration of the increases in plasma levels of PTH would be expected to stimulate new bone formation.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37522" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37522" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Osteoporosis is a disease afflicting more than 10 million women and men in the U.S. alone.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The overall weakening of bone that results in osteoporosis is caused by a shift in the equilibrium of bone remodeling in which bone formation by osteoblasts is overtaken by the resorption of old bone by osteoclasts. Current treatments to correct this imbalance may be divided into two distinct mechanistic classes. The first class is the antiresorptives which directly inhibit osteoclast activity, thereby slowing the resorption side of the bone remodeling equilibrium. This class is exemplified by bisphosphonates, selective estrogen receptor modulators (SERMs<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>), <div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: CaR, calcium receptor; PTH, parathyroid hormone; HEK, human embryonic kidney; OVX, ovariectomized; SAR, structure−activity relationship; DAT, dopamine transporter; SERT, serotonin transporter; NET, norepinephrine transporter; CYP2D6, cytochrome P450 2D6; hERG, human ether-a-go-go related gene; FLIPR, fluorimetric imaging plate reader; SERM, selective estrogen receptor modulator; HRT, hormone replacement therapy.</p></div> hormone replacement therapy (HRT), and calcitonin. All of these antiresorptive agents have proven efficacy in humans for the treatment of osteoporosis, slowing the excess resorption of bone but offering little in terms of stimulating the formation of new bone. The second mechanistic class for the treatment of osteoporosis is the bone forming agents which increase osteoblast activity allowing these cells to keep pace with or outperform bone resorbing osteoclasts. Both parathyroid hormone (PTH) (Nycomed) and its N-terminal 1−34 amino acid fragment teriparatide (Lilly),<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> when administered daily by subcutaneous injection, stimulate the formation of new bone, increase bone mineral density, and decrease the risk of fractures.</div><div class="NLM_p">An alternative approach to the development of an orally active bone forming agent, based upon the clinically validated mechanism of subcutaneously administered osteogenic PTH peptides, would be to identify an agent that would elicit the secretion of endogenously stored parathyroid hormone from the parathyroid glands. Here, the secretion of parathyroid hormone is under the control of the calcium receptor (CaR).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> This family C G-protein-coupled receptor is capable of sensing minute fluctuations in circulating levels of serum calcium such that a drop in the concentration of calcium levels (hypocalcaemia) elicits the release of PTH from the parathyroid glands while an increase in calcium levels (hypercalcimia) suppresses the release of this hormone. The effects of hypercalcemia can be mimicked by calcimimetic compounds that inhibit the secretion of PTH. One such compound is cinacalcet (<b>1</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>),<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> an allosteric activator of the CaR that is used to treat hyperparathyroidism. Calcimimetic compounds validate the view that circulating levels of PTH can be pharmacologically controlled by a small molecule acting at the parathyroid gland CaR. On the other hand, small molecule antagonists of the CaR, known as calcilytics, serve to mimic a hypocalcemic state and elicit the secretion of PTH.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> If the profile of PTH secretion following antagonism of the CaR is rapid and transient then this should promote the formation of new bone. If however the profile of PTH secretion following antagonism of the receptor is protracted, then this will have an overall catabolic effect and lead ultimately to an undesirable excess resorption of bone. As such, the design of a CaR antagonist capable of promoting overall bone growth is predicated upon this compound's ability to briefly antagonize the receptor, thereby eliciting a transient release of endogenous PTH.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/medium/jm-2009-00563e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/large/jm-2009-00563e_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Calcimimetic and calcilytic compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/large/jm-2009-00563e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900563e&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recently we have reported on the amino alcohol analogue <b>2</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> and Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) which was identified as a weak antagonist of the CaR through a screening effort of the former SmithKline Beecham compound collection.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Compound <b>2</b> had originally been profiled in a legacy program focused on the discovery of β-adrenergic receptor agonists and antagonists where it was shown to be a potent antagonist of the β<sub>2</sub>-adrenergic receptor and an agonist of the β<sub>3</sub>-adrenergic receptor. Additionally, <b>2</b>, being a lipophilic basic amine and a common pharmacophore for a variety of targets, was also a potent inhibitor of several monoamine transporters, the human ether a-go-go related gene (hERG) ion channel as well as the 2D6 cytochrome P450 (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Structure−activity studies to optimize the antagonist potency of <b>2</b> and to reduce off-target interactions led to the identification of amino alcohol <b>3</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> and Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), which is a potent antagonist of the CaR with improved selectivity over the β-adrenergic receptor family. Here, the key selectivity determinant for the CaR compared to β-adrenergic receptors was shown to be the chirality of the secondary hydroxyl group. Although this modification resulted in a significant reduction in affinity for the β-receptor, it did not greatly improve selectivity against the other off-target interactions mentioned above (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Despite concerns regarding these off-target interactions, amino alcohol <b>3</b> was progressed into an ovariectomized (OVX) rat study to assess its ability to stimulate the formation of new bone.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> When dosed orally for 8 weeks, analogue <b>3</b> elicited a robust but sustained elevation of plasma PTH in the OVX rat. This protracted rise in PTH levels ultimately led to increased bone turnover with no increases in overall bone mineral density. The undesirable PTH profile elicited by analogue <b>3</b> was attributed to its prolonged pharmacokinetic profile in the rat where it was shown to be rapidly cleared (Cl = 73.8 (mL/min)/kg) with a large volume of distribution (<i>V</i><sub>dss</sub> = 11 L/kg). On the basis of these data, an ideal follow-up to analogue <b>3</b> would have a significantly reduced volume of distribution while maintaining the rapid rate of clearance. A molecule with these two characteristics would be expected to have an improved pharmacokinetic profile with a short-lasting antagonism of the CaR, resulting in a transient plasma PTH exposure. In this account we detail structure−activity and pharmacokinetic studies that further address the off-target interactions associated with the amino alcohol class of antagonists as well as the protracted pharmacokinetic profile of analogue <b>3</b>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Potency and Selectivity Data<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th class="rowsep1" colspan="8" align="center">IC<sub>50</sub> (μM)</th></tr><tr valign="top"><th align="center">compd</th><th align="center">CaR FLIPR</th><th align="center">CaR binding</th><th align="center">SERT binding</th><th align="center">NET binding</th><th align="center">DAT binding</th><th align="center">CYP2D6</th><th align="center">hERG Bbinding</th><th align="center">β<sub>2</sub> binding</th></tr></thead><tbody><tr valign="top"><td align="left"><b>2</b></td><td align="left">11.0</td><td align="left">31.8</td><td align="left">0.061</td><td align="left">0.60</td><td align="left">1.20</td><td align="left">1.26</td><td align="left">11.8</td><td align="left">0.0013</td></tr><tr valign="top"><td align="left"><b>3</b></td><td align="left">0.058</td><td align="left">0.003</td><td align="left">0.002</td><td align="left">0.20</td><td align="left">0.20</td><td align="left">0.045</td><td align="left">3.00</td><td align="left">4.3</td></tr><tr valign="top"><td align="left"><b>5</b></td><td align="left">0.018</td><td align="left">0.003</td><td align="left">0.003</td><td align="left">0.003</td><td align="left">0.002</td><td align="left">0.100</td><td align="left">3.20</td><td align="left">ND</td></tr><tr valign="top"><td align="left"><b>9</b></td><td align="left">>25</td><td align="left">4.8</td><td align="left">0.068</td><td align="left">16.0</td><td align="left">3.7</td><td align="left">52.0</td><td align="left">38.5</td><td align="left">>30.0</td></tr><tr valign="top"><td align="left"><b>11</b></td><td align="left">0.034</td><td align="left">0.003</td><td align="left">0.078</td><td align="left">0.037</td><td align="left">0.059</td><td align="left">3.0</td><td align="left">1.7</td><td align="left">14.0</td></tr><tr valign="top"><td align="left"><b>12</b></td><td align="left">0.200</td><td align="left">0.022</td><td align="left">0.023</td><td align="left">5.40</td><td align="left">2.80</td><td align="left">>50.0</td><td align="left">32.7</td><td align="left">>30.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values represent the average of at least three individual titrations. ND = not determined.</p></div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Synthesis Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21788" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21788" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The analogues detailed in this account were synthesized according to the reactions provided in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a>−<a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Compound <b>5</b> of Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> was synthesized starting with the coupling of 2-cyanophenol (<b>4</b>) with (2<i>R</i>)-2-oxiranylmethyl 4-nitrobenzenesulfonate to provide the intermediate chiral epoxide (not shown). Opening of this epoxide with [1,1-dimethyl-2-(2-naphthalenyl)ethyl]amine in refluxing ethanol provided <b>5</b>. In a similar fashion, as outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, alkylation of ethyl 4-hydroxyhydrocinnamate (<b>6</b>) with (2<i>S</i>)-2-oxiranylmethanol provided the epoxide <b>7</b> which was opened with [1,1-dimethyl-2-(2-naphthalenyl)ethyl]amine in refluxing ethanol to provide the ethyl ester <b>8</b>. Hydrolysis of <b>8</b> under basic conditions gave the acid <b>9</b>. Analogues <b>11</b> and <b>12</b> of Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> were synthesized beginning with bromination of 4-hydroxyhydrocinnamate (<b>6</b>) followed by cyanation and alkylation with (2<i>S</i>)-2-oxiranylmethanol to provide epoxide <b>10</b>. Opening of epoxide <b>10</b> with [1,1-dimethyl-2-(2-naphthalenyl)ethyl]amine provided the ester <b>11</b> which was hydrolyzed under basic conditions to give the acid <b>12</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/medium/jm-2009-00563e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/large/jm-2009-00563e_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Antagonist <b>5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/large/jm-2009-00563e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900563e&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaH, DMF, (2<i>R</i>)-2-oxiranylmethyl 4-nitrobenzenesulfonate, 0 °C; (b) [1,1-dimethyl-2-(2-naphthalenyl)ethyl]amine, EtOH, 70 °C.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/medium/jm-2009-00563e_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/large/jm-2009-00563e_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Antagonists <b>8</b> and <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/large/jm-2009-00563e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900563e&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DIAD, PPh<sub>3</sub>, (2<i>S</i>)-2-oxiranylmethanol, THF, 0 °C to room temp; (b) [1,1-dimethyl-2-(2-naphthalenyl)ethyl]amine, EtOH, 70 °C; (c) NaOH, EtOH, H<sub>2</sub>O.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/medium/jm-2009-00563e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/large/jm-2009-00563e_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Antagonists <b>11</b> and <b>12</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/large/jm-2009-00563e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900563e&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Br<sub>2</sub>, CHCl<sub>3</sub>, 0 °C; (b) CuCN, NMP, reflux; (c) DIAD, PPh<sub>3</sub>, (2<i>S</i>)-2-oxiranylmethanol, THF, 0 °C to room temp; (d) [1,1-dimethyl-2-(2-naphthalenyl)ethyl]amine, EtOH, 70 °C; (e) CH<sub>3</sub>OH, 3 N NaOH.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00554" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00554" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To assess the ability of synthesized analogues to antagonize the CaR, two in vitro assays were used. The first was a fluorimetric imaging plate reader (FLIPR) based assay measuring the ability of test compounds to block increases in the concentration of cytoplasmic Ca<sup>2+</sup> in HEK293 cells expressing the human parathyroid CaR. The second was a binding assay where analogues were tested for their ability to displace the tritiated calcimimetic radioligand (2-(2-hydroxyphenyl)-6-methyl-5-(2-methylpropyl)-3-(2-phenylethyl)-4(3<i>H</i>)-pyrimidinone) from membrane preparations of HEK293 cells expressing the human CaR. The hydrochloride salts of the synthesized compounds were prepared in order to facilitate both compound solubility and handling.</div><div class="NLM_p">As detailed previously analogue <b>3</b> is a potent antagonist of the CaR in both the binding assay and the FLIPR assay with IC<sub>50</sub> values of 0.003 and 0.058 μM, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). This potency represents a greater than 10000-fold increase in potency in the CaR binding assay and a 190-fold increase in potency in the functional assay over the original lead <b>2</b>. In a binding assay format, analogue <b>3</b> is also a potent inhibitor of the serotonin, norepinepherine, and dopamine transporters with IC<sub>50</sub> values of 0.002, 0.200, and 0.200 μM, respectively, as well as both the 2D6 cytochrome P450 (IC<sub>50</sub> = 0.045 μM) and the hERG ion channel (IC<sub>50</sub> = 3.00 μM). Importantly, the affinity of <b>3</b> for the β<sub>2</sub>-adrenergic receptor was reduced almost 3300-fold relative to <b>2</b>. Analogue <b>5</b>, in which the chlorine atom of <b>3</b> was removed, was also a potent antagonist of the CaR with IC<sub>50</sub> values of 0.003 and 0.018 μM in the binding and functional assays, respectively. Not unexpectedly, this modification did not greatly affect the off-target interactions observed within analogues of this series of antagonists, and as such, this analogue was not further profiled in pharmacokinetic studies. However, this modification did indicate that potent antagonism of the CaR was achievable with the incorporation of a benzonitrile moiety. Incorporation of a propionic acid on the aromatic group to provide analogue <b>9</b> resulted in a significant loss in antagonist potency. This result is consistent with structure−activity trends defined earlier within this series in which an electron withdrawing moiety on this aromatic group was found to be required for potent antagonism of the CaR. Despite the lack of CaR antagonist potency for analogue <b>9</b>, what was most encouraging was the substantial increase in selectivity for the majority of the off-target interactions characteristic of this amino alcohol series. Similar to previous analogues, <b>9</b> remained a potent inhibitor of the serotonin transporter with IC<sub>50</sub> = 0.068 μM, however, a substantive reduction in potency versus the norepinephrine and dopamine transporters was seen relative to analogues <b>3</b> and <b>5</b>. Additionally, incorporation of the propionic acid moiety also led to a reduction in activity versus the 2D6 cytochrome P450 isozyme (IC<sub>50</sub> = 52 μM), the hERG ion channel (IC<sub>50</sub> = 38.5 μM), and the β<sub>2</sub>-adrenoreceptor (IC<sub>50</sub> > 30 μM). Pharmacokinetic analysis in the rat revealed that <b>9</b> had a high rate of clearance (Cl = 117.5 (mL/min)/kg) with a low volume of distribution (<i>V</i><sub>dss</sub> = 2.1 L/kg), a short half-life (<i>T</i><sub>1/2</sub> = 0.4 h), and mean residence time (MRT = 0.3 h). As discussed above, this type of pharmacokinetic profile was desirable for eliciting a rapid and transient release of PTH. Unfortunately the oral bioavailbilty of <b>9</b> was low (approximately 4%), which was likely a reflection of both the high clearance and the low intestinal absorption attributable to the zwitterionic nature of this compound.</div><div class="NLM_p">Although analogue <b>9</b> was not a potent antagonist of the CaR its improved receptor selectivity and desirable intravenous pharmacokinetic profile made this analogue the focus of additional studies aimed at improving both potency and bioavailability. As discussed above, structure−activity studies had revealed that the incorporation of an electron withdrawing moiety on this aromatic group was deemed essential for antagonist potency. Incorporation of the propionic acid side chain of <b>9</b> on the aromatic group of the potent antagonist <b>5</b> led to analogue <b>12</b>, which was a potent antagonist of the CaR with IC<sub>50</sub> = 0.022 μM in the receptor binding assay and IC<sub>50</sub> = 0.20 μM in the FLIPR assay. Despite the improved potency versus the CaR, no significant improvement in selectivity for <b>12</b> against the serotonin transporter (SERT IC<sub>50</sub> = 0.023 μM) was observed while improved selectivity over the norepinepherine (NET IC<sub>50</sub> = 5.40 μM) and dopamine transporters (DAT IC<sub>50</sub> = 2.80 μM) was observed relative to analogue <b>3</b> (SERT IC<sub>50</sub> = 0.002 μM; NET IC<sub>50</sub> = 0.002 μM, DAT IC<sub>50</sub> = 0.20 μM). Incorporation of the propionic acid moiety also led to a significant increase in selectivity of <b>12</b> versus CYP2D6 (IC<sub>50</sub> > 50.0 μM), the hERG ion channel (IC<sub>50</sub> = 32.7 μM), and the β<sub>2</sub>-adrenoreceptor (IC<sub>50</sub> > 30.0 μM).</div><div class="NLM_p">Pharmacokinetic analysis of <b>12</b> in the rat showed this compound to have a desirable profile with a short half-life (<i>T</i><sub>1/2</sub> = 0.56 h), lower mean residence time (MRT = 0.32 h), rapid clearance (Cl = 63.6 mL/min/kg), and low volume of distribution (<i>V</i><sub>dss</sub> = 1.18 L/kg). Analogue <b>12</b> had a low oral bioavailability (approximately 0.3%) when administered orally as a suspension (48 mg/kg). Dosing into the portal vein of the rat revealed that the first pass hepatic extraction of <b>12</b> was moderate to high at 68 ± 21%, suggesting that it is likely a combination of poor intestinal absorption and high first pass hepatic extraction that is limiting the systemic exposure of <b>12</b> in the rat following oral administration. Evaluation of the pharmacokinetics of <b>12</b> in the dog revealed that this compound had a short half-life (<i>T</i><sub>1/2</sub> = 1.23 h) and mean residence time (MRT = 0.85 h) with a small volume of distribution (<i>V</i><sub>dss</sub> = 0.78 L/kg) and a moderate rate of clearance (Cl = 15.4 (mL/min)/kg). As was observed in the rat, the rate of first pass hepatic extraction of <b>12</b> was high in the dog (90 ± 6%) following intraportal administration. The oral bioavailability of <b>12</b> in the dog was not determined in these studies because of the low levels of intestinal absorption and high hepatic extraction, similar to what had been previously observed in the rat.</div><div class="NLM_p">The systemic exposure of <b>12</b> in the rat and the dog was limited by two factors: high hepatic extraction and poor intestinal absorption following oral administration. The high hepatic extraction of <b>12</b> is likely a required characteristic of a compound that by necessity has to be cleared rapidly in order to limit systemic exposure and antagonize briefly the CaR. Alternatively, in order to address the poor intestinal absorption of <b>12</b>, a classic ester prodrug strategy was employed. The ethyl ester prodrug <b>11</b> of the parent acid <b>12</b> was a potent antagonist of the CaR with an IC<sub>50</sub> of 0.003 and 0.034 μM in binding and functional assays, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Not unexpectedly, the gains in receptor selectivity realized with the parent acid <b>12</b> were virtually abolished with the ester prodrug <b>11</b>, a likely reflection of this compound's greater lipophilicity (clogP(<b>11</b>) = 5.1 versus clogP(<b>12</b>) = 2.0) and cell permeability. This loss of target selectivity was of nominal concern because of the well precedented rates of ester prodrug hydrolysis which would lead to the generation of the significantly more selective parent acid <b>12</b> in the systemic circulation. Data were therefore gathered in an effort to assess the rates of this transformation in vivo.</div><div class="NLM_p">In the rat, the oral bioavailability of the parent acid <b>12</b> following dosing of a suspension of the ester prodrug <b>11</b> (4.7 mg/kg in 1% methylcellulose) was 9.5%, representing a 32-fold increase in exposure when compared to the dosing of a solution of the parent acid <b>12</b> (48 mg/kg) (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). None of the ester <b>11</b> was detectable in the systemic circulation, indicating complete hydrolysis to the parent acid <b>12</b> at this dose. Following intravenous administration, the fractional conversion of the ester <b>11</b> to the acid <b>12</b> had an apparent half-life of approximately 7 min. Additionally, none of the ester prodrug <b>11</b> was observed in the systemic circulation following intraportal infusion (1.8 mg/kg), indicating rapid hydrolysis and/or high hepatic extraction of this compound. A high dose study in the rat (47.5 mg/kg po) conducted to support safety assessment studies revealed that systemic exposure to the ester <b>11</b> was very low with maximum blood concentrations of 15−20 ng/mL, again indicative of rapid ester hydrolysis. In the dog, the oral bioavailability of the acid <b>12</b> was 9.1% following oral suspension dosing of the ester <b>11</b>. In this species the parent acid had a desired short half-life (<i>T</i><sub>1/2</sub> = 1.23 h) and mean residence time (MRT = 1.37 h) following the oral administration of a suspension dose of the ester <b>11</b>, suggesting rapid dissolution and absorption. The half-life of the ester <b>11</b> was estimated to be approximately 7 min with rapid conversion to the parent acid <b>12</b> following intravenous administration. Portal vein concentrations indicated that the ester <b>11</b> was well absorbed across the intestinal wall and that the acid <b>12</b> comprised the majority of the total portal vein AUC (73%). Combined, these data indicate that it is again high first pass hepatic extraction, not poor absorption, limiting the bioavailability of the parent acid <b>12</b> following the oral administration of the ester <b>11</b> in these two species.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Pharmacokinetic Data for Antagonists <b>3</b>, <b>9</b>, <b>11</b>, and <b>12</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th class="rowsep1" colspan="6" align="center">pharmacokinetics</th></tr><tr valign="top"><th align="center">compd</th><th align="center">species</th><th align="center">MRT (h)</th><th align="center"><i>T</i><sub>1/2</sub> (h)</th><th align="center">Cl ((mL/min)/kg)</th><th align="center"><i>V</i><sub>dss</sub> (L/kg)</th><th align="center"><i>F</i> (%)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>3</b></td><td align="left">rat</td><td align="left">2.5</td><td align="left">2.1</td><td align="center">73.8</td><td align="left">11.03</td><td align="left">11.4</td></tr><tr valign="top"><td align="left"><b>9</b></td><td align="left">rat</td><td align="left">0.3</td><td align="left">0.4</td><td align="center">117.5</td><td align="left">2.1</td><td align="left">4.0</td></tr><tr valign="top"><td align="left"><b>11</b></td><td align="left">rat</td><td align="left">0.7</td><td align="left">0.88</td><td align="center"> </td><td align="left"> </td><td align="left">9.5<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top"><td align="left"><b>11</b></td><td align="left">dog</td><td align="left">1.37</td><td align="left">1.23</td><td align="center"> </td><td align="left"> </td><td align="left">9.1<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top"><td align="left"><b>12</b></td><td align="left">rat</td><td align="left">0.32</td><td align="left">0.56</td><td align="center">63.6</td><td align="left">1.18</td><td align="left">0.29</td></tr><tr valign="top"><td align="left"><b>12</b></td><td align="left">dog</td><td align="left">0.85</td><td align="left">1.23</td><td align="center">15.4</td><td align="left">0.78</td><td align="left">ND</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Three rats or dogs were employed for the po and iv arms of these studies. ND = not determined.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Oral bioavailability of acid <b>12</b> following oral dosing of ester <b>11</b>.</p></div></div></div><div class="NLM_p">The promising pharmacokinetic profile of the potent acid <b>12</b> following oral dosing of the ester prodrug <b>11</b> prompted evaluation of this acid/ester prodrug pair for its ability to elicit an increase in plasma levels of PTH in the dog. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, oral administration of the ester <b>11</b> (23.4 mg/kg) produced a rapid increase of the parent acid <b>12</b> in the systemic circulation with an oral <i>T</i><sub>max</sub> of 0.5 h and an oral <i>C</i><sub>max</sub> of 597 ng/mL. This profile suggests that the ester <b>11</b> rapidly dissolved in intestinal fluid, was well absorbed across the intestinal wall, and was completely converted to the parent acid <b>12</b> via ester hydrolysis. Levels of the acid <b>12</b> returned to baseline in approximately 2 h, consistent with the desired profile for brief antagonism of the CaR (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). A concomitant rise in plasma PTH levels was also observed following the oral dosing of the ester <b>11</b>. Plasma PTH levels reached <i>T</i><sub>max</sub> at 0.4 h with a <i>C</i><sub>max</sub> of approximately 180 ng/mL, a pharmacokinetic profile essentially overlaying that of the acid <b>12</b>.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/medium/jm-2009-00563e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/large/jm-2009-00563e_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Mean pharmacokinetics and pharmacodynamics of analogue <b>12</b> following the oral dosing of a 23.4 mg/kg suspension dose (1% methylcellulose) of <b>11</b> in the dog (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/large/jm-2009-00563e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900563e&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76753" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76753" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In this account we have detailed structure−activity studies focused on the improvement of both the in vitro selectivity and in vivo pharmacokinetic profiles of the first generation amino alcohol-based CaR antagonist <b>3</b>. The incorporation of a polar carboxylic acid moiety into this template to provide analogue <b>12</b> served the dual purposes of improving both the  CaR selectivity and pharmacokinetic profiles of <b>3</b>. However, because of the high first pass hepatic extraction and low intestinal absorption, the oral bioavailability of <b>12</b> was low, prompting the use of an acid/ester prodrug strategy. The ester <b>11</b> was able to deliver significant levels of the acid following oral administration in both the dog and the rat and maintained a desired short exposure profile. Oral administration of the ester <b>11</b> in the dog elicited a rapid and transient increase in plasma levels of PTH. The magnitude and duration of the increases in plasma levels of PTH would be expected to stimulate new bone formation. This pharmacokinetic profile represents a significant improvement over the first generation antagonist <b>3</b>. The ability of analogues such as <b>12</b> to promote a bone building effect in vivo will be the subject of a future publication.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Procedures</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00486" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00486" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Calcium Receptor Inhibitor Assay</h3><div class="NLM_p">HEK 293 4.0-7 cells were constructed as described by Rogers et al.( <cite>J. Bone Miner. Res.</cite> <span class="NLM_year">1995</span>, <em>10</em> (Suppl. 1), S483). At 48 h prior to running the CaR assay, frozen HEK293 CaRec4.0-c17 cells are thawed, counted, and diluted to 3 × 10<sup>5</sup>/mL (15K/50 μL). The cell medium used to dilute the cells consists of 1:1 DMEM/F12 (HAM’S) with <span class="smallcaps smallerCapital">l</span>-glutamine, 15 mM HEPES, phenol red, 10% fetal bovine serum, and 1% penicillin−streptomycin solution. Cell solution is seeded at (15K cells/50 μL)/well in Greiner poly-<span class="smallcaps smallerCapital">d</span>-lysine coated 38-well, black, clear-bottom tissue culture plates and left at room temperature for 1 h to reduce the edge effect. After the first hour at room temperature, cell plates are then placed into a 37 °C, 5% CO<sub>2</sub> incubator for 48 h.</div><div class="NLM_p">On the day of the experiment, plate confluency is first checked via microscope. Wells should be ∼100% confluent in an even cell monolayer. Assay reagents are prepared fresh. Dye load buffer consists of Hank’s buffered saline solution with 0.75 mM calcium, without magnesium, without sodium bicarbonate, with 20 mM Hepes, probenecid (2.5 mM final concentration), Fluo4 (2 μM final concentration), and Brilliant Black (500 μM final concentration). Compound dilution buffer consists of Hank’s buffered saline solution without calcium, without magnesium (without sodium bicarbonate), and with CHAPS (0.01% final concentration). A ligand curve plate is also prepared fresh. A 16 point curve is dispensed into a Greiner 384-well polypropylene plate. The top concentration of the ligand, CaCl, is 2.875 mM (final concentration), and the lowest concentration is 0.375 mM (final concentration). An EC<sub>80</sub> value is generated from the curve data.</div><div class="NLM_p last">The CaR assay begins when the cell medium is aspirated from the cell plate using a Tecan plate washer, leaving nothing but the cell monolayer. Dye load buffer is added to the cell plate at 20 μL/well using a Multidrop, and the loaded plate is incubated for 45 min at 37 °C, 5% CO<sub>2</sub>. Compound plates are received with 1 μL of compound stamped at 5 mM top concentration (25 μM final concentration in cell plate). Compound dilution buffer is added to columns 1−24 in the compound plate at 65 μL/well using a Multidrop. Column 6 is prestamped with 1 μL of DMSO to represent the high control, and column 18 receives 65 μL of buffer as the low control. The compound addition takes place on a Cybi Well dispenser when 10 μL of diluted compound is added to the dye loaded cell plate. The cell plate with compound is then incubated at room temperature for 5 min. The antagonist addition takes place on the FLIPR when 10 μL of EC<sub>80</sub> challenge is added to the cell plate and fluorescence imaging proceeds for 65 s. Column 18 of the EC<sub>80</sub> challenge plate contains only buffer to represent a low control or tool antagonist.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Calcium Receptor Binding Assay</h3><div class="NLM_p">HEK 293 4.0-7 cells stably transfected with the human parathyroid calcium receptor (“HuPCaR”) were scaled up in T180 tissue culture flasks. Plasma membrane is obtained by Polytron homogenization or glass douncing in buffer (50 mM Tris-HCl, pH 7.4, 1 mM EDTA, 3 mM MgCl<sub>2</sub>) in the presence of a protease inhibitor cocktail containing 1 μM leupeptin, 0.04 μM pepstatin, and 1 mM PMSF. Aliquoted membrane was snap frozen and stored at −80 °C. <sup>3</sup>H labeled compound was radiolabeled to a radiospecific activity of 44 Ci/mmol and was aliquoted and stored in liquid nitrogen for radiochemical stability.</div><div class="NLM_p">A typical reaction mixture contains 2 nM <sup>3</sup>H compound ((<i>R</i>,<i>R</i>)-<i>N</i>-4′-methoxy-<i>t</i>-3-3′-methyl-1′-ethylphenyl-1-(1-naphthyl)ethylamine) or <sup>3</sup>H compound ((<i>R</i>)-<i>N</i>-[2-hydroxy-3-(3-chloro-2-cyanophenoxy)propyl]-1,1-dimethyl-2-(4-methoxyphenyl)ethylamine) and 4−10 μg of membrane in homogenization buffer containing 0.1% gelatin and 10% EtOH in a reaction volume of 0.5 mL. Incubation is performed in 12 × 75 polyethylene tubes in an ice−water bath. To each tube 25 μL of test sample in 100% EtOH is added, followed by 400 μL of cold incubation buffer and 25 μL of 40 nM <sup>3</sup>H-compound in 100% EtOH for a final concentration of 2 nM. The binding reaction is initiated by the addition of 50 μL of 80−200 μg/mL HEK 293 4.0-7 membrane diluted in incubation buffer, and the mixture is allowed to incubate at 4 °C for 30 min. Wash buffer is 50 mM Tris-HCl containing 0.1% PEI. Nonspecific binding is determined by the addition of 100-fold excess of unlabeled homologous ligand and is generally 20% of total binding. The binding reaction is terminated by rapid filtration onto 1% PEI pretreated GF/C filters using a Brandel harvestor. Filters are placed in scintillation fluid, and radioactivity is assessed by liquid scintillation counting.</div><div class="NLM_p last">The purities of all tested compounds that were not analyzed via elemental analysis were determined by high performance liquid chromatography. Method A was performed on a Agilent 1100 series, with a UV detector monitoring at 254 nm, a Zorbax SB-C8 column (4.6 mm × 150 mm, 5 μm), 5−100% CH<sub>3</sub>CN/H<sub>2</sub>O (with 0.02% TFA) over 12.5 min and hold for 2.5 min, and flow rate of 1.5 mL/min at 40°C. Method B was performed on a Agilent 1200 series, with a UV detector monitoring at 254 nm, a Phenomenex C18 column (4.6 mm × 150 mm, 3 μm), 5−95% CH<sub>3</sub>CN/H<sub>2</sub>O (with 0.1% TFA) over 15 min, and flow rate of 1 mL/min at 40 °C. Method C was performed on an Agilent 1200 series, with a UV detector monitoring at 254/214 nm, a Zorbax-XDB-C18 column (4.6 mm × 75 mm, 3.5 μm), 5−95% CH<sub>3</sub>CN/H<sub>2</sub>O (each with 0.10 % TFA) over 4 min and hold for 1 minute at 95 % of CH<sub>3</sub>CN (0.10% TFA), and flow rate of 2.0 mL/min. All compounds analyzed by these methods possessed purities equal to or greater than 95% with the exception of analogue <b>5</b>, which was 95.5% pure by method A and 94.9% pure by method B.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> General</h3><div class="NLM_p last">Except where indicated materials and reagents were used as supplied. Nuclear magnetic resonance spectra were recorded at either 250 or 400 MHz using, respectively, a Bruker AM 250 or Bruker AC 400 spectrometer. Mass spectra were taken on a PE Syx API III instrument using electrospray (ES) ionization techniques. Elemental analyses were obtained using a Perkin-Elmer 240C elemental analyzer. Reactions were monitored by TLC analysis using Analtech silica gel GF or E. Merck silica gel 60 F-254 thin layer plates. Flash chromatography was carried out on E. Merck Kieselgel 60 (230−400 mesh) silica gel. The purity of all tested compounds, which were not analyzed via elemental analysis, were determined by high performance liquid chromatography. Method A was performed on an Agilent 1100 series, with a UV detector monitoring at 254 nm, a Zorbax SB-C8 column (4.6 mm × 150 mm, 5 μm), 5−100% CH<sub>3</sub>CN/H<sub>2</sub>O (with 0.02% TFA) over 12.5 min and hold for 2.5 min, and flow rate of 1.5 mL/min at 40 °C. Method B was performed on a Agilent 1200 series, with a UV detector monitoring at 254 nm, a Phenomenex C18 column (4.6 mm × 150 mm, 3 μm), 5−95% CH<sub>3</sub>CN/H<sub>2</sub>O (with 0.1% TFA) over 15 min, and flow rate of 1 mL/min at 40 °C.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> 2-[((2<i>R</i>)-3-{[1,1-Dimethyl-2-(2-naphthalenyl)ethyl]amino}-2-hydroxypropyl)oxy]benzonitrile (<b>5</b>)</h3><div class="NLM_p">To a solution of (2<i>S</i>)-glycidol (2 g, 27 mmol) in dichloromethane (25 mL) at 0 °C was slowly added triethylamine (3.75 mL). Then a solution of 4-nitrobenzenesulfonyl chloride (6 g, 27 mmol) in dichloromethane (13 mL) was added to the reaction mixture at such a rate that the temperature did not rise above 15 °C. After 1 h at 0 °C the solution was allowed to warm to room temperature and maintained at this temperature overnight. The reaction mixture was concentrated and the crude material purified by flash column chromatography (0−60% EtOAc/hexane) to afford 4.2 g of the desired product (58%). MS (<i>m</i>/<i>z</i>): 260.1 (M + H).</div><div class="NLM_p">Sodium hydride (70 mg, 1.76 mmol, 60% oil suspension) was washed twice with hexane and then placed in a two-necked round-bottom flask under N<sub>2</sub> and cooled to 0 °C with an ice−water bath. Then DMF (5 mL), 2-hydroxybenzonitrile (190 mg, 1.6 mmol), and (2<i>R</i>)-2-oxiranylmethyl 4-nitrobenzenesulfonate (500 mg, 1.92 mmol) were added to this mixture. The solution was maintained at 0 °C for 6 h, whereupon it was concentrated and the crude material was purified by flash column chromatography (0−80% EtOAc/hexane) to afford 240 mg of the 2-{[(2<i>R</i>)-2-oxiranylmethyl]oxy}benzonitrile (86%).</div><div class="NLM_p last">A solution of 2-{[(2<i>R</i>)-2-oxiranylmethyl]oxy}benzonitrile (239 mg, 1.37 mmol) and 2-methyl-1-(2-naphthalenyl)-2-propanamine (327 mg, 1.64 mmol) in ethanol (10 mL) were combined and heated at 70 °C for 16 h. The mixture was concentrated and purified by column chromatography (0−10% CH<sub>2</sub>Cl<sub>2</sub>/MeOH) and afforded the desired product (272 mg, 53.2%). This material was dissolved in CH<sub>2</sub>Cl<sub>2</sub>, and HCl in ether was added. This material was concentrated and azeotropically dried with toluene to provide the hydrochloride salt <b>5</b>. <sup>1</sup>H NMR (DMSO, 400 MHz): δ 8.95 (m, 1H), 8.72 (m, 1H), 7.08−7.90 (m, 11H), 6.05 (m, 1H), 4.15−4.40 (m, 3H), 3.31−3.46 (m, 1H), 3.15−3.20 (m, 3H), 1.30 (s, 6H). MS (<i>m</i>/<i>z</i>): 375.3 (M + H). HPLC purities: method A, 95.5%, <i>t</i><sub>R</sub> = 7.2 min; method B, 94.9%, <i>t</i><sub>R</sub> = 8.9 min.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 3-{4-[((2<i>R</i>)-3-{[1,1-Dimethyl-2-(2-naphthalenyl)ethyl]amino}-2-hydroxypropyl)oxy]phenyl}propanoic Acid (<b>8</b>)</h3><div class="NLM_p">To a solution of ethyl 3-(4-hydroxyphenyl)propanoate (<b>6</b>, 5.0 g, 25.8 mmol) in 100 mL of THF was added (2<i>S</i>)-2-oxiranylmethanol (2.48 g, 33.5 mmol) and triphenylphosphine (10.2 g, 38.7 mmol). The reaction mixture was cooled to 0 °C, and DIAD (8.10 g, 38.7 mmol) was added dropwise. The mixture was allowed to warm to room temperature and maintained at this temperature overnight. A white precipitate formed upon addition with Et<sub>2</sub>O and was filtered off through a fine fritted funnel. The filtrate was concentrated and purified by column chromatography to give 4.8 g (75%) of ethyl 3-(4-{[(2<i>R</i>)-2-oxiranylmethyl]oxy}phenyl)propanoate (<b>7</b>).</div><div class="NLM_p last">A solution of ethyl 3-(4-{[(2<i>R</i>)-2-oxiranylmethyl]oxy}phenyl)propanoate (1.2 g, 4.8 mmol) and [1,1-dimethyl-2-(2-naphthalenyl)ethyl]amine (1.0 g, 5.0 mmol) in ethanol (10 mL) was combined and heated at 70 °C for 15 h. The mixture was concentrated and purified by column chromatography (0−90% ethyl acetate/hexane) and afforded ethyl 3-{4-[((2<i>R</i>)-3-{[1,1-dimethyl-2-(2-naphthalenyl)ethyl]amino}-2-hydroxypropyl)oxy]phenyl}propanoate (<b>8</b>, 1.4 g, 78%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.41 (br, 1 1 H), 8.82 (br, 1 H), 7.91 (m, 3 H), 7.52 (s, 1 H), 7.50 (m, 2 H), 7.40 (d, 1 H, <i>J</i> = 8.4 Hz), 7.15 (d, 2 H, <i>J</i> = 8.4 Hz), 6.89 (d, 2 H, <i>J</i> = 8.8 Hz), 5.95 (d, 1 H, <i>J</i> = 4.8 Hz), 4.28 (m, 1 H), 4.03 (m, 4 H), 3.21−3.09 (m, 4 H), 2.79 (t, 2 H, <i>J</i> = 7.6 Hz), 2.57 (t, 2 H, <i>J</i> = 7.6 Hz), 1.30 (s, 6 H), 1.15(t, <i>J</i>= 7.2 Hz). MS(<i>m</i>/<i>z</i>): 450.2 (M + H). Anal. Calcd for C<sub>28</sub>H<sub>35</sub>NO<sub>4</sub>·HCl: C 69.19; H 7.46; N 2.88. Found: C 69.14; H 7.44; N 2.83.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 3-{4-[((2<i>R</i>)-3-{[1,1-Dimethyl-2-(2-naphthalenyl)ethyl]amino}-2-hydroxypropyl)oxy]phenyl}propanoic Acid (<b>9</b>)</h3><div class="NLM_p last">Sodium hydroxide (3 N, 1.0 mL, 3.0 mmol) was added to a solution of ethyl 3-{4-[((2<i>R</i>)-3-{[1,1-dimethyl-2-(2-naphthalenyl)ethyl]amino}-2-hydroxypropyl)oxy]phenyl}propanoate (<b>8</b>, 0.50 g, 1.0 mmol) in methanol (15 mL). The mixture was maintained at room temperature for 15 h. The methanol was removed in vacuo, and the aqueous layer was diluted with water. The pH of the aqueous layer was adjusted to pH ∼6.0 with 6 N HCl while stirring. The precipitated white solid was collected by filtration and dried under high vacuum in the oven (∼55 °C) for ∼ 20 h. The zwitterion was taken up in acetonitrile, and 1 N HCl in ether was added and stirred for ∼2 h and then concentrated in vacuo to afford 3-{4-[((2<i>R</i>)-3-{[1,1-dimethyl-2-(2-naphthalenyl)ethyl]amino}-2-hydroxypropyl)oxy]phenyl}propanoic acid (<b>9</b>, 0.4 g, 84%) as white foam solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 11.8 (s, 1 H), 9.41 (br, 1H), 8.85 (br, 1 H), 7.91 (m, 3 H), 7.78 (s, 1 H), 7.51 (m, 2 H), 7.40 (m, 1 H), 7.15 (d, 2 H, <i>J</i> = 8.4 Hz), 6.89 (d, 2 H, <i>J</i> = 8.4 Hz), 5.96 (d, 1 H, <i>J</i> = 4.4 Hz), 4.30 (m, 1 H), 4.02 (d, 2 H, <i>J</i> = 5.2 Hz), 3.23−3.03 (m, 4 H), 2.76 (t, 2 H, <i>J</i> = 7.6 Hz), 2.50 (t, 2 H, <i>J</i> = 7.6 Hz), 1.30 (s, 6 H). MS (<i>m</i>/<i>z</i>): 422.2 (M + H). Anal. Calcd for C<sub>26</sub>H<sub>31</sub>NO<sub>4</sub>·HCl: C 68.18; H 6.61; N 2.98. Found: C 68.06; H 7.04; N 3.06</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Ethyl 3-{3-Cyano-4-[((2<i>R</i>)-3-{[1,1-dimethyl-2-(2-naphthalenyl)ethyl]amino}-2-hydroxypropyl)oxy]phenyl}propanoate Hydrochloride (<b>11</b>)</h3><div class="NLM_p">To a solution of ethyl 3-(4-hydroxyphenyl)propanoate (3.30 g, 17.01 mmol) in chloroform (30 mL) cooled in an ice bath was slowly added bromine (2.85 g, 17.86 mmol) over 25 min. The solution was stirred for 60 min at room temperature and then quenched with water and washed with brine. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, concentrated in vacuo, and purified by flash chromatography (Biotage, 0−20% EtOAc/hexanes) to yield ethyl 3-(3-bromo-4-hydroxyphenyl)propanoate (3.54 g, 76%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.26 (t, <i>J</i> = 7.07 Hz, 3 H), 2.56−2.63 (t, <i>J</i> = 7.6 Hz, 2 H), 2.88 (t, <i>J</i> = 7.71 Hz, 2 H), 4.11−4.19 (q, <i>J</i> = 7.2 Hz, 2 H), 6.95 (d, <i>J</i> = 8.34 Hz, 1 H), 7.07 (dd, <i>J</i> = 8.34, 2.02 Hz, 1 H), 7.33 (d, <i>J</i> = 2.27 Hz, 1 H).</div><div class="NLM_p">To a solution of ethyl 3-(3-bromo-4-hydroxyphenyl)propanoate (3.54 g, 12.97 mmol) in NMP (20 mL) was added CuCN (1.22 g, 13.62 mmol), and the mixture was refluxed for 2 h. The reaction mixture was cooled to room temperature, diluted with ethyl acetate (70 mL), and then washed with 1 N HCl (60 mL × 2) and brine (60 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, concentrated in vacuo, and purified by flash chromatography (Biotage, 10−28%, EtOAc/hexanes) to yield ethyl 3-(3-cyano-4-hydroxyphenyl)propanoate (2.1 g, 73.8%). LCMS (<i>m</i>/<i>z</i>): 220.0 [M + H]<sup>+</sup>.</div><div class="NLM_p">To a solution of ethyl 3-(3-cyano-4-hydroxyphenyl)propanoate (1.95 g, 8.90 mmol) in dry THF (15 mL) was added in sequence (<i>S</i>)-glycidol (1.32 g, 17.81 mmol) and PPh<sub>3</sub> (4.67 g, 17.81). The mixture was cooled in an ice bath, and DIAD (4.67 g, 17.81 mmol) was added dropwise. After 20 h, an additional 0.65 equiv of (<i>S</i>)-glycidol, PPh<sub>3</sub>, and DIAD was added and the mixture was stirred for 3 h at room temperature. The solvent was then evaporated and the residue was purified by flash chromatography (Biotage, 0−1.2% THF/CH<sub>2</sub>Cl<sub>2</sub>) to yield ethyl 3-(3-cyano-4-{[(2<i>R</i>)-2-oxiranylmethyl]oxy}phenyl)propanoate (1.40 g, 57%). MS (<i>m</i>/<i>z</i>): 294.2 [M + 18]<sup>+</sup>.</div><div class="NLM_p last">To a solution of ethyl 3-(3-cyano-4-{[(2<i>R</i>)-2-oxiranylmethyl]oxy}phenyl) propanoate (0.627 g, 2.3 mmol) in ethanol (10 mL) was added [1,1-dimethyl-2-(2-naphthalenyl)ethyl]amine (0.571 g, 2.87 mmol), and the mixture was stirred at 70 °C for 20 h. The solvent was evaporated, and the residue was purified by flash chromatography (Biotage, 0−3.2% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) to yield ethyl 3-{3-cyano-4-[((2<i>R</i>)-3-{[1,1-dimethyl-2-(2-naphthalenyl)ethyl]amino}-2-hydroxypropyl)oxy]phenyl}propanoate (0.89 g, 82%). To a solution of ethyl 3-{3-cyano-4-[((2<i>R</i>)-3-{[1,1-dimethyl-2-(2-naphthalenyl)ethyl]amino}-2-hydroxypropyl)oxy]phenyl}propanoate (202 mg, 0.426 mmol) in acetonitrile (4.0 mL) was added 1 N HCl (solution in diethyl ether) (2.13 mL, 2.13 mmol). After the mixture was stirred for 20 min the solvent was evaporated and the residue was azeotroped with toluene to yield ethyl 3-{3-cyano-4-[((2<i>R</i>)-3-{[1,1-dimethyl-2-(2-naphthalenyl)ethyl]amino}-2-hydroxypropyl)oxy]phenyl}propanoate hydrochloride as a white solid (quantitative). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.16 (s, 3 H) 1.29 (s, 6 H) 2.59−2.65 (m, 2 H), 2.79−2.86 (m, 2 H), 3.13−3.24 (m, 3 H), 3.34−3.44 (m, 1 H), 4.00−4.08 (m, 2 H), 4.15−4.31 (m, 3 H), 5.96−6.01 (m, 1 H), 7.21−7.25 (m, 1 H), 7.37−7.42 (m, 1 H), 7.48−7.59 (m, 3 H), 7.63 (s, 1 H), 7.77−7.80 (m, 1 H), 7.87−7.94 (m, 3 H), 8.60−8.81 (m, 2 H). <sup>13</sup>C NMR: δ 14.07, 22.33, 22.41, 28.78, 34.74, 42.68, 43.88, 59.70, 59.84, 65.30, 70.64, 100.55, 113.30, 116.42, 125.86, 126.17, 127.44, 127.59, 129.00,129.22, 131.94, 132.84, 132.88, 133.06, 133.82, 135.10, 158.41, 171.96. LCMS (<i>m</i>/<i>z</i>): 475.2 [M + H]<sup>+</sup>. [α]<sub class="stack">D</sub><sup class="stack">20.4</sup> +15.43 (<i>c</i> 0.77, MeOH). Anal. Calcd for C<sub>29</sub>H<sub>35</sub>N<sub>2</sub>O<sub>4</sub>Cl·0.25H<sub>2</sub>O: C, 67.56%, H 6.94%, N 5.43%. Found: C 67.16%, H 6.99%, N 5.33%.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 3-{3-Cyano-4-[((2<i>R</i>)-3-{[1,1-dimethyl-2-(2-naphthalenyl)ethyl]amino}-2-hydroxypropyl)oxy]phenyl}propanoic Acid Hydrochloride (<b>12</b>)</h3><div class="NLM_p last">To a solution ethyl 3-{3-cyano-4-[((2<i>R</i>)-3-{[1,1-dimethyl-2-(2-naphthalenyl)ethyl]amino}-2-hydroxypropyl)oxy]phenyl}propanoate (<b>11</b>, 468. 0 mg, 0.987 mmol) in methanol (4.0 mL) was added aqueous 3 N NaOH (0.823 mL, 2.47 mmol). After overnight stirring at room temperature, the solvent was evaporated and the residue was diluted with water (15 mL). The mixture was acidified to pH ∼6 to obtain a solid that was filtered and washed with ethyl ether and acetonitrile. The solid was then azeotroped with toluene, suspended in acetonitrile, and then treated with 1 N HCl (in ethyl ether) (2.71 mL, 2.71 mmol). The solid product was filtered and washed with a small amount of acetonitrile to yield the title compound (245 mg, 38.4%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.29 (s, 6 H), 2.54−2.59 (m, 2 H), 2.77−2.84 (m, 2 H), 3.18 (s, 3 H), 3.36−3.43 (m, 1 H), 4.15−4.30 (m, 3 H), 5.97−6.04 (m, 1 H), 7.24 (d, <i>J</i> = 8.59 Hz, 1 H), 7.39−7.43 (m, 1 H), 7.48−7.59 (m, 3 H), 7.63 (s, 1 H), 7.78 (s, 1 H), 7.87−7.94 (m, 3 H), 8.65−8.72 (m, 1 H), 8.76−8.85 (m, 1 H), 12.15 (s, 1 H). <sup>13</sup>C NMR: δ 22.42, 28.86, 34.94, 42.75, 43.89, 54.89, 65.38, 70.64, 100.54, 113.30, 116.46, 125.85, 126.16, 127.44, 127.57, 129.01, 129.21, 131.93, 132.82, 133.01, 134.19, 135.08, 158.35, 173.52. HRMS: 447.2282 (calcd 447.2284). [α]<sub class="stack">D</sub><sup class="stack">23.6</sup> +11.75 (<i>c</i> 0.74, DMSO). HPLC purities: method A, 98.5%, <i>t</i><sub>R</sub> = 6.95 min; method C, 100%, <i>t</i><sub>R</sub> = 2.76 min.</div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17132" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17132" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert W. Marquis</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry</span>; 
    <span class="hlFld-Affiliation affiliation">Bone and Cartilage Biology</span>; 
    <span class="hlFld-Affiliation affiliation">Drug Metabolism and Pharmacokinetics</span>; 
    <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span>; 
    <span class="hlFld-Affiliation affiliation">NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7c2e131e190e08522b52311d0e0d09150f3c1b0f17521f1311"><span class="__cf_email__" data-cfemail="e9bb868b8c9b9dc7bec7a4889b989c809aa98e9a82c78a8684">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amparo M. Lago</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry</span>; 
    <span class="hlFld-Affiliation affiliation">Bone and Cartilage Biology</span>; 
    <span class="hlFld-Affiliation affiliation">Drug Metabolism and Pharmacokinetics</span>; 
    <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span>; 
    <span class="hlFld-Affiliation affiliation">NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James F. Callahan</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry</span>; 
    <span class="hlFld-Affiliation affiliation">Bone and Cartilage Biology</span>; 
    <span class="hlFld-Affiliation affiliation">Drug Metabolism and Pharmacokinetics</span>; 
    <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span>; 
    <span class="hlFld-Affiliation affiliation">NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Attiq Rahman</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry</span>; 
    <span class="hlFld-Affiliation affiliation">Bone and Cartilage Biology</span>; 
    <span class="hlFld-Affiliation affiliation">Drug Metabolism and Pharmacokinetics</span>; 
    <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span>; 
    <span class="hlFld-Affiliation affiliation">NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaoyang Dong</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry</span>; 
    <span class="hlFld-Affiliation affiliation">Bone and Cartilage Biology</span>; 
    <span class="hlFld-Affiliation affiliation">Drug Metabolism and Pharmacokinetics</span>; 
    <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span>; 
    <span class="hlFld-Affiliation affiliation">NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">George B. Stroup</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry</span>; 
    <span class="hlFld-Affiliation affiliation">Bone and Cartilage Biology</span>; 
    <span class="hlFld-Affiliation affiliation">Drug Metabolism and Pharmacokinetics</span>; 
    <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span>; 
    <span class="hlFld-Affiliation affiliation">NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandra Hoffman</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry</span>; 
    <span class="hlFld-Affiliation affiliation">Bone and Cartilage Biology</span>; 
    <span class="hlFld-Affiliation affiliation">Drug Metabolism and Pharmacokinetics</span>; 
    <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span>; 
    <span class="hlFld-Affiliation affiliation">NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maxine Gowen</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry</span>; 
    <span class="hlFld-Affiliation affiliation">Bone and Cartilage Biology</span>; 
    <span class="hlFld-Affiliation affiliation">Drug Metabolism and Pharmacokinetics</span>; 
    <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span>; 
    <span class="hlFld-Affiliation affiliation">NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric G. DelMar</span> - <span class="hlFld-Affiliation affiliation">NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bradford C. Van Wagenen</span> - <span class="hlFld-Affiliation affiliation">NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sarah Logan</span> - <span class="hlFld-Affiliation affiliation">NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott Shimizu</span> - <span class="hlFld-Affiliation affiliation">NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Fox</span> - <span class="hlFld-Affiliation affiliation">NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edward F. Nemeth</span> - <span class="hlFld-Affiliation affiliation">NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Theresa Roethke</span> - <span class="hlFld-Affiliation affiliation">Drug Metabolism and Pharmacokinetics</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian R. Smith</span> - <span class="hlFld-Affiliation affiliation">Drug Metabolism and Pharmacokinetics</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Keith W. Ward</span> - <span class="hlFld-Affiliation affiliation">Drug Metabolism and Pharmacokinetics</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pradip Bhatnagar</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry</span>; 
    <span class="hlFld-Affiliation affiliation">Bone and Cartilage Biology</span>; 
    <span class="hlFld-Affiliation affiliation">Drug Metabolism and Pharmacokinetics</span>; 
    <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span>; 
    <span class="hlFld-Affiliation affiliation">NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm900563e" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43027" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43027" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Drs. John Gleason and Brian Metcalf for their support of this work.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74477" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74477" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 9 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Bonnick, S. L.</span><span> </span><span class="NLM_article-title">Osteoporosis in men and women</span> <span class="citation_source-journal">Clin. Cornerstone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm900563e&amp;key=10.1016%2FS1098-3597%2806%2980063-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm900563e&amp;key=17591574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A280%3ADC%252BD2sznsF2itQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=28-39&author=S.+L.+Bonnick&title=Osteoporosis+in+men+and+women"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Osteoporosis in men and women</span></div><div class="casAuthors">Bonnick Sydney L</div><div class="citationInfo"><span class="NLM_cas:title">Clinical cornerstone</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-39</span>
        ISSN:<span class="NLM_cas:issn">1098-3597</span>.
    </div><div class="casAbstract">Osteoporosis is a cause of significant morbidity and mortality in postmenopausal women as well as men.  In both men and women, increasing age and low bone mineral density (BMD) are the 2 most important independent risk factors for an initial vertebral or nonvertebral fracture.  Although the prevalence of osteoporosis is greater in women, mortality after fracture is higher among men.  In both men and women, the incidence of vertebral fracture increases with age, although the increase is more marked in women than in men.  The diagnostic criteria for postmenopausal osteoporosis in women are well established; however, there is ongoing debate about the appropriate T-scores and BMD thresholds to diagnose osteoporosis in men.  Alendronate and risedronate are considered first-line therapy for the treatment of both postmenopausal osteoporosis and male osteoporosis.  The efficacy and safety of these agents have been evaluated extensively in randomized clinical trials.  Studies suggest that these agents are similarly efficacious in men and women.  The anabolic agent teriparatide may also be used to treat men with osteoporosis at high risk for fracture.  Studies suggest that treatment with an anabolic agent like teriparatide should be followed by an antiresorptive agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQhRiX7jL_YgfxQvRxYU81tfW6udTcc2eaQUJUSwc00v7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sznsF2itQ%253D%253D&md5=69bc116a3bf51977a75aeb0c19edf634</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS1098-3597%2806%2980063-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1098-3597%252806%252980063-3%26sid%3Dliteratum%253Aachs%26aulast%3DBonnick%26aufirst%3DS.%2BL.%26atitle%3DOsteoporosis%2520in%2520men%2520and%2520women%26jtitle%3DClin.%2520Cornerstone%26date%3D2006%26volume%3D8%26spage%3D28%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_contrib-group">Bodenner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggs, A.</span><span> </span><span class="NLM_article-title">Teriparatide in the management of osteoporosis</span> <span class="citation_source-journal">Clin. Interventions Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">499</span><span class="NLM_x">–</span> <span class="NLM_lpage">507</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm900563e&amp;key=18225450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1ejsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=499-507&author=D.+Bodennerauthor=C.+Redmanauthor=A.+Riggs&title=Teriparatide+in+the+management+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Teriparatide in the management of osteoporosis</span></div><div class="casAuthors">Bodenner, Donald; Redman, Carolyn; Riggs, Ann</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Interventions in Aging</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">499-507</span>CODEN:
                <span class="NLM_cas:coden">CIALBC</span>;
        ISSN:<span class="NLM_cas:issn">1176-9092</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  Fracture of the hip is frequently a catastrophic event in the elderly, often resulting in death within a year and of the survivors, few regain pre-fracture quality of life.  Although less appreciated, fractures of the spine result in significant morbidity and are also assocd. with increased mortality compared with individuals without a fracture.  In recent years there has been an explosion in the development of new drugs for the treatment of osteoporosis.  Recombinant human parathyroid hormone (1-34) (20 μg/day) is a recent addn. to this armamentarium with a novel mechanism of action, which was approved by the US FDA for the treatment of postmenopausal osteoporosis and male osteoporosis secondary to hypogonadism in Nov. 2002.  It is the first osteoporosis treatment that leads to the formation of new bone with architecture similar to normal bone.  Intense efforts have been made to understand the effect of teriparatide on antiresorptive therapy and vice versa.  Although these relationships are not completely understood, the results of recent studies allow clinicians to begin to optimize therapeutic gains in bone mineral d. and improve anti-fracture efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoah_3atunqZbVg90H21EOLACvtfcHk0lgtfrcbxfp_pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1ejsb4%253D&md5=ce7b8894f61d7d67e2e83b9fd03c0520</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBodenner%26aufirst%3DD.%26aulast%3DRedman%26aufirst%3DC.%26aulast%3DRiggs%26aufirst%3DA.%26atitle%3DTeriparatide%2520in%2520the%2520management%2520of%2520osteoporosis%26jtitle%3DClin.%2520Interventions%2520Aging%26date%3D2007%26volume%3D2%26spage%3D499%26epage%3D507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_contrib-group">Bilezikian, J. P.</span><span> </span><span class="NLM_article-title">Anabolic therepy for osteoporosis</span> <span class="citation_source-journal">Women’s Health</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm900563e&amp;key=10.2217%2F17455057.3.2.243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit12qtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=243-253&author=J.+P.+Bilezikian&title=Anabolic+therepy+for+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Anabolic therapy for osteoporosis</span></div><div class="casAuthors">Bilezikian, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Women's Health</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">243-253</span>CODEN:
                <span class="NLM_cas:coden">WHOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1745-5057</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Antiresorptive agents for osteoporosis are a cornerstone of therapy, but anabolic drugs have recently increased our options.  By directly stimulating bone formation, anabolic agents reduce fracture incidence by improving bone qualities as well as increasing bone mass.  The anabolic agent currently approved for osteoporosis, teriparatide (recombinant human parathyroid hormone[1-34]), has emerged as a major approach for selected patients with osteoporosis.  Parathyroid hormone(1-84) is also available in Europe.  Teriparatide increases bone d. and bone turnover, improves microarchitecture and changes bone size.  The incidence of vertebral and nonvertebral fractures is reduced.  A current concept in the mechanism of teriparatide action is related to its effect of stimulating processes assocd. with bone formation before processes assocd. with bone resorption.  This sequence of events has led to the concept of the anabolic window, the period of time when teriparatide is maximally anabolic.  Newer approaches to the use of teriparatide alone and in combination with antiresorptive agents has led to ways in which the anabolic window can be expanded.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKC2jWx9LbarVg90H21EOLACvtfcHk0lgtfrcbxfp_pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit12qtL0%253D&md5=2e26b6931f831f63477e2f9a8d5f2042</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.2217%2F17455057.3.2.243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252F17455057.3.2.243%26sid%3Dliteratum%253Aachs%26aulast%3DBilezikian%26aufirst%3DJ.%2BP.%26atitle%3DAnabolic%2520therepy%2520for%2520osteoporosis%26jtitle%3DWomen%25E2%2580%2599s%2520Health%26date%3D2007%26volume%3D3%26spage%3D243%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2c"><span><span class="NLM_contrib-group">Girotra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilezikian, J. P.</span><span> </span><span class="NLM_article-title">The use of parathyroid hormone in the treatment of osteoporosis</span> <span class="citation_source-journal">Rev. Endocr. Metab. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Fjm900563e&amp;key=10.1007%2Fs11154-006-9007-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Fjm900563e&amp;key=17043762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12lsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=113-121&author=M.+Girotraauthor=M.+R.+Rubinauthor=J.+P.+Bilezikian&title=The+use+of+parathyroid+hormone+in+the+treatment+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The use of parathyroid hormone in the treatment of osteoporosis</span></div><div class="casAuthors">Girotra, Monica; Rubin, Mishaela R.; Bilezikian, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Reviews in Endocrine & Metabolic Disorders</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">113-121</span>CODEN:
                <span class="NLM_cas:coden">REMDCG</span>;
        ISSN:<span class="NLM_cas:issn">1389-9155</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Anabolic skeletal agents have recently broadened our therapeutic options for osteoporosis.  By directly stimulating bone formation, they reduce fracture incidence by improving bone qualities in addn. to increasing bone mass.  Teriparatide [recombinant human parathyroid hormone(1-34)], the only anabolic agent currently approved in the United States for osteoporosis, has emerged as a major therapeutic approach to selected patients with osteoporosis.  Teriparatide is approved for both postmenopausal women and men with osteoporosis who are at high risk for fracture.  With the use of this anabolic agent, bone d. and bone turnover increase, microarchitecture improves, and bone size is beneficially altered.  The incidence of vertebral and nonvertebral fractures is reduced with teriparatide use.  Combination therapy with parathyroid hormone and an antiresorptive does not appear to offer definitive advantages over the use of PTH or an antiresorptive alone, although recent ideas about combining these agents may offer new insights.  In order to maintain increases in bone d. acquired during PTH therapy, it is important to follow its use with an antiresorptive agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgHX2PVm7hELVg90H21EOLACvtfcHk0lgtfrcbxfp_pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12lsg%253D%253D&md5=2c3c9d800f166a7236c3314a6730ad79</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1007%2Fs11154-006-9007-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11154-006-9007-z%26sid%3Dliteratum%253Aachs%26aulast%3DGirotra%26aufirst%3DM.%26aulast%3DRubin%26aufirst%3DM.%2BR.%26aulast%3DBilezikian%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520use%2520of%2520parathyroid%2520hormone%2520in%2520the%2520treatment%2520of%2520osteoporosis%26jtitle%3DRev.%2520Endocr.%2520Metab.%2520Disord.%26date%3D2006%26volume%3D7%26spage%3D113%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2d"><span><span class="NLM_contrib-group">Eriksen, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robins, D. A.</span><span> </span><span class="NLM_article-title">Teriparatide: a bone formation treatment for osteoporosis</span> <span class="citation_source-journal">Drugs Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">935</span><span class="NLM_x">–</span> <span class="NLM_lpage">948</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=16&amp;doi=10.1021%2Fjm900563e&amp;key=10.1358%2Fdot.2004.40.11.872582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVSksbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2004&pages=935-948&author=E.+F.+Eriksenauthor=D.+A.+Robins&title=Teriparatide%3A+a+bone+formation+treatment+for+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2dR"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">TERIPARATIDE: A bone formation treatment for osteoporosis</span></div><div class="casAuthors">Eriksen, Erik F.; Robins, Deborah A.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of Today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">935-948</span>CODEN:
                <span class="NLM_cas:coden">MDACAP</span>;
        ISSN:<span class="NLM_cas:issn">0025-7656</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Teriparatide is the recombinant human N-terminal fragment (1-34) of endogenous human parathyroid hormone, and it is the first bone anabolic agent for the treatment of osteoporosis.  When given as once-daily s.c. injections, teriparatide can reverse the course of osteoporosis by stimulating formation of new bone and restoring lost architecture.  Teriparatide (20 μg) treatment of osteoporosis in postmenopausal women rapidly increased markers of bone formation and reduced the incidence of vertebral fractures by 65% and of nonvertebral fragility fractures by 53%.  In addn., treatment with this compd. increased spine bone mineral d. by 10% and hip bone mineral d. by 3% at study endpoint.  Teriparatide is well tolerated and is not assocd. with any serious side effects.  The compd. has been approved in Europe and in the US for the treatment of osteoporosis.  Duration of treatment is 18-24 mo and the dose does not need to be adjusted for age or gender.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1JIdWJtTLw7Vg90H21EOLACvtfcHk0lg_CJxEoDcwOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVSksbs%253D&md5=636570477d27ee584bc02ce954ecee68</span></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=10.1358%2Fdot.2004.40.11.872582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdot.2004.40.11.872582%26sid%3Dliteratum%253Aachs%26aulast%3DEriksen%26aufirst%3DE.%2BF.%26aulast%3DRobins%26aufirst%3DD.%2BA.%26atitle%3DTeriparatide%253A%2520a%2520bone%2520formation%2520treatment%2520for%2520osteoporosis%26jtitle%3DDrugs%2520Today%26date%3D2004%26volume%3D40%26spage%3D935%26epage%3D948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2e"><span><span class="NLM_contrib-group">Quattrocchi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kourlas, H.</span><span> </span><span class="NLM_article-title">Teriparaitide: a review</span> <span class="citation_source-journal">Clin. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">841</span><span class="NLM_x">–</span> <span class="NLM_lpage">854</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2e&amp;dbid=16&amp;doi=10.1021%2Fjm900563e&amp;key=10.1016%2FS0149-2918%2804%2990128-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2e&amp;dbid=8&amp;doi=10.1021%2Fjm900563e&amp;key=15262455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2e&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsVSisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2004&pages=841-854&author=E.+Quattrocchiauthor=H.+Kourlas&title=Teriparaitide%3A+a+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2eR"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Teriparatide: a review</span></div><div class="casAuthors">Quattrocchi, Elaena; Kourlas, Helen</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">841-854</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review.  Traditionally, the management of osteoporosis in men and women has included the use of antiresorptive agents in combination with calcium and vitamin D supplementation.  The mechanism of action of teriparatide is unique in that it possesses anabolic properties and therefore builds bone.  Since the approval of teriparatide in the United States in 2002, a great deal of interest regarding its use in osteoporosis has developed.  This article reviews the information available on the new recombinant human parathyroid hormone teriparatide (hPTH [1-34]), including its clin. pharmacol., mechanism of action, pharmacokinetic properties, clin. efficacy, safety profile, potential drug interactions, contraindications and warnings, dosage and administration, and pharmacoeconomics.  The articles included in this review were identified through searches of PubMed and MEDLINE (1966-Dec. 2003) and International Pharmaceutical Abstrs. (1970-Dec. 2003).  Search terms included teriparatide, Forteo, recombinant human parathyroid hormone (1-34), and osteoporosis.  The refs. of the identified articles were reviewed for addnl. publications.  Specific product information was also obtained from the manufacturer of teriparatide.  Teriparatide has been studied in postmenopausal women with osteoporosis, drug-induced osteoporosis (specifically, corticosteroid-induced osteoporosis), and men with osteoporosis.  The data available from various clin. trials have shown an increase in both bone mineral d. (BMD) and bone mineral content (BMC) with the use of teriparatide compared with placebo.  One study found that women treated with the 20-μg dose and the 40-μg dose were 35% and 40%, resp., less likely to have one or more new nonvertebral fractures compared with placebo (P = 0.02).  Another study compared the use of daily teriparatide 40-μg injections vs. oral daily alendronate.  Results showed that the incidence of nonvertebral fractures was significantly lower in the teriparatide group than the alendronate group (P < 0.05).  A study using 20- and 40-μg daily injections of teriparatide was performed in men with osteoporosis.  There was a statistically significant increase in lumbar spine BMD of 5.9% in the 20-μg group and 9.0% in the 40-μg group (both, P < 0.001).  In the femoral neck, a 1.5% increase in BMD occurred in the 20-μg group (P = 0.021) and a 0.9% increase in the 40-μg group (P < 0.001).  A limited no. of studies are available assessing the combination of antiresorptive medications and teriparatide; however, the available data suggest that the effects of teriparatide do not require prior stimulation of bone resorption.  Teriparatide has been shown clin. to improve BMD and BMC in postmenopausal women and in men.  Because of its anabolic capabilities, teriparatide can be used as an alternative to the traditional therapies that are currently available for the treatment of osteoporosis, with scheduled monitoring for adverse effects such as hypercalcemia and urinary calcium excretion.  In 1 study, mild hypercalcemia was seen most often 4 to 6 h after SC injection of teriparatide before returning to normal.  Urinary, calcium was obsd. to increase by 30 mg/d (0.75 mmol/d) with teriparatide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYd_uzd7xHu7Vg90H21EOLACvtfcHk0lg_CJxEoDcwOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsVSisrc%253D&md5=d8ee703da34c306140d2278bd46ebcda</span></div><a href="/servlet/linkout?suffix=cit2e&amp;dbid=16384&amp;doi=10.1016%2FS0149-2918%2804%2990128-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0149-2918%252804%252990128-2%26sid%3Dliteratum%253Aachs%26aulast%3DQuattrocchi%26aufirst%3DE.%26aulast%3DKourlas%26aufirst%3DH.%26atitle%3DTeriparaitide%253A%2520a%2520review%26jtitle%3DClin.%2520Ther.%26date%3D2004%26volume%3D26%26spage%3D841%26epage%3D854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2f"><span><span class="NLM_contrib-group">Dobnig, H.</span><span> </span><span class="NLM_article-title">A review of teriparatide and its clinical efficacy in the treatment of osteoporosis</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">710</span><span class="NLM_x">–</span> <span class="NLM_lpage">718</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2003&pages=710-718&author=H.+Dobnig&title=A+review+of+teriparatide+and+its+clinical+efficacy+in+the+treatment+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDobnig%26aufirst%3DH.%26atitle%3DA%2520review%2520of%2520teriparatide%2520and%2520its%2520clinical%2520efficacy%2520in%2520the%2520treatment%2520of%2520osteoporosis%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2003%26volume%3D57%26spage%3D710%26epage%3D718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2g"><span><span class="NLM_contrib-group">Ebling, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, R. G. G.</span><span> </span><span class="NLM_article-title">Teriparaitide (rhPTH1-34) for the treatment of osteoporosis</span> <span class="citation_source-journal">Int. J. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">710</span><span class="NLM_x">–</span> <span class="NLM_lpage">718</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2g&amp;dbid=8&amp;doi=10.1021%2Fjm900563e&amp;key=14627183" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2003&pages=710-718&author=P.+R.+Eblingauthor=R.+G.+G.+Russell&title=Teriparaitide+%28rhPTH1-34%29+for+the+treatment+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEbling%26aufirst%3DP.%2BR.%26aulast%3DRussell%26aufirst%3DR.%2BG.%2BG.%26atitle%3DTeriparaitide%2520%2528rhPTH1-34%2529%2520for%2520the%2520treatment%2520of%2520osteoporosis%26jtitle%3DInt.%2520J.%2520Clin.%2520Pract.%26date%3D2003%26volume%3D57%26spage%3D710%26epage%3D718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2h"><span><span class="NLM_contrib-group">Berg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumeyer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, P.</span><span> </span><span class="NLM_article-title">Fresh from the pipline: teriparatide</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=257-258&author=C.+Bergauthor=K.+Neumeyerauthor=P.+Kirkpatrick&title=Fresh+from+the+pipline%3A+teriparatide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DC.%26aulast%3DNeumeyer%26aufirst%3DK.%26aulast%3DKirkpatrick%26aufirst%3DP.%26atitle%3DFresh%2520from%2520the%2520pipline%253A%2520teriparatide%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D257%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_contrib-group">Brown, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLeod, R. J.</span><span> </span><span class="NLM_article-title">Extracellular calcium sensing and extracellular calcium signaling</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm900563e&amp;key=10.1152%2Fphysrev.2001.81.1.239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm900563e&amp;key=11152759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitV2ktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2001&pages=239-297&author=E.+M.+Brownauthor=R.+J.+MacLeod&title=Extracellular+calcium+sensing+and+extracellular+calcium+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Extracellular calcium sensing and extracellular calcium signaling</span></div><div class="casAuthors">Brown, Edward M.; MacLeod, R. John</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">239-297</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review, with 481 refs.  The cloning of a G protein-coupled extracellular Ca2+ (Cao2+)-sensing receptor (CaR) has elucidated the mol. basis for many of the previously recognized effects of Cao2+ on tissues that maintain systemic Cao2+ homeostasis, esp. parathyroid chief cells and several cells in the kidney.  The availability of the cloned CaR enabled the development of DNA and antibody probes for identifying the CaR's mRNA and protein, resp., within these and other tissues.  It also permitted the identification of human diseases resulting from inactivating or activating mutations of the CaR gene and the subsequent generation of mice with targeted disruption of the CaR gene.  The characteristic alterations in parathyroid and renal function in these patients and in the mice with knockout of the CaR gene have provided valuable information on the CaR's physiol. roles in these tissues participating in mineral ion homeostasis.  Nevertheless, relatively little is known about how the CaR regulates other tissues involved in systemic Cao2+ homeostasis, particularly bone and intestine.  Moreover, there is evidence that addnl. Cao2+ sensors may exist in bone cells that mediate some or even all of the known effects of Cao2+ on these cells.  Even more remains to be learned about the CaR's function in the rapidly growing list of cells that express it but are uninvolved in systemic Cao2+ metab.  Available data suggest that the receptor serves numerous roles outside of systemic mineral ion homeostasis, ranging from the regulation of hormonal secretion and the activities of various ion channels to the longer term control of gene expression, programmed cell death (apoptosis), and cellular proliferation.  In some cases, the CaR on these non-homeostatic cells responds to local changes in Cao2+ taking place within compartments of the extracellular fluid (ECF) that communicate with the outside environment (e.g., the gastrointestinal tract).  In others, localized changes in Cao2+ within the ECF can originate from several mechanisms, including fluxes of calcium ions into or out of cellular or extracellular stores or across epithelium that absorb or secrete Ca2+.  In any event, the CaR and other receptors/sensors for Cao2+ and probably for other extracellular ions represent versatile regulators of numerous cellular functions and may serve as important therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6uGVgKVIQybVg90H21EOLACvtfcHk0lg_CJxEoDcwOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitV2ktLo%253D&md5=bdaf576fbde7255da389eb9fa0d84823</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.2001.81.1.239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.2001.81.1.239%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DE.%2BM.%26aulast%3DMacLeod%26aufirst%3DR.%2BJ.%26atitle%3DExtracellular%2520calcium%2520sensing%2520and%2520extracellular%2520calcium%2520signaling%26jtitle%3DPhysiol.%2520Rev.%26date%3D2001%26volume%3D81%26spage%3D239%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_contrib-group">Nemeth, E. F.</span><span> </span><span class="NLM_article-title">Calcium receptor-dependent regulation of cellular functions</span> <span class="citation_source-journal">News Physiol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">5</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADyaK2MXkslequ7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1995&pages=1-5&author=E.+F.+Nemeth&title=Calcium+receptor-dependent+regulation+of+cellular+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Ca2+ receptor-dependent regulation of cellular functions</span></div><div class="casAuthors">Nemeth, Edward F.</div><div class="citationInfo"><span class="NLM_cas:title">News in Physiological Sciences</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">Feb.</span>),
    <span class="NLM_cas:pages">1-5</span>CODEN:
                <span class="NLM_cas:coden">NEPSEY</span>;
        ISSN:<span class="NLM_cas:issn">0886-1714</span>.
    </div><div class="casAbstract">A review, with 15 refs.  A cell-surface Ca2+ receptor enables parathyroid cells to detect and respond to extracellular Ca2+.  The recent cloning of a G protein-coupled Ca2+ receptor solidifies this view.  Ca2+ receptors regulate the activity of various cells and provide novel mol. targets for new pharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmAYKq3zbA7LVg90H21EOLACvtfcHk0ljzaB6yoAb8vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXkslequ7g%253D&md5=5c0358f59bb52230ca313049fa647144</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26atitle%3DCalcium%2520receptor-dependent%2520regulation%2520of%2520cellular%2520functions%26jtitle%3DNews%2520Physiol.%2520Sci.%26date%3D1995%26volume%3D10%26spage%3D1%26epage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_contrib-group">Brown, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLeod, R. J.</span><span> </span><span class="NLM_article-title">Extracellular calcium sensing and extracellular calcium signaling</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Fjm900563e&amp;key=10.1152%2Fphysrev.2001.81.1.239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Fjm900563e&amp;key=11152759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitV2ktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2001&pages=239-297&author=E.+M.+Brownauthor=R.+J.+MacLeod&title=Extracellular+calcium+sensing+and+extracellular+calcium+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Extracellular calcium sensing and extracellular calcium signaling</span></div><div class="casAuthors">Brown, Edward M.; MacLeod, R. John</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">239-297</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review, with 481 refs.  The cloning of a G protein-coupled extracellular Ca2+ (Cao2+)-sensing receptor (CaR) has elucidated the mol. basis for many of the previously recognized effects of Cao2+ on tissues that maintain systemic Cao2+ homeostasis, esp. parathyroid chief cells and several cells in the kidney.  The availability of the cloned CaR enabled the development of DNA and antibody probes for identifying the CaR's mRNA and protein, resp., within these and other tissues.  It also permitted the identification of human diseases resulting from inactivating or activating mutations of the CaR gene and the subsequent generation of mice with targeted disruption of the CaR gene.  The characteristic alterations in parathyroid and renal function in these patients and in the mice with knockout of the CaR gene have provided valuable information on the CaR's physiol. roles in these tissues participating in mineral ion homeostasis.  Nevertheless, relatively little is known about how the CaR regulates other tissues involved in systemic Cao2+ homeostasis, particularly bone and intestine.  Moreover, there is evidence that addnl. Cao2+ sensors may exist in bone cells that mediate some or even all of the known effects of Cao2+ on these cells.  Even more remains to be learned about the CaR's function in the rapidly growing list of cells that express it but are uninvolved in systemic Cao2+ metab.  Available data suggest that the receptor serves numerous roles outside of systemic mineral ion homeostasis, ranging from the regulation of hormonal secretion and the activities of various ion channels to the longer term control of gene expression, programmed cell death (apoptosis), and cellular proliferation.  In some cases, the CaR on these non-homeostatic cells responds to local changes in Cao2+ taking place within compartments of the extracellular fluid (ECF) that communicate with the outside environment (e.g., the gastrointestinal tract).  In others, localized changes in Cao2+ within the ECF can originate from several mechanisms, including fluxes of calcium ions into or out of cellular or extracellular stores or across epithelium that absorb or secrete Ca2+.  In any event, the CaR and other receptors/sensors for Cao2+ and probably for other extracellular ions represent versatile regulators of numerous cellular functions and may serve as important therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6uGVgKVIQybVg90H21EOLACvtfcHk0ljzaB6yoAb8vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitV2ktLo%253D&md5=bdaf576fbde7255da389eb9fa0d84823</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.2001.81.1.239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.2001.81.1.239%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DE.%2BM.%26aulast%3DMacLeod%26aufirst%3DR.%2BJ.%26atitle%3DExtracellular%2520calcium%2520sensing%2520and%2520extracellular%2520calcium%2520signaling%26jtitle%3DPhysiol.%2520Rev.%26date%3D2001%26volume%3D81%26spage%3D239%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3d"><span><span class="NLM_contrib-group">Chen, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, W. G.</span><span> </span><span class="NLM_article-title">Role of the calcium-sensing receptor in parathyroid gland physiology</span> <span class="citation_source-journal">Am. J. Physiol.: Renal Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">F1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">F1011</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2004&pages=F1005-F1011&author=R.+A.+Chenauthor=W.+G.+Goodman&title=Role+of+the+calcium-sensing+receptor+in+parathyroid+gland+physiology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DR.%2BA.%26aulast%3DGoodman%26aufirst%3DW.%2BG.%26atitle%3DRole%2520of%2520the%2520calcium-sensing%2520receptor%2520in%2520parathyroid%2520gland%2520physiology%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Renal%2520Physiol.%26date%3D2004%26volume%3D286%26spage%3DF1005%26epage%3DF1011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3e"><span><span class="NLM_contrib-group">Tfelt-Hansen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, E. M.</span><span> </span><span class="NLM_article-title">The calcium-sensing receptor in normal physiology and pathophysiology: a review</span> <span class="citation_source-journal">Crit. Rev. Clin. Lab. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3e&amp;dbid=16&amp;doi=10.1021%2Fjm900563e&amp;key=10.1080%2F10408360590886606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3e&amp;dbid=8&amp;doi=10.1021%2Fjm900563e&amp;key=15697170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3e&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFSnsbrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2005&pages=35-70&author=J.+Tfelt-Hansenauthor=E.+M.+Brown&title=The+calcium-sensing+receptor+in+normal+physiology+and+pathophysiology%3A+a+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3eR"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The Calcium-Sensing Receptor in Normal Physiology and Pathophysiology: A Review</span></div><div class="casAuthors">Tfelt-Hansen, Jacob; Brown, Edward</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Clinical Laboratory Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-70</span>CODEN:
                <span class="NLM_cas:coden">CRCLBH</span>;
        ISSN:<span class="NLM_cas:issn">1040-8363</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A review.  The discovery of a G protein-coupled, calcium-sensing receptor (CaR) a decade ago and of diseases caused by CaR mutations provided unquestionable evidence of the CaR's crit. role in the maintenance of systemic calcium homeostasis.  On the cell membrane of the chief cells of the parathyroid glands, the CaR "senses" the extracellular calcium concn. and, subsequently, alters the release of parathyroid hormone (PTH).  The CaR is likewise functionally expressed in bone, kidney, and gut-the three major calcium-translocating organs involved in calcium homeostasis.  Intracellular signal pathways to which the CaR couples via its assocd. G proteins include phospholipase C (PLC), protein kinase B (AKT); and mitogen-activated protein kinases (MAPKs).  The receptor is widely expressed in various tissues and regulates important cellular functions in addn. to its role in maintaining systemic calcium homeostasis, i.e., protection against apoptosis, cellular proliferation, and membrane voltage.  Functionally significant mutations in the receptor have been shown to induce diseases of calcium homeostasis owing to changes in the set point for calcium-regulated PTH release as well as alterations in the renal handling of calcium.  Gain-of-function mutations cause hypocalcemia, whereas loss-of-function mutations produce hypercalcemia.  Recent studies have shown that the latter clin. presentation can also be caused by inactivating autoantibodies directed against the CaR.  Newly discovered type II allosteric activators of the CaR have been found to be effective as a medical treatment for renal secondary hyperparathyroidism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoguMPL6ZwnCrVg90H21EOLACvtfcHk0ljzaB6yoAb8vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFSnsbrE&md5=341363042e4477a3c4e35bba0395b201</span></div><a href="/servlet/linkout?suffix=cit3e&amp;dbid=16384&amp;doi=10.1080%2F10408360590886606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10408360590886606%26sid%3Dliteratum%253Aachs%26aulast%3DTfelt-Hansen%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DE.%2BM.%26atitle%3DThe%2520calcium-sensing%2520receptor%2520in%2520normal%2520physiology%2520and%2520pathophysiology%253A%2520a%2520review%26jtitle%3DCrit.%2520Rev.%2520Clin.%2520Lab.%2520Sci.%26date%3D2005%26volume%3D42%26spage%3D35%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_contrib-group">Locatelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pontoriero, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limbardo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tentori, F.</span><span> </span><span class="NLM_article-title">Cinacalcet hydrochloride: calcimimnetic for the treatment of hyperparathyroidism</span> <span class="citation_source-journal">Expert Opin. Endocr. Metabol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm900563e&amp;key=10.1586%2F17446651.1.2.167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsVyjtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=167-179&author=F.+Locatelliauthor=G.+Pontorieroauthor=M.+Limbardoauthor=F.+Tentori&title=Cinacalcet+hydrochloride%3A+calcimimnetic+for+the+treatment+of+hyperparathyroidism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cinacalcet hydrochloride: calcimimetic for the treatment of hyperparathyroidism</span></div><div class="casAuthors">Locatelli, Francesco; Pontoriero, Giuseppe; Limardo, Monica; Tentori, Flavia</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Endocrinology & Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-179</span>CODEN:
                <span class="NLM_cas:coden">EREMBI</span>;
        ISSN:<span class="NLM_cas:issn">1744-6651</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Mineral metab. disorders, including those related to secondary hyperparathyroidism, affect a large no. of patients with chronic kidney disease and are assocd. with increased relative risk of morbidity and mortality in hemodialysis patients.  The traditional therapy of secondary hyperparathyroidism based on vitamin D compds. and calcium-based phosphate binders is often limited by the increase of serum calcium and phosphorus levels limiting the dose that can be given safely, and thus, preventing the attainment of treatment targets.  Cinacalcet hydrochloride (Sensipar, Mimpara, Parareg) is the first in a new class of therapeutic agents, the calcimimetics, that increase the sensitivity of calcium-sensing receptors to the extracellular calcium ions, thus lowering parathyroid hormone prodn. and release, decreasing serum calcium and phosphorous concns. simultaneously.  Different randomized, double-blind, placebo-controlled trials evaluated the safety and ability of cinacalcet hydrochloride treatment to improve achievement of target levels of parathyroid hormone, calcium, phosphorus and calcium phosphorus product in dialysis patients.  Cinacalcet hydrochloride has also demonstrated to be effective in reducing parathyroid hormone and serum calcium concns. in patients with primary hyperparathyroidism.  On the basis of available data, calcimimetics represent an important innovation and will change the management of mineral metab. disorders in patients with chronic kidney disease and primary hyperparathyroidism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqokYx_j51YkLVg90H21EOLACvtfcHk0lj3uEmkP9DlAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsVyjtLg%253D&md5=1f846e815b348b14531f5232dd19b37a</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1586%2F17446651.1.2.167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F17446651.1.2.167%26sid%3Dliteratum%253Aachs%26aulast%3DLocatelli%26aufirst%3DF.%26aulast%3DPontoriero%26aufirst%3DG.%26aulast%3DLimbardo%26aufirst%3DM.%26aulast%3DTentori%26aufirst%3DF.%26atitle%3DCinacalcet%2520hydrochloride%253A%2520calcimimnetic%2520for%2520the%2520treatment%2520of%2520hyperparathyroidism%26jtitle%3DExpert%2520Opin.%2520Endocr.%2520Metabol.%26date%3D2006%26volume%3D1%26spage%3D167%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_contrib-group">Dong, B. J.</span><span> </span><span class="NLM_article-title">Cinacalcet: an oral calcimimetic agent for the management of hyperparathyroidism</span> <span class="citation_source-journal">Clin. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1725</span><span class="NLM_x">–</span> <span class="NLM_lpage">1751</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm900563e&amp;key=10.1016%2Fj.clinthera.2005.11.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm900563e&amp;key=16368445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADC%252BD28XntlWnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2005&pages=1725-1751&author=B.+J.+Dong&title=Cinacalcet%3A+an+oral+calcimimetic+agent+for+the+management+of+hyperparathyroidism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cinacalcet: an oral calcimimetic agent for the management of hyperparathyroidism</span></div><div class="casAuthors">Dong, Betty J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1725-1751</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review.  Uncontrolled hyperparathyroidism (HPT), particularly HPT resulting from chronic kidney disease (CKD), is assocd. with significant morbidity and cardiovascular mortality.  Traditional medical therapy (eg, vitamin D sterols, calcium, phosphate binders) has been inadequate for the management of HPT and its vascular and skeletal complications.  The goal of this article was to review the efficacy and safety profile of cinacalcet, a second-generation calcimimetic, in the management of HPT secondary to CKD, primary HPT, and parathyroid carcinoma.  MEDLINE, Web of Science, and International Pharmaceutical Abstrs. were searched from 1995 to July 2005 using the terms cinacalcet, AMG 073, KRN 1493, calcimimetics, hypercalcemia, and hyperparathyroidism.  Compared with placebo, cinacalcet significantly reduced parathyroid hormone levels within 2 to 4 h after administration (P < 0.05).  In Phase III trials involving 1136 patients with secondary HPT, 56% of those who received cinacalcet achieved the National Kidney Foundation Kidney Disease Outcomes Quality Initiative target of a redn. in parathyroid hormone to <300 pg/mL, 65% achieved a calcium-phosphorus product <55 mg2/dL2, and a resp. 49% and 46% achieved normalized serum calcium and phosphorus levels (P < 0.001).  Cinacalcet's effects were similar regardless of patients' demog. characteristics, duration or mode of dialysis, severity of HPT, or use of concomitant medical therapy.  Preliminary evidence suggests that cinacalcet may reverse cortical bone loss.  Cinacalcet was well tolerated, with nausea (31%) and vomiting (27%) being the most commonly reported adverse effects.  Hypocalcemia was transient in 5% of patients, was usually asymptomatic, and was cor. by dose redn.  Based on the available evidence, cinacalcet is effective and well tolerated in the treatment of secondary HPT and refractory parathyroid carcinoma.  Its use in primary HPT appears promising.  Further investigations are needed to det. if cinacalcet can prevent the long-term complications of HPT and reduce mortality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpua2ISxtUru7Vg90H21EOLACvtfcHk0lj3uEmkP9DlAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntlWnuw%253D%253D&md5=fb128fa6543bc3e7dd33c05892a5979c</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1016%2Fj.clinthera.2005.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinthera.2005.11.015%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DB.%2BJ.%26atitle%3DCinacalcet%253A%2520an%2520oral%2520calcimimetic%2520agent%2520for%2520the%2520management%2520of%2520hyperparathyroidism%26jtitle%3DClin.%2520Ther.%26date%3D2005%26volume%3D27%26spage%3D1725%26epage%3D1751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_contrib-group">de Francisco, A. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cinacalcet, H. C. L.</span><span> </span><span class="NLM_article-title">A novel therapeutic for the treatment of hyperparathyroidism</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">452</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Fjm900563e&amp;key=10.1517%2F14656566.6.3.441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Fjm900563e&amp;key=15794735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVyrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=441-452&author=A.+L.+M.+de+Franciscoauthor=H.+C.+L.+Cinacalcet&title=A+novel+therapeutic+for+the+treatment+of+hyperparathyroidism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cinacalcet HCl: A novel therapeutic for hyperparathyroidism</span></div><div class="casAuthors">de Francisco, Angel L. M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">441-452</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Hyperparathyroidism (HPT) is a significant clin. concern for patients with a variety of diseases, notably the secondary HPT assocd. with chronic kidney disease requiring dialysis.  Secondary HPT is assocd. with elevated parathyroid hormone (PTH) levels, decreased levels of 1,25 dihydroxyvitamin D, and disordered mineral levels (usually high calcium and phosphorus).  If not controlled, secondary HPT can result in bone disease, vascular calcification, and ultimately, patient mortality.  Established, conventional therapies, such as 1,25 dihydroxyvitamin D analogs (vitamin D analogs) and phosphate binders, have proven to be inadequate in enabling patients to meet the National Kidney Foundation's-Kidney Disease Outcomes Quality Initiative (NKF-K/DOQI) treatment goals for PTH, calcium and phosphorus levels.  A novel therapeutic, cinacalcet HCl (formerly AMG 073; Sensipar in the US and Mimpara in Europe; Amgen, Inc.), binds directly to the calcium-sensing receptor (CaR) on the cells of the parathyroid gland, increasing the receptor's sensitivity to calcium and reducing PTH, serum calcium and phosphorus levels.  Treatment with cinacalcet in clin. trials has safely and effectively improved achievement of the NKF-K/DOQI goals.  Cinacalcet has also reduced serum calcium levels in patients with primary HPT, including parathyroid carcinoma, in the clin. trial setting.  Evidence suggesting the utility of cinacalcet in these diseases and the potential for addnl. therapeutic applications will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotj4JefW4n8rVg90H21EOLACvtfcHk0lj3uEmkP9DlAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVyrtr0%253D&md5=6047d3cacc2148532f4d737c9c0c8cfc</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1517%2F14656566.6.3.441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.6.3.441%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BFrancisco%26aufirst%3DA.%2BL.%2BM.%26aulast%3DCinacalcet%26aufirst%3DH.%2BC.%2BL.%26atitle%3DA%2520novel%2520therapeutic%2520for%2520the%2520treatment%2520of%2520hyperparathyroidism%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2005%26volume%3D6%26spage%3D441%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delmar, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleason, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span> </span><span class="NLM_article-title">Calcilytic compounds: potent and selective Ca<sup>+2</sup> receptor antagonists that stimulate secretion of parathyroid hormone</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm900563e&amp;key=11561095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntFWltbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2001&pages=323-331&author=E.+F.+Nemethauthor=E.+C.+Delmarauthor=W.+L.+Heatonauthor=M.+A.+Millerauthor=L.+D.+Lambertauthor=R.+L.+Conklinauthor=M.+Gowenauthor=J.+G.+Gleasonauthor=P.+K.+Bhatnagarauthor=J.+Fox&title=Calcilytic+compounds%3A+potent+and+selective+Ca%2B2+receptor+antagonists+that+stimulate+secretion+of+parathyroid+hormone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Calcilytic compounds: potent and selective Ca2+ receptor antagonists that stimulate secretion of parathyroid hormone</span></div><div class="casAuthors">Nemeth, Edward F.; Delmar, Eric G.; Heaton, William L.; Miller, Michael A.; Lambert, Lyssa D.; Conklin, Rebecca L.; Gowen, Maxine; Gleason, John G.; Bhatnagar, Pradip K.; Fox, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">323-331</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Despite the discovery of many ions and mols. that activate the Ca2+ receptor, there are no known ligands that block this receptor.  Reported here are the pharmacodynamic properties of a small mol., NPS 2143, which acts as an antagonist at the Ca2+ receptor.  This compd. blocked (IC50 of 43 nM) increases in cytoplasmic Ca2+ concns. [Ca2+]i elicited by activating the Ca2+ receptor in HEK 293 cells expressing the human Ca2+ receptor.  NPS 2143, even when tested at much higher concns. (3 μM), did not affect the activity of a no. of other G protein-coupled receptors, including those most structurally homologous to the Ca2+ receptor.  NPS 2143 stimulated parathyroid hormone (PTH) secretion from bovine parathyroid cells (EC50 of 41 nM) over a range of extracellular Ca2+ concns. and reversed the effects of the calcimimetic compd. NPS R-467 on [Ca2+]i and on secretion of PTH.  When infused i.v. in normal rats, NPS 2143 caused a rapid and large increase in plasma levels of PTH.  Ca2+ receptor antagonists are termed calcilytics and NPS 2143 is the first substance (either at. or mol.) shown to possess such activity.  The pharmacodynamic properties of NPS 2143 together with the recently demonstrated effects of this compd. on bone formation support the view that orally active calcilytic compds. might provide a novel anabolic therapy for osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5irxzzwLOvbVg90H21EOLACvtfcHk0lh0EC8IcYY1gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntFWltbk%253D&md5=14cedbe167bc3f0de96cec16d9ce73b4</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DDelmar%26aufirst%3DE.%2BC.%26aulast%3DHeaton%26aufirst%3DW.%2BL.%26aulast%3DMiller%26aufirst%3DM.%2BA.%26aulast%3DLambert%26aufirst%3DL.%2BD.%26aulast%3DConklin%26aufirst%3DR.%2BL.%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DGleason%26aufirst%3DJ.%2BG.%26aulast%3DBhatnagar%26aufirst%3DP.%2BK.%26aulast%3DFox%26aufirst%3DJ.%26atitle%3DCalcilytic%2520compounds%253A%2520potent%2520and%2520selective%2520Ca%252B2%2520receptor%2520antagonists%2520that%2520stimulate%2520secretion%2520of%2520parathyroid%2520hormone%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D299%26spage%3D323%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroup, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodds, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Votta, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lago, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Mar, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span> </span><span class="NLM_article-title">Antagonizing the parathyroid calcium receptor stimulates parathyroid secretion and bone formation in osteopenic rats</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">1595</span><span class="NLM_x">–</span> <span class="NLM_lpage">1604</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2000&pages=1595-1604&author=M.+Gowenauthor=G.+B.+Stroupauthor=R.+A.+Doddsauthor=I.+E.+Jamesauthor=B.+J.+Vottaauthor=B.+R.+Smithauthor=P.+K.+Bhatnagarauthor=A.+M.+Lagoauthor=J.+F.+Callahanauthor=E.+G.+Del+Marauthor=M.+A.+Millerauthor=E.+F.+Nemethauthor=J.+Fox&title=Antagonizing+the+parathyroid+calcium+receptor+stimulates+parathyroid+secretion+and+bone+formation+in+osteopenic+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DStroup%26aufirst%3DG.%2BB.%26aulast%3DDodds%26aufirst%3DR.%2BA.%26aulast%3DJames%26aufirst%3DI.%2BE.%26aulast%3DVotta%26aufirst%3DB.%2BJ.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DBhatnagar%26aufirst%3DP.%2BK.%26aulast%3DLago%26aufirst%3DA.%2BM.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DDel%2BMar%26aufirst%3DE.%2BG.%26aulast%3DMiller%26aufirst%3DM.%2BA.%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DFox%26aufirst%3DJ.%26atitle%3DAntagonizing%2520the%2520parathyroid%2520calcium%2520receptor%2520stimulates%2520parathyroid%2520secretion%2520and%2520bone%2520formation%2520in%2520osteopenic%2520rats%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2000%26volume%3D105%26spage%3D1595%26epage%3D1604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_contrib-group">Arey, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swartz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, J. K.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feyen, J. H. M.</span><span> </span><span class="NLM_article-title">A novel calcium-sensing receptor antagonist transiently stimulates parathyroid hormone secretion in vivo</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1131</span><span class="NLM_x">–</span> <span class="NLM_lpage">1136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1131-1136&author=B.+J.+Areyauthor=R.+Seethalaauthor=Z.+Maauthor=A.+Furaauthor=J.+Morinauthor=J.+Swartzauthor=V.+Vyasauthor=W.+Yangauthor=J.+K.+Dicksonauthor=J.+H.+M.+Feyen&title=A+novel+calcium-sensing+receptor+antagonist+transiently+stimulates+parathyroid+hormone+secretion+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArey%26aufirst%3DB.%2BJ.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DMorin%26aufirst%3DJ.%26aulast%3DSwartz%26aufirst%3DJ.%26aulast%3DVyas%26aufirst%3DV.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DDickson%26aufirst%3DJ.%2BK.%26aulast%3DFeyen%26aufirst%3DJ.%2BH.%2BM.%26atitle%3DA%2520novel%2520calcium-sensing%2520receptor%2520antagonist%2520transiently%2520stimulates%2520parathyroid%2520hormone%2520secretion%2520in%2520vivo%26jtitle%3DEndocrinology%26date%3D2005%26volume%3D5%26spage%3D1131%26epage%3D1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5d"><span><span class="NLM_contrib-group">Dauban, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, R. H.</span><span> </span><span class="NLM_article-title"><i>N</i><sup>1</sup>-Arylsulfonyl-<i>N</i><sup>2</sup>-(1-aryl)ethyl-3-phenylpropane-1,2-diamines as novel calcimimetics acting on the calcium sensing receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2001</span><span class="NLM_x">–</span> <span class="NLM_lpage">2004</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=2001-2004&author=P.+Daubanauthor=S.+Ferryauthor=H.+Faureauthor=M.+Ruatauthor=R.+H.+Dodd&title=N1-Arylsulfonyl-N2-%281-aryl%29ethyl-3-phenylpropane-1%2C2-diamines+as+novel+calcimimetics+acting+on+the+calcium+sensing+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDauban%26aufirst%3DP.%26aulast%3DFerry%26aufirst%3DS.%26aulast%3DFaure%26aufirst%3DH.%26aulast%3DRuat%26aufirst%3DM.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26atitle%3DN1-Arylsulfonyl-N2-%25281-aryl%2529ethyl-3-phenylpropane-1%252C2-diamines%2520as%2520novel%2520calcimimetics%2520acting%2520on%2520the%2520calcium%2520sensing%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D2001%26epage%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5e"><span><span class="NLM_contrib-group">Kessler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauban, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, R. H.</span><span> </span><span class="NLM_article-title"><i>N</i><sup>2</sup>-Benzyl-<i>N</i><sup>1</sup>-(1-(1-naphthyl)ethyl)-3-phenylpropane-1,2-diamines and conformationally constrained indole analogues: development of calindol as a new calcimimetic acting at the calcium-sensing receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3345</span><span class="NLM_x">–</span> <span class="NLM_lpage">3349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3345-3349&author=A.+Kesslerauthor=H.+Faureauthor=M.+Ruatauthor=P.+Daubanauthor=R.+H.+Dodd&title=N2-Benzyl-N1-%281-%281-naphthyl%29ethyl%29-3-phenylpropane-1%2C2-diamines+and+conformationally+constrained+indole+analogues%3A+development+of+calindol+as+a+new+calcimimetic+acting+at+the+calcium-sensing+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKessler%26aufirst%3DA.%26aulast%3DFaure%26aufirst%3DH.%26aulast%3DRuat%26aufirst%3DM.%26aulast%3DDauban%26aufirst%3DP.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26atitle%3DN2-Benzyl-N1-%25281-%25281-naphthyl%2529ethyl%2529-3-phenylpropane-1%252C2-diamines%2520and%2520conformationally%2520constrained%2520indole%2520analogues%253A%2520development%2520of%2520calindol%2520as%2520a%2520new%2520calcimimetic%2520acting%2520at%2520the%2520calcium-sensing%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3345%26epage%3D3349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5f"><span><span class="NLM_contrib-group">Kessler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roussanne, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauben, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, R. H.</span><span> </span><span class="NLM_article-title"><i>N</i><sup>1</sup>-Arylsulfonyl-<i>N</i><sup>2</sup>-(1-(1-naphthyl)ethyl)-1,2-diaminocyclohexanes: a new class of calcilytic agents acting at the calcium-sensing receptor</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1131</span><span class="NLM_x">–</span> <span class="NLM_lpage">1136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=1131-1136&author=A.+Kesslerauthor=H.+Faureauthor=M.+C.+Roussanneauthor=S.+Ferryauthor=M.+Ruatauthor=P.+Daubenauthor=R.+H.+Dodd&title=N1-Arylsulfonyl-N2-%281-%281-naphthyl%29ethyl%29-1%2C2-diaminocyclohexanes%3A+a+new+class+of+calcilytic+agents+acting+at+the+calcium-sensing+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKessler%26aufirst%3DA.%26aulast%3DFaure%26aufirst%3DH.%26aulast%3DRoussanne%26aufirst%3DM.%2BC.%26aulast%3DFerry%26aufirst%3DS.%26aulast%3DRuat%26aufirst%3DM.%26aulast%3DDauben%26aufirst%3DP.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26atitle%3DN1-Arylsulfonyl-N2-%25281-%25281-naphthyl%2529ethyl%2529-1%252C2-diaminocyclohexanes%253A%2520a%2520new%2520class%2520of%2520calcilytic%2520agents%2520acting%2520at%2520the%2520calcium-sensing%2520receptor%26jtitle%3DChemBioChem%26date%3D2004%26volume%3D5%26spage%3D1131%26epage%3D1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5g"><span><span class="NLM_contrib-group">Arey, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swartz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, J. K.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feyen, J. H. M.</span><span> </span><span class="NLM_article-title">A novel calcium-sensing receptor antagonist transiently stimulates parathyroid hormone secretion in vivo</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1131</span><span class="NLM_x">–</span> <span class="NLM_lpage">1136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1131-1136&author=B.+J.+Areyauthor=R.+Seethalaauthor=Z.+Maauthor=A.+Furaauthor=J.+Morinauthor=J.+Swartzauthor=V.+Vyasauthor=W.+Yangauthor=J.+K.+Dicksonauthor=J.+H.+M.+Feyen&title=A+novel+calcium-sensing+receptor+antagonist+transiently+stimulates+parathyroid+hormone+secretion+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArey%26aufirst%3DB.%2BJ.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DMorin%26aufirst%3DJ.%26aulast%3DSwartz%26aufirst%3DJ.%26aulast%3DVyas%26aufirst%3DV.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DDickson%26aufirst%3DJ.%2BK.%26aulast%3DFeyen%26aufirst%3DJ.%2BH.%2BM.%26atitle%3DA%2520novel%2520calcium-sensing%2520receptor%2520antagonist%2520transiently%2520stimulates%2520parathyroid%2520hormone%2520secretion%2520in%2520vivo%26jtitle%3DEndocrinology%26date%3D2005%26volume%3D5%26spage%3D1131%26epage%3D1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5h"><span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberge, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawerence, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotella, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feyen, J. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, J. K.,  Jr.</span><span> </span><span class="NLM_article-title">Discovery and structure activity relationships of benzylpyrrolidine substituted aryloxypropanols as calcium-sensing receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1225</span><span class="NLM_x">–</span> <span class="NLM_lpage">1228</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1225-1228&author=W.+Yangauthor=Y.+Wangauthor=J.+Y.+Robergeauthor=Z.+Maauthor=Y.+Liuauthor=R.+M.+Lawerenceauthor=D.+P.+Rotellaauthor=R.+Seethalaauthor=J.+H.+M.+Feyenauthor=J.+K.+Dickson&title=Discovery+and+structure+activity+relationships+of+benzylpyrrolidine+substituted+aryloxypropanols+as+calcium-sensing+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DRoberge%26aufirst%3DJ.%2BY.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLawerence%26aufirst%3DR.%2BM.%26aulast%3DRotella%26aufirst%3DD.%2BP.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DFeyen%26aufirst%3DJ.%2BH.%2BM.%26aulast%3DDickson%26aufirst%3DJ.%2BK.%26atitle%3DDiscovery%2520and%2520structure%2520activity%2520relationships%2520of%2520benzylpyrrolidine%2520substituted%2520aryloxypropanols%2520as%2520calcium-sensing%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1225%26epage%3D1228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5i"><span><span class="NLM_contrib-group">Gavai, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaz, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikkilineni, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberge, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corte, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednarz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, J. K.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feyen, J. H. M.</span><span> </span><span class="NLM_article-title">Discovery of novel 1-arylmethyl pyrrolidin-2-yl ethanol amines as calcium-sensing receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">5478</span><span class="NLM_x">–</span> <span class="NLM_lpage">5482</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=5478-5482&author=A.+V.+Gavaiauthor=R.+J.+Vazauthor=A.+B.+Mikkilineniauthor=J.+Y.+Robergeauthor=Y.+Liuauthor=R.+M.+Lawrenceauthor=J.+R.+Corteauthor=W.+Yangauthor=M.+Bednarzauthor=J.+K.+Dicksonauthor=Z.+Maauthor=R.+Seethalaauthor=J.+H.+M.+Feyen&title=Discovery+of+novel+1-arylmethyl+pyrrolidin-2-yl+ethanol+amines+as+calcium-sensing+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGavai%26aufirst%3DA.%2BV.%26aulast%3DVaz%26aufirst%3DR.%2BJ.%26aulast%3DMikkilineni%26aufirst%3DA.%2BB.%26aulast%3DRoberge%26aufirst%3DJ.%2BY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLawrence%26aufirst%3DR.%2BM.%26aulast%3DCorte%26aufirst%3DJ.%2BR.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DBednarz%26aufirst%3DM.%26aulast%3DDickson%26aufirst%3DJ.%2BK.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DFeyen%26aufirst%3DJ.%2BH.%2BM.%26atitle%3DDiscovery%2520of%2520novel%25201-arylmethyl%2520pyrrolidin-2-yl%2520ethanol%2520amines%2520as%2520calcium-sensing%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D5478%26epage%3D5482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5j"><span><span class="NLM_contrib-group">Shcherbakova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balandrin, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghatak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, R. L.</span><span> </span><span class="NLM_article-title">3H-Quinazolin-4-ones as a new calcilytic template for the potential treatment of osteoporosis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1557</span><span class="NLM_x">–</span> <span class="NLM_lpage">1560</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1557-1560&author=I.+Shcherbakovaauthor=M.+F.+Balandrinauthor=J.+Foxauthor=A.+Ghatakauthor=W.+Heatonauthor=R.+L.+Conklin&title=3H-Quinazolin-4-ones+as+a+new+calcilytic+template+for+the+potential+treatment+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShcherbakova%26aufirst%3DI.%26aulast%3DBalandrin%26aufirst%3DM.%2BF.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DGhatak%26aufirst%3DA.%26aulast%3DHeaton%26aufirst%3DW.%26aulast%3DConklin%26aufirst%3DR.%2BL.%26atitle%3D3H-Quinazolin-4-ones%2520as%2520a%2520new%2520calcilytic%2520template%2520for%2520the%2520potential%2520treatment%2520of%2520osteoporosis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1557%26epage%3D1560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5k"><span><span class="NLM_contrib-group">Shcherbakova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoffroy, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swierczek, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balandrin, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, R. L.</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2537</span><span class="NLM_x">–</span> <span class="NLM_lpage">2540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Shcherbakova%2C+I.%3B+Huang%2C+G.%3B+Geoffroy%2C+O.+J.%3B+Nair%2C+S.+K.%3B+Swierczek%2C+K.%3B+Balandrin%2C+M.+F.%3B+Fox%2C+J.%3B+Heaton%2C+W.+L.%3B+Conklin%2C+R.+L.Bioorg.+Med.+Chem.+Lett.+2005%2C+15%2C+2537%E2%80%932540"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5k&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShcherbakova%26aufirst%3DI.%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DGeoffroy%26aufirst%3DO.%2BJ.%26aulast%3DNair%26aufirst%3DS.%2BK.%26aulast%3DSwierczek%26aufirst%3DK.%26aulast%3DBalandrin%26aufirst%3DM.%2BF.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DHeaton%26aufirst%3DW.%2BL.%26aulast%3DConklin%26aufirst%3DR.%2BL.%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2537%26epage%3D2540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_contrib-group">Dobnig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, R. T.</span><span> </span><span class="NLM_article-title">Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">3632</span><span class="NLM_x">–</span> <span class="NLM_lpage">3638</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=1995&pages=3632-3638&author=H.+Dobnigauthor=R.+T.+Turner&title=Evidence+that+intermittent+treatment+with+parathyroid+hormone+increases+bone+formation+in+adult+rats+by+activation+of+bone+lining+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDobnig%26aufirst%3DH.%26aulast%3DTurner%26aufirst%3DR.%2BT.%26atitle%3DEvidence%2520that%2520intermittent%2520treatment%2520with%2520parathyroid%2520hormone%2520increases%2520bone%2520formation%2520in%2520adult%2520rats%2520by%2520activation%2520of%2520bone%2520lining%2520cells%26jtitle%3DEndocrinology%26date%3D1995%26volume%3D136%26spage%3D3632%26epage%3D3638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_contrib-group">Ishizuya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokose, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshiki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, A.</span><span> </span><span class="NLM_article-title">Parathyroid hormone exerts disparate effects on osteoclast differentiation depending on exposure time in rat osteoblastic cells</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">2961</span><span class="NLM_x">–</span> <span class="NLM_lpage">2970</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1997&pages=2961-2970&author=T.+Ishizuyaauthor=S.+Yokoseauthor=M.+Horiauthor=T.+Nodaauthor=T.+Sudaauthor=S.+Yoshikiauthor=A.+Yamaguchi&title=Parathyroid+hormone+exerts+disparate+effects+on+osteoclast+differentiation+depending+on+exposure+time+in+rat+osteoblastic+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIshizuya%26aufirst%3DT.%26aulast%3DYokose%26aufirst%3DS.%26aulast%3DHori%26aufirst%3DM.%26aulast%3DNoda%26aufirst%3DT.%26aulast%3DSuda%26aufirst%3DT.%26aulast%3DYoshiki%26aufirst%3DS.%26aulast%3DYamaguchi%26aufirst%3DA.%26atitle%3DParathyroid%2520hormone%2520exerts%2520disparate%2520effects%2520on%2520osteoclast%2520differentiation%2520depending%2520on%2520exposure%2520time%2520in%2520rat%2520osteoblastic%2520cells%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1997%26volume%3D99%26spage%3D2961%26epage%3D2970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6c"><span><span class="NLM_contrib-group">Frolik, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cain, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satterwhite, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown-Augsburger, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hock, J. M.</span><span> </span><span class="NLM_article-title">Anabolic and catabolic bone effects of human parathyroid hormone (1−34) are predicted by duration of hormone exposure</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">372</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2003&pages=372-379&author=C.+A.+Frolikauthor=E.+C.+Blackauthor=R.+L.+Cainauthor=J.+H.+Satterwhiteauthor=P.+L.+Brown-Augsburgerauthor=M.+Satoauthor=J.+M.+Hock&title=Anabolic+and+catabolic+bone+effects+of+human+parathyroid+hormone+%281%E2%88%9234%29+are+predicted+by+duration+of+hormone+exposure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrolik%26aufirst%3DC.%2BA.%26aulast%3DBlack%26aufirst%3DE.%2BC.%26aulast%3DCain%26aufirst%3DR.%2BL.%26aulast%3DSatterwhite%26aufirst%3DJ.%2BH.%26aulast%3DBrown-Augsburger%26aufirst%3DP.%2BL.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DHock%26aufirst%3DJ.%2BM.%26atitle%3DAnabolic%2520and%2520catabolic%2520bone%2520effects%2520of%2520human%2520parathyroid%2520hormone%2520%25281%25E2%2588%259234%2529%2520are%2520predicted%2520by%2520duration%2520of%2520hormone%2520exposure%26jtitle%3DBone%26date%3D2003%26volume%3D33%26spage%3D372%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6d"><span><span class="NLM_contrib-group">Onyia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helvering, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbert, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dow, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotinun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halladay, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miles, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambrose, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frolik, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, R. T.</span><span> </span><span class="NLM_article-title">Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: an analysis of DNA microarray</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">418</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2005&pages=403-418&author=J.+E.+Onyiaauthor=L.+M.+Helveringauthor=L.+Gelbertauthor=T.+Weiauthor=S.+Huangauthor=P.+Chenauthor=E.+R.+Dowauthor=A.+Maranauthor=M.+Zhangauthor=S.+Lotinunauthor=D.+L.+Halladayauthor=R.+R.+Milesauthor=N.+H.+Kulkarniauthor=E.+M.+Ambroseauthor=Y.+L.+Maauthor=C.+A.+Frolikauthor=M.+Satoauthor=H.+U.+Bryantauthor=R.+T.+Turner&title=Molecular+profile+of+catabolic+versus+anabolic+treatment+regimens+of+parathyroid+hormone+%28PTH%29+in+rat+bone%3A+an+analysis+of+DNA+microarray"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOnyia%26aufirst%3DJ.%2BE.%26aulast%3DHelvering%26aufirst%3DL.%2BM.%26aulast%3DGelbert%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DDow%26aufirst%3DE.%2BR.%26aulast%3DMaran%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DLotinun%26aufirst%3DS.%26aulast%3DHalladay%26aufirst%3DD.%2BL.%26aulast%3DMiles%26aufirst%3DR.%2BR.%26aulast%3DKulkarni%26aufirst%3DN.%2BH.%26aulast%3DAmbrose%26aufirst%3DE.%2BM.%26aulast%3DMa%26aufirst%3DY.%2BL.%26aulast%3DFrolik%26aufirst%3DC.%2BA.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DBryant%26aufirst%3DH.%2BU.%26aulast%3DTurner%26aufirst%3DR.%2BT.%26atitle%3DMolecular%2520profile%2520of%2520catabolic%2520versus%2520anabolic%2520treatment%2520regimens%2520of%2520parathyroid%2520hormone%2520%2528PTH%2529%2520in%2520rat%2520bone%253A%2520an%2520analysis%2520of%2520DNA%2520microarray%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2005%26volume%3D95%26spage%3D403%26epage%3D418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Marquis, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lago, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trout, R. E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DelMar, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Vegnan, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roethke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, P.</span><span> </span><span class="NLM_article-title">Antagonists of the calcium receptor I. Amino alcohol-based parathyroid hormone secretagogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3982</span><span class="NLM_x">–</span> <span class="NLM_lpage">3993</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900364m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvVSgtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3982-3993&author=R.+W.+Marquisauthor=A.+M.+Lagoauthor=J.+F.+Callahanauthor=R.+E.+L.+Troutauthor=M.+Gowenauthor=R.+G.+DelMarauthor=B.+C.+Van+Vegnanauthor=S.+Loganauthor=S.+Shimizuauthor=J.+Foxauthor=E.+F.+Nemethauthor=Z.+Yangauthor=T.+Roethkeauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=J.+Leeauthor=R.+M.+Keenanauthor=P.+Bhatnagar&title=Antagonists+of+the+calcium+receptor+I.+Amino+alcohol-based+parathyroid+hormone+secretagogues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonists of the Calcium Receptor I. Amino Alcohol-Based Parathyroid Hormone Secretagogues</span></div><div class="casAuthors">Marquis, Robert W.; Lago, Amparo M.; Callahan, James F.; Trout, Robert E. Lee; Gowen, Maxine; DelMar, Eric G.; Van Wagenen, Bradford C.; Logan, Sarah; Shimizu, Scott; Fox, John; Nemeth, Edward F.; Yang, Zheng; Roethke, Theresa; Smith, Brian R.; Ward, Keith W.; Lee, John; Keenan, Richard M.; Bhatnagar, Pradip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3982-3993</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Functional screening of the former SmithKline Beecham compd. collection against the human calcium receptor (CaR) resulted in the identification of the amino alc.-based hit 2 (IC50 = 11 μM).  Structure-activity studies of 2 focused on the optimization of the right- and left-hand side arom. moieties as well as the amino alc. linker region.  Crit. to the optimization of this antagonist template was the discovery that the chirality of the C-2 secondary alc. played a key role in enhancing both CaR potency as well as selectivity over the β-adrenergic receptor subtypes.  These SAR studies ultimately led to the identification of 38 (NPS 2143; SB-262470A), a potent and orally active CaR antagonist.  Pharmacokinetic characterization of 38 in the rat revealed that this mol. had a large vol. of distribution (11 L/kg), which resulted in a prolonged systemic exposure, protracted increases in the plasma levels of PTH, and an overall lack of net bone formation effect in a rodent model of osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEH_JHFpGSM7Vg90H21EOLACvtfcHk0liv2DdDmdyG8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvVSgtL0%253D&md5=7737a92f22bb30886f925395753243fd</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm900364m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900364m%26sid%3Dliteratum%253Aachs%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DLago%26aufirst%3DA.%2BM.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DTrout%26aufirst%3DR.%2BE.%2BL.%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DDelMar%26aufirst%3DR.%2BG.%26aulast%3DVan%2BVegnan%26aufirst%3DB.%2BC.%26aulast%3DLogan%26aufirst%3DS.%26aulast%3DShimizu%26aufirst%3DS.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DRoethke%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DKeenan%26aufirst%3DR.%2BM.%26aulast%3DBhatnagar%26aufirst%3DP.%26atitle%3DAntagonists%2520of%2520the%2520calcium%2520receptor%2520I.%2520Amino%2520alcohol-based%2520parathyroid%2520hormone%2520secretagogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3982%26epage%3D3993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_contrib-group">Crivori, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poggesi, I.</span><span> </span><span class="NLM_article-title">Predictive model for identifying potential CYP2D6 Inhibitors</span> <span class="citation_source-journal">Basic Clin. Pharm. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Fjm900563e&amp;key=10.1111%2Fj.1742-7843.2005.pto960320.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Fjm900563e&amp;key=15733226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisFSlsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2005&pages=251-253&author=P.+Crivoriauthor=I.+Poggesi&title=Predictive+model+for+identifying+potential+CYP2D6+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Predictive model for identifying potential CYP2D6 inhibitors</span></div><div class="casAuthors">Crivori, Patrizia; Poggesi, Italo</div><div class="citationInfo"><span class="NLM_cas:title">Basic & Clinical Pharmacology & Toxicology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">251-253</span>CODEN:
                <span class="NLM_cas:coden">BCPTBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-7835</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A model for predicting the cytochrome P 450 2D6 (CYP2D6) inhibition potential based on the mol. structures of drug candidates was developed and evaluated using Almond program.  The QSPR model was developed by correlating the exptl. inhibition consts. with the unscaled descriptors calcd. for all conformers generated for the training set.  GRIND descriptors appear to be a valuable tool for modeling CYP2D6 inhibitors.  Although the exptl. data utilized to train the model comes from different labs, the GRIND-based model appears robust and useful to predict CYP2D6 inhibition consts. of external sets of compds.  The performance of this model is at least as good as that reported for other computational models of CYP2D6 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK2FQqoXFbirVg90H21EOLACvtfcHk0liv2DdDmdyG8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisFSlsrY%253D&md5=0fda143645d8ff0a469957247294c70c</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-7843.2005.pto960320.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-7843.2005.pto960320.x%26sid%3Dliteratum%253Aachs%26aulast%3DCrivori%26aufirst%3DP.%26aulast%3DPoggesi%26aufirst%3DI.%26atitle%3DPredictive%2520model%2520for%2520identifying%2520potential%2520CYP2D6%2520Inhibitors%26jtitle%3DBasic%2520Clin.%2520Pharm.%2520Toxicol.%26date%3D2005%26volume%3D96%26spage%3D251%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_contrib-group">Ekins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gianpaolo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ring, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkel, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrighton, S. A.</span><span> </span><span class="NLM_article-title">Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors</span> <span class="citation_source-journal">Pharmacogenetics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">489</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Fjm900563e&amp;key=10780267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADyaK1MXmtlGjs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=477-489&author=S.+Ekinsauthor=B.+Gianpaoloauthor=S.+Binkleyauthor=J.+S.+Gillespieauthor=B.+J.+Ringauthor=J.+H.+Winkelauthor=S.+A.+Wrighton&title=Three+and+four+dimensional-quantitative+structure+activity+relationship+%283D%2F4D-QSAR%29+analyses+of+CYP2D6+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors</span></div><div class="casAuthors">Ekins, Sean; Bravi, Gianpaolo; Binkley, Shelly; Gillespie, Jennifer S.; Ring, Barbara J.; Wikel, James H.; Wrighton, Steven A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacogenetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">477-489</span>CODEN:
                <span class="NLM_cas:coden">PHMCEE</span>;
        ISSN:<span class="NLM_cas:issn">0960-314X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Three- and four-dimensional quant. structure activity relationship (3D/4D-QSAR) pharmacophore models of competitive inhibitors of CYP2D6 were constructed using data from our lab. or the literature.  The 3D-QSAR pharmacophore models of the common structural features of CYP2D6 inhibitors were built using the program Catalyst (Mol. Simulations, San Diego, CA, USA).  These 3D-QSAR models were compared with 3D and 4D-QSAR partial least squares (PLS) models which were constructed using mol. surface-weighted holistic invariant mol. (MS-WHIM) descriptors of size and shape of inhibitors.  The first Catalyst model was generated from multiple conformers of competitive inhibitors (n = 20) of CYP2D6 mediated bufurolol 1'-hydroxylation.  This model demonstrated a correlation of obsd. and predicted Ki (apparent) values of r = 0.75.  A second Catalyst model was constructed from literature derived Ki (apparent) values (n = 31) for the inhibition of CYP2D6.  This model provided a correlation of obsd. and predicted inhibition for CYP2D6 of r = 0.91.  Both Catalyst Ki pharmacophores were then validated by predicting the Ki (apparent) of a test set of known CYP2D6 inhibitors (n = 15).  Ten out of 15 of these Ki (apparent) values were predicted to be within one log residual of the obsd. value using our CYP2D6 inhibitor model, while the literature model predicted nine out of 15 values.  Similarly, 3D- and 4D-QSARs derived from PLS MS-WHIM for our dataset yielded predictable models as assessed using cross-validation.  The corresponding cross-validated PLS MS-WHIM model for the literature dataset yielded a comparable 3D-QSAR and improved 4D-QSAR value.  Such computational models will aid in future prediction of drug-drug interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcRiE7XUQvY7Vg90H21EOLACvtfcHk0liv2DdDmdyG8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtlGjs7w%253D&md5=b714320963218c19c858e31376b9b528</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEkins%26aufirst%3DS.%26aulast%3DGianpaolo%26aufirst%3DB.%26aulast%3DBinkley%26aufirst%3DS.%26aulast%3DGillespie%26aufirst%3DJ.%2BS.%26aulast%3DRing%26aufirst%3DB.%2BJ.%26aulast%3DWinkel%26aufirst%3DJ.%2BH.%26aulast%3DWrighton%26aufirst%3DS.%2BA.%26atitle%3DThree%2520and%2520four%2520dimensional-quantitative%2520structure%2520activity%2520relationship%2520%25283D%252F4D-QSAR%2529%2520analyses%2520of%2520CYP2D6%2520inhibitors%26jtitle%3DPharmacogenetics%26date%3D1999%26volume%3D9%26spage%3D477%26epage%3D489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_contrib-group">De Groot, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackland, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B. C.</span><span> </span><span class="NLM_article-title">Novel approach to predicting P450-mediated drug metabolism: development of a combined protein and pharmacophore model for CYP2D6</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1515</span><span class="NLM_x">–</span> <span class="NLM_lpage">1524</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm981118h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1515-1524&author=M.+J.+De+Grootauthor=M.+J.+Acklandauthor=V.+A.+Horneauthor=A.+A.+Alexauthor=B.+C.+Jones&title=Novel+approach+to+predicting+P450-mediated+drug+metabolism%3A+development+of+a+combined+protein+and+pharmacophore+model+for+CYP2D6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1021%2Fjm981118h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm981118h%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BGroot%26aufirst%3DM.%2BJ.%26aulast%3DAckland%26aufirst%3DM.%2BJ.%26aulast%3DHorne%26aufirst%3DV.%2BA.%26aulast%3DAlex%26aufirst%3DA.%2BA.%26aulast%3DJones%26aufirst%3DB.%2BC.%26atitle%3DNovel%2520approach%2520to%2520predicting%2520P450-mediated%2520drug%2520metabolism%253A%2520development%2520of%2520a%2520combined%2520protein%2520and%2520pharmacophore%2520model%2520for%2520CYP2D6%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1515%26epage%3D1524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8d"><span><span class="NLM_contrib-group">Rowland, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smyth, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leydon, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oxbrow, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tennant, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eggleston, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenery, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, A. M.</span><span> </span><span class="NLM_article-title">Crystal structure of the human cytochrome P450 2D6</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">7614</span><span class="NLM_x">–</span> <span class="NLM_lpage">7622</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=7614-7622&author=P.+Rowlandauthor=F.+E.+Blaneyauthor=M.+G.+Smythauthor=J.+J.+Jonesauthor=V.+R.+Leydonauthor=A.+K.+Oxbrowauthor=C.+J.+Lewisauthor=M.+G.+Tennantauthor=S.+Modiauthor=D.+S.+Egglestonauthor=R.+J.+Cheneryauthor=A.+M.+Bridges&title=Crystal+structure+of+the+human+cytochrome+P450+2D6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DBlaney%26aufirst%3DF.%2BE.%26aulast%3DSmyth%26aufirst%3DM.%2BG.%26aulast%3DJones%26aufirst%3DJ.%2BJ.%26aulast%3DLeydon%26aufirst%3DV.%2BR.%26aulast%3DOxbrow%26aufirst%3DA.%2BK.%26aulast%3DLewis%26aufirst%3DC.%2BJ.%26aulast%3DTennant%26aufirst%3DM.%2BG.%26aulast%3DModi%26aufirst%3DS.%26aulast%3DEggleston%26aufirst%3DD.%2BS.%26aulast%3DChenery%26aufirst%3DR.%2BJ.%26aulast%3DBridges%26aufirst%3DA.%2BM.%26atitle%3DCrystal%2520structure%2520of%2520the%2520human%2520cytochrome%2520P450%25202D6%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D7614%26epage%3D7622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8e"><span><span class="NLM_contrib-group">Mitcheson, J. S.</span><span> </span><span class="NLM_article-title">hERG potassium channels and the structural basis of drug-induced arrhythmias</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx800035b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=1005-1010&author=J.+S.+Mitcheson&title=hERG+potassium+channels+and+the+structural+basis+of+drug-induced+arrhythmias"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8e&amp;dbid=16384&amp;doi=10.1021%2Ftx800035b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx800035b%26sid%3Dliteratum%253Aachs%26aulast%3DMitcheson%26aufirst%3DJ.%2BS.%26atitle%3DhERG%2520potassium%2520channels%2520and%2520the%2520structural%2520basis%2520of%2520drug-induced%2520arrhythmias%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D1005%26epage%3D1010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8f"><span><span class="NLM_contrib-group">Kramer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kriegel, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, T.</span><span> </span><span class="NLM_article-title">A composite model for hERG blockade</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">254</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=254-265&author=C.+Kramerauthor=B.+Beckauthor=J.+M.+Kriegelauthor=T.+Clark&title=A+composite+model+for+hERG+blockade"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DC.%26aulast%3DBeck%26aufirst%3DB.%26aulast%3DKriegel%26aufirst%3DJ.%2BM.%26aulast%3DClark%26aufirst%3DT.%26atitle%3DA%2520composite%2520model%2520for%2520hERG%2520blockade%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D254%26epage%3D265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8g"><span><span class="NLM_contrib-group">Stansfeld, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gedeck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosling, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitcheson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, M. J.</span><span> </span><span class="NLM_article-title">Drug block of the hERG potassium channel: insights from modeling</span> <span class="citation_source-journal">Proteins: Struct., Funct., Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">568</span><span class="NLM_x">–</span> <span class="NLM_lpage">580</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2007&pages=568-580&author=P.+J.+Stansfeldauthor=P.+Gedeckauthor=M.+Goslingauthor=B.+Coxauthor=J.+S.+Mitchesonauthor=M.+J.+Sutcliffe&title=Drug+block+of+the+hERG+potassium+channel%3A+insights+from+modeling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStansfeld%26aufirst%3DP.%2BJ.%26aulast%3DGedeck%26aufirst%3DP.%26aulast%3DGosling%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DB.%26aulast%3DMitcheson%26aufirst%3DJ.%2BS.%26aulast%3DSutcliffe%26aufirst%3DM.%2BJ.%26atitle%3DDrug%2520block%2520of%2520the%2520hERG%2520potassium%2520channel%253A%2520insights%2520from%2520modeling%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Bioinf.%26date%3D2007%26volume%3D68%26spage%3D568%26epage%3D580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8h"><span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tristani-Firouzi, M.</span><span> </span><span class="NLM_article-title">hERG potassium channels and cardiac arrhythmia</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">440</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8h&amp;dbid=16&amp;doi=10.1021%2Fjm900563e&amp;key=10.1038%2Fnature04710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8h&amp;dbid=8&amp;doi=10.1021%2Fjm900563e&amp;key=16554806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8h&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1OlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=2006&pages=463-469&author=M.+C.+Sanguinettiauthor=M.+Tristani-Firouzi&title=hERG+potassium+channels+and+cardiac+arrhythmia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8hR"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">hERG potassium channels and cardiac arrhythmia</span></div><div class="casAuthors">Sanguinetti, Michael C.; Tristani-Firouzi, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">440</span>
        (<span class="NLM_cas:issue">7083</span>),
    <span class="NLM_cas:pages">463-469</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  HERG potassium channels are essential for normal elec. activity in the heart.  Inherited mutations in the HERG gene cause long QT syndrome, a disorder that predisposes individuals to life-threatening arrhythmias.  Arrhythmia can also be induced by a blockage of hERG channels by a surprisingly diverse group of drugs.  This side effect is a common reason for drug failure in preclin. safety trials.  Insights gained from the crystal structures of other potassium channels have helped our understanding of the block of hERG channels and the mechanisms of gating.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopS3WBEpuAUrVg90H21EOLACvtfcHk0lgtVsVj4C1GeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1OlsLs%253D&md5=3f355dcd51da3488d73c7c91cbe8d3b8</span></div><a href="/servlet/linkout?suffix=cit8h&amp;dbid=16384&amp;doi=10.1038%2Fnature04710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04710%26sid%3Dliteratum%253Aachs%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26aulast%3DTristani-Firouzi%26aufirst%3DM.%26atitle%3DhERG%2520potassium%2520channels%2520and%2520cardiac%2520arrhythmia%26jtitle%3DNature%26date%3D2006%26volume%3D440%26spage%3D463%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8i"><span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitcheson, J. S.</span><span> </span><span class="NLM_article-title">Predicting drug-hERG channel interactions that cause acquired long QT syndrome</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=119-124&author=M.+C.+Sanguinettiauthor=J.+S.+Mitcheson&title=Predicting+drug-hERG+channel+interactions+that+cause+acquired+long+QT+syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26aulast%3DMitcheson%26aufirst%3DJ.%2BS.%26atitle%3DPredicting%2520drug-hERG%2520channel%2520interactions%2520that%2520cause%2520acquired%2520long%2520QT%2520syndrome%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2005%26volume%3D26%26spage%3D119%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8j"><span><span class="NLM_contrib-group">Fernandez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghanta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span> </span><span class="NLM_article-title">Physiochemical features of the hERG channel binding site</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">10120</span><span class="NLM_x">–</span> <span class="NLM_lpage">10127</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=10120-10127&author=D.+Fernandezauthor=A.+Ghantaauthor=G.+W.+Kauffmanauthor=M.+C.+Sanguinetti&title=Physiochemical+features+of+the+hERG+channel+binding+site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez%26aufirst%3DD.%26aulast%3DGhanta%26aufirst%3DA.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26atitle%3DPhysiochemical%2520features%2520of%2520the%2520hERG%2520channel%2520binding%2520site%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D10120%26epage%3D10127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8k"><span><span class="NLM_contrib-group">Tonioli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crisma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Formaggio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peggion, C.</span><span> </span><span class="NLM_article-title">Control of peptide conformation by the Thorpe−Ingold effect (C-α tetrasubstitution)</span> <span class="citation_source-journal">Biopolymers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">396</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2001&pages=396-419&author=C.+Tonioliauthor=M.+Crismaauthor=F.+Formaggioauthor=C.+Peggion&title=Control+of+peptide+conformation+by+the+Thorpe%E2%88%92Ingold+effect+%28C-%CE%B1+tetrasubstitution%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8k&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTonioli%26aufirst%3DC.%26aulast%3DCrisma%26aufirst%3DM.%26aulast%3DFormaggio%26aufirst%3DF.%26aulast%3DPeggion%26aufirst%3DC.%26atitle%3DControl%2520of%2520peptide%2520conformation%2520by%2520the%2520Thorpe%25E2%2588%2592Ingold%2520effect%2520%2528C-%25CE%25B1%2520tetrasubstitution%2529%26jtitle%3DBiopolymers%26date%3D2001%26volume%3D60%26spage%3D396%26epage%3D419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span> See first two references of ref <span class="NLM_xref">6</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+See+first+two+references+of+ref+6."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2a','cit2b','cit2c','cit2d','cit2e','cit2f','cit2g','cit2h'],'ref3':['cit3a','cit3b','cit3c','cit3d','cit3e'],'ref4':['cit4a','cit4b','cit4c'],'ref5':['cit5a','cit5b','cit5c','cit5d','cit5e','cit5f','cit5g','cit5h','cit5i','cit5j','cit5k'],'ref6':['cit6a','cit6b','cit6c','cit6d'],'ref7':['cit7'],'ref8':['cit8a','cit8b','cit8c','cit8d','cit8e','cit8f','cit8g','cit8h','cit8i','cit8j','cit8k'],'ref9':['cit9']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 21 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jiayin Diao, Aaron DeBono, Tracy M. Josephs, Jane E. Bourke, Ben Capuano, Karen J. Gregory, <span class="NLM_string-name hlFld-ContribAuthor">Katie Leach</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Opportunities of Targeting Allosteric Binding Sites on the Calcium-Sensing Receptor. </span><span class="cited-content_cbyCitation_journal-name">ACS Pharmacology & Translational Science</span><span> <strong>2021,</strong> <em>4 </em>
                                    (2)
                                     , 666-679. <a href="https://doi.org/10.1021/acsptsci.1c00046" title="DOI URL">https://doi.org/10.1021/acsptsci.1c00046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsptsci.1c00046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsptsci.1c00046%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Pharmacology%2520%2526%2520Translational%2520Science%26atitle%3DTherapeutic%252BOpportunities%252Bof%252BTargeting%252BAllosteric%252BBinding%252BSites%252Bon%252Bthe%252BCalcium-Sensing%252BReceptor%26aulast%3DDiao%26aufirst%3DJiayin%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D04022021%26date%3D08032021%26volume%3D4%26issue%3D2%26spage%3D666%26epage%3D679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Boram  Seo</span>, <span class="hlFld-ContribAuthor ">Hyunseok  Kim</span>, <span class="hlFld-ContribAuthor ">Ya Gob  Kim</span>, <span class="hlFld-ContribAuthor ">Yonghyeon  Baek</span>, <span class="hlFld-ContribAuthor ">Kyusik  Um</span>, and <span class="hlFld-ContribAuthor ">Phil Ho  Lee</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of Bicyclic Isothiazoles through an Intramolecular Rhodium-Catalyzed Transannulation of Cyanothiadiazoles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (19)
                                     , 10574-10582. <a href="https://doi.org/10.1021/acs.joc.7b02077" title="DOI URL">https://doi.org/10.1021/acs.joc.7b02077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b02077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b02077%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BBicyclic%252BIsothiazoles%252Bthrough%252Ban%252BIntramolecular%252BRhodium-Catalyzed%252BTransannulation%252Bof%252BCyanothiadiazoles%26aulast%3DSeo%26aufirst%3DBoram%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D16082017%26date%3D25092017%26date%3D06102017%26date%3D09092017%26volume%3D82%26issue%3D19%26spage%3D10574%26epage%3D10582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao-Yan  Lin</span>, <span class="hlFld-ContribAuthor ">Hai-Hong  Wu</span>, <span class="hlFld-ContribAuthor ">Jian-Jun  Feng</span>, and <span class="hlFld-ContribAuthor ">Junliang  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Transfer of Chirality in the Rhodium-Catalyzed Chemoselective and Regioselective Allylic Alkylation of Hydroxyarenes with Vinyl Aziridines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2017,</strong> <em>19 </em>
                                    (11)
                                     , 2897-2900. <a href="https://doi.org/10.1021/acs.orglett.7b01136" title="DOI URL">https://doi.org/10.1021/acs.orglett.7b01136</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.7b01136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.7b01136%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DTransfer%252Bof%252BChirality%252Bin%252Bthe%252BRhodium-Catalyzed%252BChemoselective%252Band%252BRegioselective%252BAllylic%252BAlkylation%252Bof%252BHydroxyarenes%252Bwith%252BVinyl%252BAziridines%26aulast%3DLin%26aufirst%3DTao-Yan%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D14042017%26date%3D22052017%26date%3D02062017%26volume%3D19%26issue%3D11%26spage%3D2897%26epage%3D2900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bruce J.  Melancon</span>, <span class="hlFld-ContribAuthor ">Corey R.  Hopkins</span>, <span class="hlFld-ContribAuthor ">Michael R.  Wood</span>, <span class="hlFld-ContribAuthor ">Kyle A.  Emmitte</span>, <span class="hlFld-ContribAuthor ">Colleen M.  Niswender</span>, <span class="hlFld-ContribAuthor ">Arthur  Christopoulos</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>, and <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>  . </span><span class="cited-content_cbyCitation_article-title">Allosteric Modulation of Seven Transmembrane Spanning Receptors: Theory, Practice, and Opportunities for Central Nervous System Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (4)
                                     , 1445-1464. <a href="https://doi.org/10.1021/jm201139r" title="DOI URL">https://doi.org/10.1021/jm201139r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201139r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201139r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAllosteric%252BModulation%252Bof%252BSeven%252BTransmembrane%252BSpanning%252BReceptors%25253A%252BTheory%25252C%252BPractice%25252C%252Band%252BOpportunities%252Bfor%252BCentral%252BNervous%252BSystem%252BDrug%252BDiscovery%26aulast%3DMelancon%26aufirst%3DBruce%2BJ.%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D25082011%26date%3D06012012%26date%3D23022012%26date%3D09122011%26volume%3D55%26issue%3D4%26spage%3D1445%26epage%3D1464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuko  Shinagawa</span>, <span class="hlFld-ContribAuthor ">Teruhiko  Inoue</span>, <span class="hlFld-ContribAuthor ">Takeo  Katsushima</span>, <span class="hlFld-ContribAuthor ">Toshihiro  Kiguchi</span>, <span class="hlFld-ContribAuthor ">Taku  Ikenogami</span>, <span class="hlFld-ContribAuthor ">Naoki  Ogawa</span>, <span class="hlFld-ContribAuthor ">Kenji  Fukuda</span>, <span class="hlFld-ContribAuthor ">Kazuyuki  Hirata</span>, <span class="hlFld-ContribAuthor ">Kazuhito  Harada</span>, <span class="hlFld-ContribAuthor ">Masaki  Takagi</span>, <span class="hlFld-ContribAuthor ">Takashi  Nakagawa</span>, <span class="hlFld-ContribAuthor ">Shuichi  Kimura</span>, <span class="hlFld-ContribAuthor ">Yushi  Matsuo</span>, <span class="hlFld-ContribAuthor ">Mariko  Maekawa</span>, <span class="hlFld-ContribAuthor ">Mikio  Hayashi</span>, <span class="hlFld-ContribAuthor ">Yuki  Soejima</span>, <span class="hlFld-ContribAuthor ">Mitsuru  Takahashi</span>, <span class="hlFld-ContribAuthor ">Masanori  Shindo</span>, and <span class="hlFld-ContribAuthor ">Hiromasa  Hashimoto</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent and Short−Acting Oral Calcilytic with a Pulsatile Secretion of Parathyroid Hormone. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>2 </em>
                                    (3)
                                     , 238-242. <a href="https://doi.org/10.1021/ml100268k" title="DOI URL">https://doi.org/10.1021/ml100268k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml100268k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml100268k%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252Band%252BShort%2525E2%252588%252592Acting%252BOral%252BCalcilytic%252Bwith%252Ba%252BPulsatile%252BSecretion%252Bof%252BParathyroid%252BHormone%26aulast%3DShinagawa%26aufirst%3DYuko%26date%3D2011%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D09112010%26date%3D21122010%26date%3D29122010%26date%3D10032011%26volume%3D2%26issue%3D3%26spage%3D238%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James A.  Southers</span>, <span class="hlFld-ContribAuthor ">Jonathan N.  Bauman</span>, <span class="hlFld-ContribAuthor ">David A.  Price</span>, <span class="hlFld-ContribAuthor ">Paul S.  Humphries</span>, <span class="hlFld-ContribAuthor ">Gayatri  Balan</span>, <span class="hlFld-ContribAuthor ">John F.  Sagal</span>, <span class="hlFld-ContribAuthor ">Tristan S.  Maurer</span>, <span class="hlFld-ContribAuthor ">Yan  Zhang</span>, <span class="hlFld-ContribAuthor ">Robert  Oliver</span>, <span class="hlFld-ContribAuthor ">Michael  Herr</span>, <span class="hlFld-ContribAuthor ">David R.  Healy</span>, <span class="hlFld-ContribAuthor ">Mei  Li</span>, <span class="hlFld-ContribAuthor ">Brendon  Kapinos</span>, <span class="hlFld-ContribAuthor ">Gwendolyn D.  Fate</span>, <span class="hlFld-ContribAuthor ">Keith A.  Riccardi</span>, <span class="hlFld-ContribAuthor ">Vishwas M.  Paralkar</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Brown</span> and <span class="hlFld-ContribAuthor ">Amit S.  Kalgutkar</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolism-Guided Design of Short-Acting Calcium-Sensing Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>1 </em>
                                    (5)
                                     , 219-223. <a href="https://doi.org/10.1021/ml100058w" title="DOI URL">https://doi.org/10.1021/ml100058w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml100058w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml100058w%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DMetabolism-Guided%252BDesign%252Bof%252BShort-Acting%252BCalcium-Sensing%252BReceptor%252BAntagonists%26aulast%3DSouthers%26aufirst%3DJames%2BA.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D08042010%26date%3D10052010%26date%3D13052010%26date%3D12082010%26volume%3D1%26issue%3D5%26spage%3D219%26epage%3D223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amit S.  Kalgutkar</span>, <span class="hlFld-ContribAuthor ">David A.  Griffith</span>, <span class="hlFld-ContribAuthor ">Tim  Ryder</span>, <span class="hlFld-ContribAuthor ">Hao  Sun</span>, <span class="hlFld-ContribAuthor ">Zhuang  Miao</span>, <span class="hlFld-ContribAuthor ">Jonathan N.  Bauman</span>, <span class="hlFld-ContribAuthor ">Mary T.  Didiuk</span>, <span class="hlFld-ContribAuthor ">Kosea S.  Frederick</span>, <span class="hlFld-ContribAuthor ">Sabrina X.  Zhao</span>, <span class="hlFld-ContribAuthor ">Chandra  Prakash</span>, <span class="hlFld-ContribAuthor ">John R.  Soglia</span>, <span class="hlFld-ContribAuthor ">Scott W.  Bagley</span>, <span class="hlFld-ContribAuthor ">Bruce M.  Bechle</span>, <span class="hlFld-ContribAuthor ">Ryan M.  Kelley</span>, <span class="hlFld-ContribAuthor ">Kenneth  Dirico</span>, <span class="hlFld-ContribAuthor ">Michael  Zawistoski</span>, <span class="hlFld-ContribAuthor ">Jianke  Li</span>, <span class="hlFld-ContribAuthor ">Robert  Oliver</span>, <span class="hlFld-ContribAuthor ">Angel  Guzman-Perez</span>, <span class="hlFld-ContribAuthor ">Kevin K. C.  Liu</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Walker</span>, <span class="hlFld-ContribAuthor ">John W.  Benbow</span> and <span class="hlFld-ContribAuthor ">Joel  Morris</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery Tactics To Mitigate Toxicity Risks Due to Reactive Metabolite Formation with 2-(2-Hydroxyaryl)-5-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3H)-one Derivatives, Potent Calcium-Sensing Receptor Antagonists and Clinical Candidate(s) for the Treatment of Osteoporosis. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Toxicology</span><span> <strong>2010,</strong> <em>23 </em>
                                    (6)
                                     , 1115-1126. <a href="https://doi.org/10.1021/tx100137n" title="DOI URL">https://doi.org/10.1021/tx100137n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/tx100137n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Ftx100137n%26sid%3Dliteratum%253Aachs%26aulast%3DDidiuk%26date%3D2009%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26volume%3D19%26spage%3D4555%26epage%3D4559%26jtitle%3DChemical%2520Research%2520in%2520Toxicology%26atitle%3DDiscovery%252BTactics%252BTo%252BMitigate%252BToxicity%252BRisks%252BDue%252Bto%252BReactive%252BMetabolite%252BFormation%252Bwith%252B2-%2525282-Hydroxyaryl%252529-5-%252528trifluoromethyl%252529pyrido%25255B4%25252C3-d%25255Dpyrimidin-4%2525283H%252529-one%252BDerivatives%25252C%252BPotent%252BCalcium-Sensing%252BReceptor%252BAntagonists%252Band%252BClinical%252BCandidate%252528s%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BOsteoporosis%26aulast%3DKalgutkar%26aufirst%3DAmit%2BS.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D12%252004%25202010%26date%3D27052010%26date%3D21062010%26volume%3D23%26issue%3D6%26spage%3D1115%26epage%3D1126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alex  Tuffour</span>, <span class="hlFld-ContribAuthor ">Anthony Adebayiga  Kosiba</span>, <span class="hlFld-ContribAuthor ">Yao  Zhang</span>, <span class="hlFld-ContribAuthor ">Frank Addai  Peprah</span>, <span class="hlFld-ContribAuthor ">Jie  Gu</span>, <span class="hlFld-ContribAuthor ">Haifeng  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Role of the calcium-sensing receptor (CaSR) in cancer metastasis to bone: Identifying a potential therapeutic target. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Reviews on Cancer</span><span> <strong>2021,</strong> <em>1875 </em>
                                    (2)
                                     , 188528. <a href="https://doi.org/10.1016/j.bbcan.2021.188528" title="DOI URL">https://doi.org/10.1016/j.bbcan.2021.188528</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbcan.2021.188528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbcan.2021.188528%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Reviews%2520on%2520Cancer%26atitle%3DRole%252Bof%252Bthe%252Bcalcium-sensing%252Breceptor%252B%252528CaSR%252529%252Bin%252Bcancer%252Bmetastasis%252Bto%252Bbone%25253A%252BIdentifying%252Ba%252Bpotential%252Btherapeutic%252Btarget%26aulast%3DTuffour%26aufirst%3DAlex%26date%3D2021%26volume%3D1875%26issue%3D2%26spage%3D188528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shiyang  Zhou</span>, <span class="hlFld-ContribAuthor ">Gangliang  Huang</span>, <span class="hlFld-ContribAuthor ">Guangying  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological activities of drugs for the treatment of osteoporosis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>197 </em>, 112313. <a href="https://doi.org/10.1016/j.ejmech.2020.112313" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112313</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112313%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bactivities%252Bof%252Bdrugs%252Bfor%252Bthe%252Btreatment%252Bof%252Bosteoporosis%26aulast%3DZhou%26aufirst%3DShiyang%26date%3D2020%26volume%3D197%26spage%3D112313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sebastian  Frees</span>, <span class="hlFld-ContribAuthor ">Ines  Breuksch</span>, <span class="hlFld-ContribAuthor ">Tobias  Haber</span>, <span class="hlFld-ContribAuthor ">Heide-Katharina  Bauer</span>, <span class="hlFld-ContribAuthor ">Claudia  Chavez-Munoz</span>, <span class="hlFld-ContribAuthor ">Peter  Raven</span>, <span class="hlFld-ContribAuthor ">Igor  Moskalev</span>, <span class="hlFld-ContribAuthor ">Ninadh  D´Costa</span>, <span class="hlFld-ContribAuthor ">Zheng  Tan</span>, <span class="hlFld-ContribAuthor ">Mads  Daugaard</span>, <span class="hlFld-ContribAuthor ">Joachim W.  Thüroff</span>, <span class="hlFld-ContribAuthor ">Axel  Haferkamp</span>, <span class="hlFld-ContribAuthor ">Dirk  Prawitt</span>, <span class="hlFld-ContribAuthor ">Alan  So</span>, <span class="hlFld-ContribAuthor ">Walburgis  Brenner</span>. </span><span class="cited-content_cbyCitation_article-title">Calcium-sensing receptor (CaSR) promotes development of bone metastasis in renal cell carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2018,</strong> <em>9 </em>
                                    (21)
                                     , 15766-15779. <a href="https://doi.org/10.18632/oncotarget.24607" title="DOI URL">https://doi.org/10.18632/oncotarget.24607</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.24607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.24607%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DCalcium-sensing%252Breceptor%252B%252528CaSR%252529%252Bpromotes%252Bdevelopment%252Bof%252Bbone%252Bmetastasis%252Bin%252Brenal%252Bcell%252Bcarcinoma%26aulast%3DFrees%26aufirst%3DSebastian%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D21%26spage%3D15766%26epage%3D15779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edward F.  Nemeth</span>, <span class="hlFld-ContribAuthor ">Bradford C.  Van Wagenen</span>, <span class="hlFld-ContribAuthor ">Manuel F.  Balandrin</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Development of Calcimimetic and Calcilytic Compounds. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 1-86. <a href="https://doi.org/10.1016/bs.pmch.2017.12.001" title="DOI URL">https://doi.org/10.1016/bs.pmch.2017.12.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.pmch.2017.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.pmch.2017.12.001%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Band%252BDevelopment%252Bof%252BCalcimimetic%252Band%252BCalcilytic%252BCompounds%26aulast%3DNemeth%26aufirst%3DEdward%2BF.%26date%3D2018%26spage%3D1%26epage%3D86%26pub%3DElsevier%26date%3D2018%26volume%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chuang  Shen</span>, <span class="hlFld-ContribAuthor ">Xiang  Guo</span>, <span class="hlFld-ContribAuthor ">Jun  Yu</span>, <span class="hlFld-ContribAuthor ">Xian-Guo  Zeng</span>, <span class="hlFld-ContribAuthor ">Li  Peng</span>, <span class="hlFld-ContribAuthor ">Chuan-meng  Zhao</span>, <span class="hlFld-ContribAuthor ">Fu-Li  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2-(phenoxymethyl)oxirane derivatives through unexpected rearrangement of oxiran-2-ylmethyl benzenesulfonates. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2017,</strong> <em>47 </em>
                                    (4)
                                     , 273-278. <a href="https://doi.org/10.1080/00397911.2016.1258579" title="DOI URL">https://doi.org/10.1080/00397911.2016.1258579</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2016.1258579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2016.1258579%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DSynthesis%252Bof%252B2-%252528phenoxymethyl%252529oxirane%252Bderivatives%252Bthrough%252Bunexpected%252Brearrangement%252Bof%252Boxiran-2-ylmethyl%252Bbenzenesulfonates%26aulast%3DShen%26aufirst%3DChuang%26date%3D2017%26date%3D2017%26volume%3D47%26issue%3D4%26spage%3D273%26epage%3D278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gui-Bai  Liang</span>, <span class="hlFld-ContribAuthor ">Changyou  Zhou</span>, <span class="hlFld-ContribAuthor ">Xianghong  Huo</span>, <span class="hlFld-ContribAuthor ">Hank  Wang</span>, <span class="hlFld-ContribAuthor ">Xuelin  Yang</span>, <span class="hlFld-ContribAuthor ">Shaoqiang  Huang</span>, <span class="hlFld-ContribAuthor ">Haisheng  Wang</span>, <span class="hlFld-ContribAuthor ">Hilary  Wilkinson</span>, <span class="hlFld-ContribAuthor ">Lusong  Luo</span>, <span class="hlFld-ContribAuthor ">Wei  Tang</span>, <span class="hlFld-ContribAuthor ">David  Sutton</span>, <span class="hlFld-ContribAuthor ">Hong  Li</span>, <span class="hlFld-ContribAuthor ">Dennis  Zaller</span>, <span class="hlFld-ContribAuthor ">Peter T.  Meinke</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel dihydrobenzofuran cyclopropane carboxylic acid based calcium sensing receptor antagonists for the treatment of osteoporosis. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (16)
                                     , 4077-4080. <a href="https://doi.org/10.1016/j.bmcl.2016.06.073" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.06.073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.06.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.06.073%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnovel%252Bdihydrobenzofuran%252Bcyclopropane%252Bcarboxylic%252Bacid%252Bbased%252Bcalcium%252Bsensing%252Breceptor%252Bantagonists%252Bfor%252Bthe%252Btreatment%252Bof%252Bosteoporosis%26aulast%3DLiang%26aufirst%3DGui-Bai%26date%3D2016%26volume%3D26%26issue%3D16%26spage%3D4077%26epage%3D4080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.  Schepelmann</span>, <span class="hlFld-ContribAuthor ">P. L.  Yarova</span>, <span class="hlFld-ContribAuthor ">I.  Lopez-Fernandez</span>, <span class="hlFld-ContribAuthor ">T. S.  Davies</span>, <span class="hlFld-ContribAuthor ">S. C.  Brennan</span>, <span class="hlFld-ContribAuthor ">P. J.  Edwards</span>, <span class="hlFld-ContribAuthor ">A.  Aggarwal</span>, <span class="hlFld-ContribAuthor ">J.  Graça</span>, <span class="hlFld-ContribAuthor ">K.  Rietdorf</span>, <span class="hlFld-ContribAuthor ">V.  Matchkov</span>, <span class="hlFld-ContribAuthor ">R. A.  Fenton</span>, <span class="hlFld-ContribAuthor ">W.  Chang</span>, <span class="hlFld-ContribAuthor ">M.  Krssak</span>, <span class="hlFld-ContribAuthor ">A.  Stewart</span>, <span class="hlFld-ContribAuthor ">K. J.  Broadley</span>, <span class="hlFld-ContribAuthor ">D. T.  Ward</span>, <span class="hlFld-ContribAuthor ">S. A.  Price</span>, <span class="hlFld-ContribAuthor ">D. H.  Edwards</span>, <span class="hlFld-ContribAuthor ">P. J.  Kemp</span>, <span class="hlFld-ContribAuthor ">D.  Riccardi</span>. </span><span class="cited-content_cbyCitation_article-title">The vascular Ca
              2+
              -sensing receptor regulates blood vessel tone and blood pressure. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Physiology-Cell Physiology</span><span> <strong>2016,</strong> <em>310 </em>
                                    (3)
                                     , C193-C204. <a href="https://doi.org/10.1152/ajpcell.00248.2015" title="DOI URL">https://doi.org/10.1152/ajpcell.00248.2015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1152/ajpcell.00248.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1152%2Fajpcell.00248.2015%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Physiology-Cell%2520Physiology%26atitle%3DThe%252Bvascular%252BCa%252B2%25252B%252B-sensing%252Breceptor%252Bregulates%252Bblood%252Bvessel%252Btone%252Band%252Bblood%252Bpressure%26aulast%3DSchepelmann%26aufirst%3DM.%26date%3D2016%26volume%3D310%26issue%3D3%26spage%3DC193%26epage%3DC204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikolai G.  Nikolov</span>, <span class="hlFld-ContribAuthor ">Marianne  Dybdahl</span>, <span class="hlFld-ContribAuthor ">Svava Ó.  Jónsdóttir</span>, <span class="hlFld-ContribAuthor ">Eva B.  Wedebye</span>. </span><span class="cited-content_cbyCitation_article-title">hERG blocking potential of acids and zwitterions characterized by three thresholds for acidity, size and reactivity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (21)
                                     , 6004-6013. <a href="https://doi.org/10.1016/j.bmc.2014.09.007" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.09.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.09.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DhERG%252Bblocking%252Bpotential%252Bof%252Bacids%252Band%252Bzwitterions%252Bcharacterized%252Bby%252Bthree%252Bthresholds%252Bfor%252Bacidity%25252C%252Bsize%252Band%252Breactivity%26aulast%3DNikolov%26aufirst%3DNikolai%2BG.%26date%3D2014%26volume%3D22%26issue%3D21%26spage%3D6004%26epage%3D6013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheng-Li  Zhou</span>, <span class="hlFld-ContribAuthor ">Hsuan-Liang  Liu</span>, <span class="hlFld-ContribAuthor ">Josephine W.  Wu</span>, <span class="hlFld-ContribAuthor ">Cheng-Wen  Tsao</span>, <span class="hlFld-ContribAuthor ">Wei-Hsi  Chen</span>, <span class="hlFld-ContribAuthor ">Kung-Tien  Liu</span>, <span class="hlFld-ContribAuthor ">Yih  Ho</span>. </span><span class="cited-content_cbyCitation_article-title">Combining Structure-Based Pharmacophore and
              In Silico
              Approaches to Discover Novel Selective Serotonin Reuptake Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2013,</strong> <em>82 </em>
                                    (6)
                                     , 705-717. <a href="https://doi.org/10.1111/cbdd.12192" title="DOI URL">https://doi.org/10.1111/cbdd.12192</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12192%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DCombining%252BStructure-Based%252BPharmacophore%252Band%252BIn%252BSilico%252BApproaches%252Bto%252BDiscover%252BNovel%252BSelective%252BSerotonin%252BReuptake%252BInhibitors%26aulast%3DZhou%26aufirst%3DZheng-Li%26date%3D2013%26date%3D2013%26volume%3D82%26issue%3D6%26spage%3D705%26epage%3D717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hans  Maag</span>. </span><span class="cited-content_cbyCitation_article-title">Overcoming poor permeability – the role of prodrugs for oral drug delivery. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today: Technologies</span><span> <strong>2012,</strong> <em>9 </em>
                                    (2)
                                     , e121-e130. <a href="https://doi.org/10.1016/j.ddtec.2012.04.002" title="DOI URL">https://doi.org/10.1016/j.ddtec.2012.04.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ddtec.2012.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ddtec.2012.04.002%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technologies%26atitle%3DOvercoming%252Bpoor%252Bpermeability%252B%2525E2%252580%252593%252Bthe%252Brole%252Bof%252Bprodrugs%252Bfor%252Boral%252Bdrug%252Bdelivery%26aulast%3DMaag%26aufirst%3DHans%26date%3D2012%26volume%3D9%26issue%3D2%26spage%3De121%26epage%3De130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Donald T  Ward</span>, <span class="hlFld-ContribAuthor ">Daniela  Riccardi</span>. </span><span class="cited-content_cbyCitation_article-title">New concepts in calcium-sensing receptor pharmacology and signalling. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2012,</strong> <em>165 </em>
                                    (1)
                                     , 35-48. <a href="https://doi.org/10.1111/j.1476-5381.2011.01511.x" title="DOI URL">https://doi.org/10.1111/j.1476-5381.2011.01511.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1476-5381.2011.01511.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1476-5381.2011.01511.x%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DNew%252Bconcepts%252Bin%252Bcalcium-sensing%252Breceptor%252Bpharmacology%252Band%252Bsignalling%26aulast%3DWard%26aufirst%3DDonald%2BT%26date%3D2012%26date%3D2011%26volume%3D165%26issue%3D1%26spage%3D35%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anson K.  Abraham</span>, <span class="hlFld-ContribAuthor ">Tristan S.  Maurer</span>, <span class="hlFld-ContribAuthor ">Amit S.  Kalgutkar</span>, <span class="hlFld-ContribAuthor ">Xiang  Gao</span>, <span class="hlFld-ContribAuthor ">Mei  Li</span>, <span class="hlFld-ContribAuthor ">David R.  Healy</span>, <span class="hlFld-ContribAuthor ">Donna N.  Petersen</span>, <span class="hlFld-ContribAuthor ">David A.  Griffith</span>, <span class="hlFld-ContribAuthor ">Donald E.  Mager</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacodynamic Model of Parathyroid Hormone Modulation by a Negative Allosteric Modulator of the Calcium-Sensing Receptor. </span><span class="cited-content_cbyCitation_journal-name">The AAPS Journal</span><span> <strong>2011,</strong> <em>13 </em>
                                    (2)
                                     , 265-273. <a href="https://doi.org/10.1208/s12248-011-9266-9" title="DOI URL">https://doi.org/10.1208/s12248-011-9266-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1208/s12248-011-9266-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1208%2Fs12248-011-9266-9%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520AAPS%2520Journal%26atitle%3DPharmacodynamic%252BModel%252Bof%252BParathyroid%252BHormone%252BModulation%252Bby%252Ba%252BNegative%252BAllosteric%252BModulator%252Bof%252Bthe%252BCalcium-Sensing%252BReceptor%26aulast%3DAbraham%26aufirst%3DAnson%2BK.%26date%3D2011%26date%3D2011%26volume%3D13%26issue%3D2%26spage%3D265%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leo  Widler</span>. </span><span class="cited-content_cbyCitation_article-title">Calcilytics: antagonists of the calcium-sensing receptor for the treatment of osteoporosis. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2011,</strong> <em>3 </em>
                                    (5)
                                     , 535-547. <a href="https://doi.org/10.4155/fmc.11.17" title="DOI URL">https://doi.org/10.4155/fmc.11.17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.11.17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.11.17%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DCalcilytics%25253A%252Bantagonists%252Bof%252Bthe%252Bcalcium-sensing%252Breceptor%252Bfor%252Bthe%252Btreatment%252Bof%252Bosteoporosis%26aulast%3DWidler%26aufirst%3DLeo%26date%3D2011%26volume%3D3%26issue%3D5%26spage%3D535%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephan  Urwyler</span>, . </span><span class="cited-content_cbyCitation_article-title">Allosteric Modulation of Family C G-Protein-Coupled Receptors: from Molecular Insights to Therapeutic Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reviews</span><span> <strong>2011,</strong> <em>63 </em>
                                    (1)
                                     , 59-126. <a href="https://doi.org/10.1124/pr.109.002501" title="DOI URL">https://doi.org/10.1124/pr.109.002501</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/pr.109.002501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fpr.109.002501%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reviews%26atitle%3DAllosteric%252BModulation%252Bof%252BFamily%252BC%252BG-Protein-Coupled%252BReceptors%25253A%252Bfrom%252BMolecular%252BInsights%252Bto%252BTherapeutic%252BPerspectives%26aulast%3DUrwyler%26aufirst%3DStephan%26date%3D2011%26date%3D2011%26volume%3D63%26issue%3D1%26spage%3D59%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/medium/jm-2009-00563e_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/large/jm-2009-00563e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900563e&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/medium/jm-2009-00563e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/large/jm-2009-00563e_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Calcimimetic and calcilytic compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/large/jm-2009-00563e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900563e&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/medium/jm-2009-00563e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/large/jm-2009-00563e_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Antagonist <b>5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/large/jm-2009-00563e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900563e&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaH, DMF, (2<i>R</i>)-2-oxiranylmethyl 4-nitrobenzenesulfonate, 0 °C; (b) [1,1-dimethyl-2-(2-naphthalenyl)ethyl]amine, EtOH, 70 °C.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/medium/jm-2009-00563e_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/large/jm-2009-00563e_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Antagonists <b>8</b> and <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/large/jm-2009-00563e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900563e&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DIAD, PPh<sub>3</sub>, (2<i>S</i>)-2-oxiranylmethanol, THF, 0 °C to room temp; (b) [1,1-dimethyl-2-(2-naphthalenyl)ethyl]amine, EtOH, 70 °C; (c) NaOH, EtOH, H<sub>2</sub>O.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/medium/jm-2009-00563e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/large/jm-2009-00563e_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Antagonists <b>11</b> and <b>12</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/large/jm-2009-00563e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900563e&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Br<sub>2</sub>, CHCl<sub>3</sub>, 0 °C; (b) CuCN, NMP, reflux; (c) DIAD, PPh<sub>3</sub>, (2<i>S</i>)-2-oxiranylmethanol, THF, 0 °C to room temp; (d) [1,1-dimethyl-2-(2-naphthalenyl)ethyl]amine, EtOH, 70 °C; (e) CH<sub>3</sub>OH, 3 N NaOH.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/medium/jm-2009-00563e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/large/jm-2009-00563e_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Mean pharmacokinetics and pharmacodynamics of analogue <b>12</b> following the oral dosing of a 23.4 mg/kg suspension dose (1% methylcellulose) of <b>11</b> in the dog (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm900563e/production/images/large/jm-2009-00563e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900563e&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i20">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16785" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16785" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 9 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Bonnick, S. L.</span><span> </span><span class="NLM_article-title">Osteoporosis in men and women</span> <span class="citation_source-journal">Clin. Cornerstone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm900563e&amp;key=10.1016%2FS1098-3597%2806%2980063-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm900563e&amp;key=17591574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A280%3ADC%252BD2sznsF2itQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=28-39&author=S.+L.+Bonnick&title=Osteoporosis+in+men+and+women"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Osteoporosis in men and women</span></div><div class="casAuthors">Bonnick Sydney L</div><div class="citationInfo"><span class="NLM_cas:title">Clinical cornerstone</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-39</span>
        ISSN:<span class="NLM_cas:issn">1098-3597</span>.
    </div><div class="casAbstract">Osteoporosis is a cause of significant morbidity and mortality in postmenopausal women as well as men.  In both men and women, increasing age and low bone mineral density (BMD) are the 2 most important independent risk factors for an initial vertebral or nonvertebral fracture.  Although the prevalence of osteoporosis is greater in women, mortality after fracture is higher among men.  In both men and women, the incidence of vertebral fracture increases with age, although the increase is more marked in women than in men.  The diagnostic criteria for postmenopausal osteoporosis in women are well established; however, there is ongoing debate about the appropriate T-scores and BMD thresholds to diagnose osteoporosis in men.  Alendronate and risedronate are considered first-line therapy for the treatment of both postmenopausal osteoporosis and male osteoporosis.  The efficacy and safety of these agents have been evaluated extensively in randomized clinical trials.  Studies suggest that these agents are similarly efficacious in men and women.  The anabolic agent teriparatide may also be used to treat men with osteoporosis at high risk for fracture.  Studies suggest that treatment with an anabolic agent like teriparatide should be followed by an antiresorptive agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQhRiX7jL_YgfxQvRxYU81tfW6udTcc2eY4Oz-mVuCt4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sznsF2itQ%253D%253D&md5=69bc116a3bf51977a75aeb0c19edf634</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS1098-3597%2806%2980063-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1098-3597%252806%252980063-3%26sid%3Dliteratum%253Aachs%26aulast%3DBonnick%26aufirst%3DS.%2BL.%26atitle%3DOsteoporosis%2520in%2520men%2520and%2520women%26jtitle%3DClin.%2520Cornerstone%26date%3D2006%26volume%3D8%26spage%3D28%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_contrib-group">Bodenner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggs, A.</span><span> </span><span class="NLM_article-title">Teriparatide in the management of osteoporosis</span> <span class="citation_source-journal">Clin. Interventions Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">499</span><span class="NLM_x">–</span> <span class="NLM_lpage">507</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm900563e&amp;key=18225450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1ejsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=499-507&author=D.+Bodennerauthor=C.+Redmanauthor=A.+Riggs&title=Teriparatide+in+the+management+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Teriparatide in the management of osteoporosis</span></div><div class="casAuthors">Bodenner, Donald; Redman, Carolyn; Riggs, Ann</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Interventions in Aging</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">499-507</span>CODEN:
                <span class="NLM_cas:coden">CIALBC</span>;
        ISSN:<span class="NLM_cas:issn">1176-9092</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  Fracture of the hip is frequently a catastrophic event in the elderly, often resulting in death within a year and of the survivors, few regain pre-fracture quality of life.  Although less appreciated, fractures of the spine result in significant morbidity and are also assocd. with increased mortality compared with individuals without a fracture.  In recent years there has been an explosion in the development of new drugs for the treatment of osteoporosis.  Recombinant human parathyroid hormone (1-34) (20 μg/day) is a recent addn. to this armamentarium with a novel mechanism of action, which was approved by the US FDA for the treatment of postmenopausal osteoporosis and male osteoporosis secondary to hypogonadism in Nov. 2002.  It is the first osteoporosis treatment that leads to the formation of new bone with architecture similar to normal bone.  Intense efforts have been made to understand the effect of teriparatide on antiresorptive therapy and vice versa.  Although these relationships are not completely understood, the results of recent studies allow clinicians to begin to optimize therapeutic gains in bone mineral d. and improve anti-fracture efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoah_3atunqZbVg90H21EOLACvtfcHk0liVdQfHlvFNBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1ejsb4%253D&md5=ce7b8894f61d7d67e2e83b9fd03c0520</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBodenner%26aufirst%3DD.%26aulast%3DRedman%26aufirst%3DC.%26aulast%3DRiggs%26aufirst%3DA.%26atitle%3DTeriparatide%2520in%2520the%2520management%2520of%2520osteoporosis%26jtitle%3DClin.%2520Interventions%2520Aging%26date%3D2007%26volume%3D2%26spage%3D499%26epage%3D507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_contrib-group">Bilezikian, J. P.</span><span> </span><span class="NLM_article-title">Anabolic therepy for osteoporosis</span> <span class="citation_source-journal">Women’s Health</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm900563e&amp;key=10.2217%2F17455057.3.2.243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit12qtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=243-253&author=J.+P.+Bilezikian&title=Anabolic+therepy+for+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Anabolic therapy for osteoporosis</span></div><div class="casAuthors">Bilezikian, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Women's Health</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">243-253</span>CODEN:
                <span class="NLM_cas:coden">WHOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1745-5057</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Antiresorptive agents for osteoporosis are a cornerstone of therapy, but anabolic drugs have recently increased our options.  By directly stimulating bone formation, anabolic agents reduce fracture incidence by improving bone qualities as well as increasing bone mass.  The anabolic agent currently approved for osteoporosis, teriparatide (recombinant human parathyroid hormone[1-34]), has emerged as a major approach for selected patients with osteoporosis.  Parathyroid hormone(1-84) is also available in Europe.  Teriparatide increases bone d. and bone turnover, improves microarchitecture and changes bone size.  The incidence of vertebral and nonvertebral fractures is reduced.  A current concept in the mechanism of teriparatide action is related to its effect of stimulating processes assocd. with bone formation before processes assocd. with bone resorption.  This sequence of events has led to the concept of the anabolic window, the period of time when teriparatide is maximally anabolic.  Newer approaches to the use of teriparatide alone and in combination with antiresorptive agents has led to ways in which the anabolic window can be expanded.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKC2jWx9LbarVg90H21EOLACvtfcHk0li-EC-67PKufg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit12qtL0%253D&md5=2e26b6931f831f63477e2f9a8d5f2042</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.2217%2F17455057.3.2.243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252F17455057.3.2.243%26sid%3Dliteratum%253Aachs%26aulast%3DBilezikian%26aufirst%3DJ.%2BP.%26atitle%3DAnabolic%2520therepy%2520for%2520osteoporosis%26jtitle%3DWomen%25E2%2580%2599s%2520Health%26date%3D2007%26volume%3D3%26spage%3D243%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_contrib-group">Girotra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilezikian, J. P.</span><span> </span><span class="NLM_article-title">The use of parathyroid hormone in the treatment of osteoporosis</span> <span class="citation_source-journal">Rev. Endocr. Metab. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Fjm900563e&amp;key=10.1007%2Fs11154-006-9007-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Fjm900563e&amp;key=17043762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12lsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=113-121&author=M.+Girotraauthor=M.+R.+Rubinauthor=J.+P.+Bilezikian&title=The+use+of+parathyroid+hormone+in+the+treatment+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The use of parathyroid hormone in the treatment of osteoporosis</span></div><div class="casAuthors">Girotra, Monica; Rubin, Mishaela R.; Bilezikian, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Reviews in Endocrine & Metabolic Disorders</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">113-121</span>CODEN:
                <span class="NLM_cas:coden">REMDCG</span>;
        ISSN:<span class="NLM_cas:issn">1389-9155</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Anabolic skeletal agents have recently broadened our therapeutic options for osteoporosis.  By directly stimulating bone formation, they reduce fracture incidence by improving bone qualities in addn. to increasing bone mass.  Teriparatide [recombinant human parathyroid hormone(1-34)], the only anabolic agent currently approved in the United States for osteoporosis, has emerged as a major therapeutic approach to selected patients with osteoporosis.  Teriparatide is approved for both postmenopausal women and men with osteoporosis who are at high risk for fracture.  With the use of this anabolic agent, bone d. and bone turnover increase, microarchitecture improves, and bone size is beneficially altered.  The incidence of vertebral and nonvertebral fractures is reduced with teriparatide use.  Combination therapy with parathyroid hormone and an antiresorptive does not appear to offer definitive advantages over the use of PTH or an antiresorptive alone, although recent ideas about combining these agents may offer new insights.  In order to maintain increases in bone d. acquired during PTH therapy, it is important to follow its use with an antiresorptive agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgHX2PVm7hELVg90H21EOLACvtfcHk0li-EC-67PKufg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12lsg%253D%253D&md5=2c3c9d800f166a7236c3314a6730ad79</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1007%2Fs11154-006-9007-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11154-006-9007-z%26sid%3Dliteratum%253Aachs%26aulast%3DGirotra%26aufirst%3DM.%26aulast%3DRubin%26aufirst%3DM.%2BR.%26aulast%3DBilezikian%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520use%2520of%2520parathyroid%2520hormone%2520in%2520the%2520treatment%2520of%2520osteoporosis%26jtitle%3DRev.%2520Endocr.%2520Metab.%2520Disord.%26date%3D2006%26volume%3D7%26spage%3D113%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2d"><span><span class="NLM_contrib-group">Eriksen, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robins, D. A.</span><span> </span><span class="NLM_article-title">Teriparatide: a bone formation treatment for osteoporosis</span> <span class="citation_source-journal">Drugs Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">935</span><span class="NLM_x">–</span> <span class="NLM_lpage">948</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=16&amp;doi=10.1021%2Fjm900563e&amp;key=10.1358%2Fdot.2004.40.11.872582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVSksbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2004&pages=935-948&author=E.+F.+Eriksenauthor=D.+A.+Robins&title=Teriparatide%3A+a+bone+formation+treatment+for+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2dR"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">TERIPARATIDE: A bone formation treatment for osteoporosis</span></div><div class="casAuthors">Eriksen, Erik F.; Robins, Deborah A.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of Today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">935-948</span>CODEN:
                <span class="NLM_cas:coden">MDACAP</span>;
        ISSN:<span class="NLM_cas:issn">0025-7656</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Teriparatide is the recombinant human N-terminal fragment (1-34) of endogenous human parathyroid hormone, and it is the first bone anabolic agent for the treatment of osteoporosis.  When given as once-daily s.c. injections, teriparatide can reverse the course of osteoporosis by stimulating formation of new bone and restoring lost architecture.  Teriparatide (20 μg) treatment of osteoporosis in postmenopausal women rapidly increased markers of bone formation and reduced the incidence of vertebral fractures by 65% and of nonvertebral fragility fractures by 53%.  In addn., treatment with this compd. increased spine bone mineral d. by 10% and hip bone mineral d. by 3% at study endpoint.  Teriparatide is well tolerated and is not assocd. with any serious side effects.  The compd. has been approved in Europe and in the US for the treatment of osteoporosis.  Duration of treatment is 18-24 mo and the dose does not need to be adjusted for age or gender.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1JIdWJtTLw7Vg90H21EOLACvtfcHk0li-EC-67PKufg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVSksbs%253D&md5=636570477d27ee584bc02ce954ecee68</span></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=10.1358%2Fdot.2004.40.11.872582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdot.2004.40.11.872582%26sid%3Dliteratum%253Aachs%26aulast%3DEriksen%26aufirst%3DE.%2BF.%26aulast%3DRobins%26aufirst%3DD.%2BA.%26atitle%3DTeriparatide%253A%2520a%2520bone%2520formation%2520treatment%2520for%2520osteoporosis%26jtitle%3DDrugs%2520Today%26date%3D2004%26volume%3D40%26spage%3D935%26epage%3D948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2e"><span><span class="NLM_contrib-group">Quattrocchi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kourlas, H.</span><span> </span><span class="NLM_article-title">Teriparaitide: a review</span> <span class="citation_source-journal">Clin. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">841</span><span class="NLM_x">–</span> <span class="NLM_lpage">854</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2e&amp;dbid=16&amp;doi=10.1021%2Fjm900563e&amp;key=10.1016%2FS0149-2918%2804%2990128-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2e&amp;dbid=8&amp;doi=10.1021%2Fjm900563e&amp;key=15262455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2e&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsVSisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2004&pages=841-854&author=E.+Quattrocchiauthor=H.+Kourlas&title=Teriparaitide%3A+a+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2eR"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Teriparatide: a review</span></div><div class="casAuthors">Quattrocchi, Elaena; Kourlas, Helen</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">841-854</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review.  Traditionally, the management of osteoporosis in men and women has included the use of antiresorptive agents in combination with calcium and vitamin D supplementation.  The mechanism of action of teriparatide is unique in that it possesses anabolic properties and therefore builds bone.  Since the approval of teriparatide in the United States in 2002, a great deal of interest regarding its use in osteoporosis has developed.  This article reviews the information available on the new recombinant human parathyroid hormone teriparatide (hPTH [1-34]), including its clin. pharmacol., mechanism of action, pharmacokinetic properties, clin. efficacy, safety profile, potential drug interactions, contraindications and warnings, dosage and administration, and pharmacoeconomics.  The articles included in this review were identified through searches of PubMed and MEDLINE (1966-Dec. 2003) and International Pharmaceutical Abstrs. (1970-Dec. 2003).  Search terms included teriparatide, Forteo, recombinant human parathyroid hormone (1-34), and osteoporosis.  The refs. of the identified articles were reviewed for addnl. publications.  Specific product information was also obtained from the manufacturer of teriparatide.  Teriparatide has been studied in postmenopausal women with osteoporosis, drug-induced osteoporosis (specifically, corticosteroid-induced osteoporosis), and men with osteoporosis.  The data available from various clin. trials have shown an increase in both bone mineral d. (BMD) and bone mineral content (BMC) with the use of teriparatide compared with placebo.  One study found that women treated with the 20-μg dose and the 40-μg dose were 35% and 40%, resp., less likely to have one or more new nonvertebral fractures compared with placebo (P = 0.02).  Another study compared the use of daily teriparatide 40-μg injections vs. oral daily alendronate.  Results showed that the incidence of nonvertebral fractures was significantly lower in the teriparatide group than the alendronate group (P < 0.05).  A study using 20- and 40-μg daily injections of teriparatide was performed in men with osteoporosis.  There was a statistically significant increase in lumbar spine BMD of 5.9% in the 20-μg group and 9.0% in the 40-μg group (both, P < 0.001).  In the femoral neck, a 1.5% increase in BMD occurred in the 20-μg group (P = 0.021) and a 0.9% increase in the 40-μg group (P < 0.001).  A limited no. of studies are available assessing the combination of antiresorptive medications and teriparatide; however, the available data suggest that the effects of teriparatide do not require prior stimulation of bone resorption.  Teriparatide has been shown clin. to improve BMD and BMC in postmenopausal women and in men.  Because of its anabolic capabilities, teriparatide can be used as an alternative to the traditional therapies that are currently available for the treatment of osteoporosis, with scheduled monitoring for adverse effects such as hypercalcemia and urinary calcium excretion.  In 1 study, mild hypercalcemia was seen most often 4 to 6 h after SC injection of teriparatide before returning to normal.  Urinary, calcium was obsd. to increase by 30 mg/d (0.75 mmol/d) with teriparatide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYd_uzd7xHu7Vg90H21EOLACvtfcHk0lgk7WC00g62LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsVSisrc%253D&md5=d8ee703da34c306140d2278bd46ebcda</span></div><a href="/servlet/linkout?suffix=cit2e&amp;dbid=16384&amp;doi=10.1016%2FS0149-2918%2804%2990128-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0149-2918%252804%252990128-2%26sid%3Dliteratum%253Aachs%26aulast%3DQuattrocchi%26aufirst%3DE.%26aulast%3DKourlas%26aufirst%3DH.%26atitle%3DTeriparaitide%253A%2520a%2520review%26jtitle%3DClin.%2520Ther.%26date%3D2004%26volume%3D26%26spage%3D841%26epage%3D854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2f"><span><span class="NLM_contrib-group">Dobnig, H.</span><span> </span><span class="NLM_article-title">A review of teriparatide and its clinical efficacy in the treatment of osteoporosis</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">710</span><span class="NLM_x">–</span> <span class="NLM_lpage">718</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2003&pages=710-718&author=H.+Dobnig&title=A+review+of+teriparatide+and+its+clinical+efficacy+in+the+treatment+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDobnig%26aufirst%3DH.%26atitle%3DA%2520review%2520of%2520teriparatide%2520and%2520its%2520clinical%2520efficacy%2520in%2520the%2520treatment%2520of%2520osteoporosis%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2003%26volume%3D57%26spage%3D710%26epage%3D718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2g"><span><span class="NLM_contrib-group">Ebling, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, R. G. G.</span><span> </span><span class="NLM_article-title">Teriparaitide (rhPTH1-34) for the treatment of osteoporosis</span> <span class="citation_source-journal">Int. J. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">710</span><span class="NLM_x">–</span> <span class="NLM_lpage">718</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2g&amp;dbid=8&amp;doi=10.1021%2Fjm900563e&amp;key=14627183" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2003&pages=710-718&author=P.+R.+Eblingauthor=R.+G.+G.+Russell&title=Teriparaitide+%28rhPTH1-34%29+for+the+treatment+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEbling%26aufirst%3DP.%2BR.%26aulast%3DRussell%26aufirst%3DR.%2BG.%2BG.%26atitle%3DTeriparaitide%2520%2528rhPTH1-34%2529%2520for%2520the%2520treatment%2520of%2520osteoporosis%26jtitle%3DInt.%2520J.%2520Clin.%2520Pract.%26date%3D2003%26volume%3D57%26spage%3D710%26epage%3D718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2h"><span><span class="NLM_contrib-group">Berg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumeyer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, P.</span><span> </span><span class="NLM_article-title">Fresh from the pipline: teriparatide</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=257-258&author=C.+Bergauthor=K.+Neumeyerauthor=P.+Kirkpatrick&title=Fresh+from+the+pipline%3A+teriparatide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DC.%26aulast%3DNeumeyer%26aufirst%3DK.%26aulast%3DKirkpatrick%26aufirst%3DP.%26atitle%3DFresh%2520from%2520the%2520pipline%253A%2520teriparatide%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D257%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_contrib-group">Brown, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLeod, R. J.</span><span> </span><span class="NLM_article-title">Extracellular calcium sensing and extracellular calcium signaling</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm900563e&amp;key=10.1152%2Fphysrev.2001.81.1.239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm900563e&amp;key=11152759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitV2ktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2001&pages=239-297&author=E.+M.+Brownauthor=R.+J.+MacLeod&title=Extracellular+calcium+sensing+and+extracellular+calcium+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Extracellular calcium sensing and extracellular calcium signaling</span></div><div class="casAuthors">Brown, Edward M.; MacLeod, R. John</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">239-297</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review, with 481 refs.  The cloning of a G protein-coupled extracellular Ca2+ (Cao2+)-sensing receptor (CaR) has elucidated the mol. basis for many of the previously recognized effects of Cao2+ on tissues that maintain systemic Cao2+ homeostasis, esp. parathyroid chief cells and several cells in the kidney.  The availability of the cloned CaR enabled the development of DNA and antibody probes for identifying the CaR's mRNA and protein, resp., within these and other tissues.  It also permitted the identification of human diseases resulting from inactivating or activating mutations of the CaR gene and the subsequent generation of mice with targeted disruption of the CaR gene.  The characteristic alterations in parathyroid and renal function in these patients and in the mice with knockout of the CaR gene have provided valuable information on the CaR's physiol. roles in these tissues participating in mineral ion homeostasis.  Nevertheless, relatively little is known about how the CaR regulates other tissues involved in systemic Cao2+ homeostasis, particularly bone and intestine.  Moreover, there is evidence that addnl. Cao2+ sensors may exist in bone cells that mediate some or even all of the known effects of Cao2+ on these cells.  Even more remains to be learned about the CaR's function in the rapidly growing list of cells that express it but are uninvolved in systemic Cao2+ metab.  Available data suggest that the receptor serves numerous roles outside of systemic mineral ion homeostasis, ranging from the regulation of hormonal secretion and the activities of various ion channels to the longer term control of gene expression, programmed cell death (apoptosis), and cellular proliferation.  In some cases, the CaR on these non-homeostatic cells responds to local changes in Cao2+ taking place within compartments of the extracellular fluid (ECF) that communicate with the outside environment (e.g., the gastrointestinal tract).  In others, localized changes in Cao2+ within the ECF can originate from several mechanisms, including fluxes of calcium ions into or out of cellular or extracellular stores or across epithelium that absorb or secrete Ca2+.  In any event, the CaR and other receptors/sensors for Cao2+ and probably for other extracellular ions represent versatile regulators of numerous cellular functions and may serve as important therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6uGVgKVIQybVg90H21EOLACvtfcHk0lgk7WC00g62LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitV2ktLo%253D&md5=bdaf576fbde7255da389eb9fa0d84823</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.2001.81.1.239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.2001.81.1.239%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DE.%2BM.%26aulast%3DMacLeod%26aufirst%3DR.%2BJ.%26atitle%3DExtracellular%2520calcium%2520sensing%2520and%2520extracellular%2520calcium%2520signaling%26jtitle%3DPhysiol.%2520Rev.%26date%3D2001%26volume%3D81%26spage%3D239%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_contrib-group">Nemeth, E. F.</span><span> </span><span class="NLM_article-title">Calcium receptor-dependent regulation of cellular functions</span> <span class="citation_source-journal">News Physiol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">5</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADyaK2MXkslequ7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1995&pages=1-5&author=E.+F.+Nemeth&title=Calcium+receptor-dependent+regulation+of+cellular+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Ca2+ receptor-dependent regulation of cellular functions</span></div><div class="casAuthors">Nemeth, Edward F.</div><div class="citationInfo"><span class="NLM_cas:title">News in Physiological Sciences</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">Feb.</span>),
    <span class="NLM_cas:pages">1-5</span>CODEN:
                <span class="NLM_cas:coden">NEPSEY</span>;
        ISSN:<span class="NLM_cas:issn">0886-1714</span>.
    </div><div class="casAbstract">A review, with 15 refs.  A cell-surface Ca2+ receptor enables parathyroid cells to detect and respond to extracellular Ca2+.  The recent cloning of a G protein-coupled Ca2+ receptor solidifies this view.  Ca2+ receptors regulate the activity of various cells and provide novel mol. targets for new pharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmAYKq3zbA7LVg90H21EOLACvtfcHk0lgk7WC00g62LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXkslequ7g%253D&md5=5c0358f59bb52230ca313049fa647144</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26atitle%3DCalcium%2520receptor-dependent%2520regulation%2520of%2520cellular%2520functions%26jtitle%3DNews%2520Physiol.%2520Sci.%26date%3D1995%26volume%3D10%26spage%3D1%26epage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_contrib-group">Brown, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLeod, R. J.</span><span> </span><span class="NLM_article-title">Extracellular calcium sensing and extracellular calcium signaling</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Fjm900563e&amp;key=10.1152%2Fphysrev.2001.81.1.239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Fjm900563e&amp;key=11152759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitV2ktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2001&pages=239-297&author=E.+M.+Brownauthor=R.+J.+MacLeod&title=Extracellular+calcium+sensing+and+extracellular+calcium+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Extracellular calcium sensing and extracellular calcium signaling</span></div><div class="casAuthors">Brown, Edward M.; MacLeod, R. John</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">239-297</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review, with 481 refs.  The cloning of a G protein-coupled extracellular Ca2+ (Cao2+)-sensing receptor (CaR) has elucidated the mol. basis for many of the previously recognized effects of Cao2+ on tissues that maintain systemic Cao2+ homeostasis, esp. parathyroid chief cells and several cells in the kidney.  The availability of the cloned CaR enabled the development of DNA and antibody probes for identifying the CaR's mRNA and protein, resp., within these and other tissues.  It also permitted the identification of human diseases resulting from inactivating or activating mutations of the CaR gene and the subsequent generation of mice with targeted disruption of the CaR gene.  The characteristic alterations in parathyroid and renal function in these patients and in the mice with knockout of the CaR gene have provided valuable information on the CaR's physiol. roles in these tissues participating in mineral ion homeostasis.  Nevertheless, relatively little is known about how the CaR regulates other tissues involved in systemic Cao2+ homeostasis, particularly bone and intestine.  Moreover, there is evidence that addnl. Cao2+ sensors may exist in bone cells that mediate some or even all of the known effects of Cao2+ on these cells.  Even more remains to be learned about the CaR's function in the rapidly growing list of cells that express it but are uninvolved in systemic Cao2+ metab.  Available data suggest that the receptor serves numerous roles outside of systemic mineral ion homeostasis, ranging from the regulation of hormonal secretion and the activities of various ion channels to the longer term control of gene expression, programmed cell death (apoptosis), and cellular proliferation.  In some cases, the CaR on these non-homeostatic cells responds to local changes in Cao2+ taking place within compartments of the extracellular fluid (ECF) that communicate with the outside environment (e.g., the gastrointestinal tract).  In others, localized changes in Cao2+ within the ECF can originate from several mechanisms, including fluxes of calcium ions into or out of cellular or extracellular stores or across epithelium that absorb or secrete Ca2+.  In any event, the CaR and other receptors/sensors for Cao2+ and probably for other extracellular ions represent versatile regulators of numerous cellular functions and may serve as important therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6uGVgKVIQybVg90H21EOLACvtfcHk0lgk7WC00g62LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitV2ktLo%253D&md5=bdaf576fbde7255da389eb9fa0d84823</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.2001.81.1.239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.2001.81.1.239%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DE.%2BM.%26aulast%3DMacLeod%26aufirst%3DR.%2BJ.%26atitle%3DExtracellular%2520calcium%2520sensing%2520and%2520extracellular%2520calcium%2520signaling%26jtitle%3DPhysiol.%2520Rev.%26date%3D2001%26volume%3D81%26spage%3D239%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3d"><span><span class="NLM_contrib-group">Chen, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, W. G.</span><span> </span><span class="NLM_article-title">Role of the calcium-sensing receptor in parathyroid gland physiology</span> <span class="citation_source-journal">Am. J. Physiol.: Renal Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">F1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">F1011</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2004&pages=F1005-F1011&author=R.+A.+Chenauthor=W.+G.+Goodman&title=Role+of+the+calcium-sensing+receptor+in+parathyroid+gland+physiology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DR.%2BA.%26aulast%3DGoodman%26aufirst%3DW.%2BG.%26atitle%3DRole%2520of%2520the%2520calcium-sensing%2520receptor%2520in%2520parathyroid%2520gland%2520physiology%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Renal%2520Physiol.%26date%3D2004%26volume%3D286%26spage%3DF1005%26epage%3DF1011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3e"><span><span class="NLM_contrib-group">Tfelt-Hansen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, E. M.</span><span> </span><span class="NLM_article-title">The calcium-sensing receptor in normal physiology and pathophysiology: a review</span> <span class="citation_source-journal">Crit. Rev. Clin. Lab. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3e&amp;dbid=16&amp;doi=10.1021%2Fjm900563e&amp;key=10.1080%2F10408360590886606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3e&amp;dbid=8&amp;doi=10.1021%2Fjm900563e&amp;key=15697170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3e&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFSnsbrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2005&pages=35-70&author=J.+Tfelt-Hansenauthor=E.+M.+Brown&title=The+calcium-sensing+receptor+in+normal+physiology+and+pathophysiology%3A+a+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3eR"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The Calcium-Sensing Receptor in Normal Physiology and Pathophysiology: A Review</span></div><div class="casAuthors">Tfelt-Hansen, Jacob; Brown, Edward</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Clinical Laboratory Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-70</span>CODEN:
                <span class="NLM_cas:coden">CRCLBH</span>;
        ISSN:<span class="NLM_cas:issn">1040-8363</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A review.  The discovery of a G protein-coupled, calcium-sensing receptor (CaR) a decade ago and of diseases caused by CaR mutations provided unquestionable evidence of the CaR's crit. role in the maintenance of systemic calcium homeostasis.  On the cell membrane of the chief cells of the parathyroid glands, the CaR "senses" the extracellular calcium concn. and, subsequently, alters the release of parathyroid hormone (PTH).  The CaR is likewise functionally expressed in bone, kidney, and gut-the three major calcium-translocating organs involved in calcium homeostasis.  Intracellular signal pathways to which the CaR couples via its assocd. G proteins include phospholipase C (PLC), protein kinase B (AKT); and mitogen-activated protein kinases (MAPKs).  The receptor is widely expressed in various tissues and regulates important cellular functions in addn. to its role in maintaining systemic calcium homeostasis, i.e., protection against apoptosis, cellular proliferation, and membrane voltage.  Functionally significant mutations in the receptor have been shown to induce diseases of calcium homeostasis owing to changes in the set point for calcium-regulated PTH release as well as alterations in the renal handling of calcium.  Gain-of-function mutations cause hypocalcemia, whereas loss-of-function mutations produce hypercalcemia.  Recent studies have shown that the latter clin. presentation can also be caused by inactivating autoantibodies directed against the CaR.  Newly discovered type II allosteric activators of the CaR have been found to be effective as a medical treatment for renal secondary hyperparathyroidism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoguMPL6ZwnCrVg90H21EOLACvtfcHk0lip-0SFgfc3aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFSnsbrE&md5=341363042e4477a3c4e35bba0395b201</span></div><a href="/servlet/linkout?suffix=cit3e&amp;dbid=16384&amp;doi=10.1080%2F10408360590886606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10408360590886606%26sid%3Dliteratum%253Aachs%26aulast%3DTfelt-Hansen%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DE.%2BM.%26atitle%3DThe%2520calcium-sensing%2520receptor%2520in%2520normal%2520physiology%2520and%2520pathophysiology%253A%2520a%2520review%26jtitle%3DCrit.%2520Rev.%2520Clin.%2520Lab.%2520Sci.%26date%3D2005%26volume%3D42%26spage%3D35%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_contrib-group">Locatelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pontoriero, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limbardo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tentori, F.</span><span> </span><span class="NLM_article-title">Cinacalcet hydrochloride: calcimimnetic for the treatment of hyperparathyroidism</span> <span class="citation_source-journal">Expert Opin. Endocr. Metabol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm900563e&amp;key=10.1586%2F17446651.1.2.167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsVyjtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=167-179&author=F.+Locatelliauthor=G.+Pontorieroauthor=M.+Limbardoauthor=F.+Tentori&title=Cinacalcet+hydrochloride%3A+calcimimnetic+for+the+treatment+of+hyperparathyroidism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cinacalcet hydrochloride: calcimimetic for the treatment of hyperparathyroidism</span></div><div class="casAuthors">Locatelli, Francesco; Pontoriero, Giuseppe; Limardo, Monica; Tentori, Flavia</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Endocrinology & Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-179</span>CODEN:
                <span class="NLM_cas:coden">EREMBI</span>;
        ISSN:<span class="NLM_cas:issn">1744-6651</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Mineral metab. disorders, including those related to secondary hyperparathyroidism, affect a large no. of patients with chronic kidney disease and are assocd. with increased relative risk of morbidity and mortality in hemodialysis patients.  The traditional therapy of secondary hyperparathyroidism based on vitamin D compds. and calcium-based phosphate binders is often limited by the increase of serum calcium and phosphorus levels limiting the dose that can be given safely, and thus, preventing the attainment of treatment targets.  Cinacalcet hydrochloride (Sensipar, Mimpara, Parareg) is the first in a new class of therapeutic agents, the calcimimetics, that increase the sensitivity of calcium-sensing receptors to the extracellular calcium ions, thus lowering parathyroid hormone prodn. and release, decreasing serum calcium and phosphorous concns. simultaneously.  Different randomized, double-blind, placebo-controlled trials evaluated the safety and ability of cinacalcet hydrochloride treatment to improve achievement of target levels of parathyroid hormone, calcium, phosphorus and calcium phosphorus product in dialysis patients.  Cinacalcet hydrochloride has also demonstrated to be effective in reducing parathyroid hormone and serum calcium concns. in patients with primary hyperparathyroidism.  On the basis of available data, calcimimetics represent an important innovation and will change the management of mineral metab. disorders in patients with chronic kidney disease and primary hyperparathyroidism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqokYx_j51YkLVg90H21EOLACvtfcHk0lip-0SFgfc3aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsVyjtLg%253D&md5=1f846e815b348b14531f5232dd19b37a</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1586%2F17446651.1.2.167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F17446651.1.2.167%26sid%3Dliteratum%253Aachs%26aulast%3DLocatelli%26aufirst%3DF.%26aulast%3DPontoriero%26aufirst%3DG.%26aulast%3DLimbardo%26aufirst%3DM.%26aulast%3DTentori%26aufirst%3DF.%26atitle%3DCinacalcet%2520hydrochloride%253A%2520calcimimnetic%2520for%2520the%2520treatment%2520of%2520hyperparathyroidism%26jtitle%3DExpert%2520Opin.%2520Endocr.%2520Metabol.%26date%3D2006%26volume%3D1%26spage%3D167%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_contrib-group">Dong, B. J.</span><span> </span><span class="NLM_article-title">Cinacalcet: an oral calcimimetic agent for the management of hyperparathyroidism</span> <span class="citation_source-journal">Clin. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1725</span><span class="NLM_x">–</span> <span class="NLM_lpage">1751</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm900563e&amp;key=10.1016%2Fj.clinthera.2005.11.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm900563e&amp;key=16368445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADC%252BD28XntlWnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2005&pages=1725-1751&author=B.+J.+Dong&title=Cinacalcet%3A+an+oral+calcimimetic+agent+for+the+management+of+hyperparathyroidism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cinacalcet: an oral calcimimetic agent for the management of hyperparathyroidism</span></div><div class="casAuthors">Dong, Betty J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1725-1751</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review.  Uncontrolled hyperparathyroidism (HPT), particularly HPT resulting from chronic kidney disease (CKD), is assocd. with significant morbidity and cardiovascular mortality.  Traditional medical therapy (eg, vitamin D sterols, calcium, phosphate binders) has been inadequate for the management of HPT and its vascular and skeletal complications.  The goal of this article was to review the efficacy and safety profile of cinacalcet, a second-generation calcimimetic, in the management of HPT secondary to CKD, primary HPT, and parathyroid carcinoma.  MEDLINE, Web of Science, and International Pharmaceutical Abstrs. were searched from 1995 to July 2005 using the terms cinacalcet, AMG 073, KRN 1493, calcimimetics, hypercalcemia, and hyperparathyroidism.  Compared with placebo, cinacalcet significantly reduced parathyroid hormone levels within 2 to 4 h after administration (P < 0.05).  In Phase III trials involving 1136 patients with secondary HPT, 56% of those who received cinacalcet achieved the National Kidney Foundation Kidney Disease Outcomes Quality Initiative target of a redn. in parathyroid hormone to <300 pg/mL, 65% achieved a calcium-phosphorus product <55 mg2/dL2, and a resp. 49% and 46% achieved normalized serum calcium and phosphorus levels (P < 0.001).  Cinacalcet's effects were similar regardless of patients' demog. characteristics, duration or mode of dialysis, severity of HPT, or use of concomitant medical therapy.  Preliminary evidence suggests that cinacalcet may reverse cortical bone loss.  Cinacalcet was well tolerated, with nausea (31%) and vomiting (27%) being the most commonly reported adverse effects.  Hypocalcemia was transient in 5% of patients, was usually asymptomatic, and was cor. by dose redn.  Based on the available evidence, cinacalcet is effective and well tolerated in the treatment of secondary HPT and refractory parathyroid carcinoma.  Its use in primary HPT appears promising.  Further investigations are needed to det. if cinacalcet can prevent the long-term complications of HPT and reduce mortality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpua2ISxtUru7Vg90H21EOLACvtfcHk0lip-0SFgfc3aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntlWnuw%253D%253D&md5=fb128fa6543bc3e7dd33c05892a5979c</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1016%2Fj.clinthera.2005.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinthera.2005.11.015%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DB.%2BJ.%26atitle%3DCinacalcet%253A%2520an%2520oral%2520calcimimetic%2520agent%2520for%2520the%2520management%2520of%2520hyperparathyroidism%26jtitle%3DClin.%2520Ther.%26date%3D2005%26volume%3D27%26spage%3D1725%26epage%3D1751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_contrib-group">de Francisco, A. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cinacalcet, H. C. L.</span><span> </span><span class="NLM_article-title">A novel therapeutic for the treatment of hyperparathyroidism</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">452</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Fjm900563e&amp;key=10.1517%2F14656566.6.3.441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Fjm900563e&amp;key=15794735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVyrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=441-452&author=A.+L.+M.+de+Franciscoauthor=H.+C.+L.+Cinacalcet&title=A+novel+therapeutic+for+the+treatment+of+hyperparathyroidism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cinacalcet HCl: A novel therapeutic for hyperparathyroidism</span></div><div class="casAuthors">de Francisco, Angel L. M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">441-452</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Hyperparathyroidism (HPT) is a significant clin. concern for patients with a variety of diseases, notably the secondary HPT assocd. with chronic kidney disease requiring dialysis.  Secondary HPT is assocd. with elevated parathyroid hormone (PTH) levels, decreased levels of 1,25 dihydroxyvitamin D, and disordered mineral levels (usually high calcium and phosphorus).  If not controlled, secondary HPT can result in bone disease, vascular calcification, and ultimately, patient mortality.  Established, conventional therapies, such as 1,25 dihydroxyvitamin D analogs (vitamin D analogs) and phosphate binders, have proven to be inadequate in enabling patients to meet the National Kidney Foundation's-Kidney Disease Outcomes Quality Initiative (NKF-K/DOQI) treatment goals for PTH, calcium and phosphorus levels.  A novel therapeutic, cinacalcet HCl (formerly AMG 073; Sensipar in the US and Mimpara in Europe; Amgen, Inc.), binds directly to the calcium-sensing receptor (CaR) on the cells of the parathyroid gland, increasing the receptor's sensitivity to calcium and reducing PTH, serum calcium and phosphorus levels.  Treatment with cinacalcet in clin. trials has safely and effectively improved achievement of the NKF-K/DOQI goals.  Cinacalcet has also reduced serum calcium levels in patients with primary HPT, including parathyroid carcinoma, in the clin. trial setting.  Evidence suggesting the utility of cinacalcet in these diseases and the potential for addnl. therapeutic applications will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotj4JefW4n8rVg90H21EOLACvtfcHk0lgC6519npWCDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVyrtr0%253D&md5=6047d3cacc2148532f4d737c9c0c8cfc</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1517%2F14656566.6.3.441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.6.3.441%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BFrancisco%26aufirst%3DA.%2BL.%2BM.%26aulast%3DCinacalcet%26aufirst%3DH.%2BC.%2BL.%26atitle%3DA%2520novel%2520therapeutic%2520for%2520the%2520treatment%2520of%2520hyperparathyroidism%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2005%26volume%3D6%26spage%3D441%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delmar, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleason, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span> </span><span class="NLM_article-title">Calcilytic compounds: potent and selective Ca<sup>+2</sup> receptor antagonists that stimulate secretion of parathyroid hormone</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm900563e&amp;key=11561095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntFWltbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2001&pages=323-331&author=E.+F.+Nemethauthor=E.+C.+Delmarauthor=W.+L.+Heatonauthor=M.+A.+Millerauthor=L.+D.+Lambertauthor=R.+L.+Conklinauthor=M.+Gowenauthor=J.+G.+Gleasonauthor=P.+K.+Bhatnagarauthor=J.+Fox&title=Calcilytic+compounds%3A+potent+and+selective+Ca%2B2+receptor+antagonists+that+stimulate+secretion+of+parathyroid+hormone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Calcilytic compounds: potent and selective Ca2+ receptor antagonists that stimulate secretion of parathyroid hormone</span></div><div class="casAuthors">Nemeth, Edward F.; Delmar, Eric G.; Heaton, William L.; Miller, Michael A.; Lambert, Lyssa D.; Conklin, Rebecca L.; Gowen, Maxine; Gleason, John G.; Bhatnagar, Pradip K.; Fox, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">323-331</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Despite the discovery of many ions and mols. that activate the Ca2+ receptor, there are no known ligands that block this receptor.  Reported here are the pharmacodynamic properties of a small mol., NPS 2143, which acts as an antagonist at the Ca2+ receptor.  This compd. blocked (IC50 of 43 nM) increases in cytoplasmic Ca2+ concns. [Ca2+]i elicited by activating the Ca2+ receptor in HEK 293 cells expressing the human Ca2+ receptor.  NPS 2143, even when tested at much higher concns. (3 μM), did not affect the activity of a no. of other G protein-coupled receptors, including those most structurally homologous to the Ca2+ receptor.  NPS 2143 stimulated parathyroid hormone (PTH) secretion from bovine parathyroid cells (EC50 of 41 nM) over a range of extracellular Ca2+ concns. and reversed the effects of the calcimimetic compd. NPS R-467 on [Ca2+]i and on secretion of PTH.  When infused i.v. in normal rats, NPS 2143 caused a rapid and large increase in plasma levels of PTH.  Ca2+ receptor antagonists are termed calcilytics and NPS 2143 is the first substance (either at. or mol.) shown to possess such activity.  The pharmacodynamic properties of NPS 2143 together with the recently demonstrated effects of this compd. on bone formation support the view that orally active calcilytic compds. might provide a novel anabolic therapy for osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5irxzzwLOvbVg90H21EOLACvtfcHk0lgC6519npWCDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntFWltbk%253D&md5=14cedbe167bc3f0de96cec16d9ce73b4</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DDelmar%26aufirst%3DE.%2BC.%26aulast%3DHeaton%26aufirst%3DW.%2BL.%26aulast%3DMiller%26aufirst%3DM.%2BA.%26aulast%3DLambert%26aufirst%3DL.%2BD.%26aulast%3DConklin%26aufirst%3DR.%2BL.%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DGleason%26aufirst%3DJ.%2BG.%26aulast%3DBhatnagar%26aufirst%3DP.%2BK.%26aulast%3DFox%26aufirst%3DJ.%26atitle%3DCalcilytic%2520compounds%253A%2520potent%2520and%2520selective%2520Ca%252B2%2520receptor%2520antagonists%2520that%2520stimulate%2520secretion%2520of%2520parathyroid%2520hormone%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D299%26spage%3D323%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroup, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodds, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Votta, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lago, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Mar, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span> </span><span class="NLM_article-title">Antagonizing the parathyroid calcium receptor stimulates parathyroid secretion and bone formation in osteopenic rats</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">1595</span><span class="NLM_x">–</span> <span class="NLM_lpage">1604</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2000&pages=1595-1604&author=M.+Gowenauthor=G.+B.+Stroupauthor=R.+A.+Doddsauthor=I.+E.+Jamesauthor=B.+J.+Vottaauthor=B.+R.+Smithauthor=P.+K.+Bhatnagarauthor=A.+M.+Lagoauthor=J.+F.+Callahanauthor=E.+G.+Del+Marauthor=M.+A.+Millerauthor=E.+F.+Nemethauthor=J.+Fox&title=Antagonizing+the+parathyroid+calcium+receptor+stimulates+parathyroid+secretion+and+bone+formation+in+osteopenic+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DStroup%26aufirst%3DG.%2BB.%26aulast%3DDodds%26aufirst%3DR.%2BA.%26aulast%3DJames%26aufirst%3DI.%2BE.%26aulast%3DVotta%26aufirst%3DB.%2BJ.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DBhatnagar%26aufirst%3DP.%2BK.%26aulast%3DLago%26aufirst%3DA.%2BM.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DDel%2BMar%26aufirst%3DE.%2BG.%26aulast%3DMiller%26aufirst%3DM.%2BA.%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DFox%26aufirst%3DJ.%26atitle%3DAntagonizing%2520the%2520parathyroid%2520calcium%2520receptor%2520stimulates%2520parathyroid%2520secretion%2520and%2520bone%2520formation%2520in%2520osteopenic%2520rats%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2000%26volume%3D105%26spage%3D1595%26epage%3D1604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_contrib-group">Arey, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swartz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, J. K.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feyen, J. H. M.</span><span> </span><span class="NLM_article-title">A novel calcium-sensing receptor antagonist transiently stimulates parathyroid hormone secretion in vivo</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1131</span><span class="NLM_x">–</span> <span class="NLM_lpage">1136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1131-1136&author=B.+J.+Areyauthor=R.+Seethalaauthor=Z.+Maauthor=A.+Furaauthor=J.+Morinauthor=J.+Swartzauthor=V.+Vyasauthor=W.+Yangauthor=J.+K.+Dicksonauthor=J.+H.+M.+Feyen&title=A+novel+calcium-sensing+receptor+antagonist+transiently+stimulates+parathyroid+hormone+secretion+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArey%26aufirst%3DB.%2BJ.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DMorin%26aufirst%3DJ.%26aulast%3DSwartz%26aufirst%3DJ.%26aulast%3DVyas%26aufirst%3DV.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DDickson%26aufirst%3DJ.%2BK.%26aulast%3DFeyen%26aufirst%3DJ.%2BH.%2BM.%26atitle%3DA%2520novel%2520calcium-sensing%2520receptor%2520antagonist%2520transiently%2520stimulates%2520parathyroid%2520hormone%2520secretion%2520in%2520vivo%26jtitle%3DEndocrinology%26date%3D2005%26volume%3D5%26spage%3D1131%26epage%3D1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_contrib-group">Dauban, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, R. H.</span><span> </span><span class="NLM_article-title"><i>N</i><sup>1</sup>-Arylsulfonyl-<i>N</i><sup>2</sup>-(1-aryl)ethyl-3-phenylpropane-1,2-diamines as novel calcimimetics acting on the calcium sensing receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2001</span><span class="NLM_x">–</span> <span class="NLM_lpage">2004</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=2001-2004&author=P.+Daubanauthor=S.+Ferryauthor=H.+Faureauthor=M.+Ruatauthor=R.+H.+Dodd&title=N1-Arylsulfonyl-N2-%281-aryl%29ethyl-3-phenylpropane-1%2C2-diamines+as+novel+calcimimetics+acting+on+the+calcium+sensing+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDauban%26aufirst%3DP.%26aulast%3DFerry%26aufirst%3DS.%26aulast%3DFaure%26aufirst%3DH.%26aulast%3DRuat%26aufirst%3DM.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26atitle%3DN1-Arylsulfonyl-N2-%25281-aryl%2529ethyl-3-phenylpropane-1%252C2-diamines%2520as%2520novel%2520calcimimetics%2520acting%2520on%2520the%2520calcium%2520sensing%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D2001%26epage%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5e"><span><span class="NLM_contrib-group">Kessler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauban, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, R. H.</span><span> </span><span class="NLM_article-title"><i>N</i><sup>2</sup>-Benzyl-<i>N</i><sup>1</sup>-(1-(1-naphthyl)ethyl)-3-phenylpropane-1,2-diamines and conformationally constrained indole analogues: development of calindol as a new calcimimetic acting at the calcium-sensing receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3345</span><span class="NLM_x">–</span> <span class="NLM_lpage">3349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3345-3349&author=A.+Kesslerauthor=H.+Faureauthor=M.+Ruatauthor=P.+Daubanauthor=R.+H.+Dodd&title=N2-Benzyl-N1-%281-%281-naphthyl%29ethyl%29-3-phenylpropane-1%2C2-diamines+and+conformationally+constrained+indole+analogues%3A+development+of+calindol+as+a+new+calcimimetic+acting+at+the+calcium-sensing+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKessler%26aufirst%3DA.%26aulast%3DFaure%26aufirst%3DH.%26aulast%3DRuat%26aufirst%3DM.%26aulast%3DDauban%26aufirst%3DP.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26atitle%3DN2-Benzyl-N1-%25281-%25281-naphthyl%2529ethyl%2529-3-phenylpropane-1%252C2-diamines%2520and%2520conformationally%2520constrained%2520indole%2520analogues%253A%2520development%2520of%2520calindol%2520as%2520a%2520new%2520calcimimetic%2520acting%2520at%2520the%2520calcium-sensing%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3345%26epage%3D3349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5f"><span><span class="NLM_contrib-group">Kessler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roussanne, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauben, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, R. H.</span><span> </span><span class="NLM_article-title"><i>N</i><sup>1</sup>-Arylsulfonyl-<i>N</i><sup>2</sup>-(1-(1-naphthyl)ethyl)-1,2-diaminocyclohexanes: a new class of calcilytic agents acting at the calcium-sensing receptor</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1131</span><span class="NLM_x">–</span> <span class="NLM_lpage">1136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=1131-1136&author=A.+Kesslerauthor=H.+Faureauthor=M.+C.+Roussanneauthor=S.+Ferryauthor=M.+Ruatauthor=P.+Daubenauthor=R.+H.+Dodd&title=N1-Arylsulfonyl-N2-%281-%281-naphthyl%29ethyl%29-1%2C2-diaminocyclohexanes%3A+a+new+class+of+calcilytic+agents+acting+at+the+calcium-sensing+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKessler%26aufirst%3DA.%26aulast%3DFaure%26aufirst%3DH.%26aulast%3DRoussanne%26aufirst%3DM.%2BC.%26aulast%3DFerry%26aufirst%3DS.%26aulast%3DRuat%26aufirst%3DM.%26aulast%3DDauben%26aufirst%3DP.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26atitle%3DN1-Arylsulfonyl-N2-%25281-%25281-naphthyl%2529ethyl%2529-1%252C2-diaminocyclohexanes%253A%2520a%2520new%2520class%2520of%2520calcilytic%2520agents%2520acting%2520at%2520the%2520calcium-sensing%2520receptor%26jtitle%3DChemBioChem%26date%3D2004%26volume%3D5%26spage%3D1131%26epage%3D1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5g"><span><span class="NLM_contrib-group">Arey, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swartz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, J. K.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feyen, J. H. M.</span><span> </span><span class="NLM_article-title">A novel calcium-sensing receptor antagonist transiently stimulates parathyroid hormone secretion in vivo</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1131</span><span class="NLM_x">–</span> <span class="NLM_lpage">1136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1131-1136&author=B.+J.+Areyauthor=R.+Seethalaauthor=Z.+Maauthor=A.+Furaauthor=J.+Morinauthor=J.+Swartzauthor=V.+Vyasauthor=W.+Yangauthor=J.+K.+Dicksonauthor=J.+H.+M.+Feyen&title=A+novel+calcium-sensing+receptor+antagonist+transiently+stimulates+parathyroid+hormone+secretion+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArey%26aufirst%3DB.%2BJ.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DMorin%26aufirst%3DJ.%26aulast%3DSwartz%26aufirst%3DJ.%26aulast%3DVyas%26aufirst%3DV.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DDickson%26aufirst%3DJ.%2BK.%26aulast%3DFeyen%26aufirst%3DJ.%2BH.%2BM.%26atitle%3DA%2520novel%2520calcium-sensing%2520receptor%2520antagonist%2520transiently%2520stimulates%2520parathyroid%2520hormone%2520secretion%2520in%2520vivo%26jtitle%3DEndocrinology%26date%3D2005%26volume%3D5%26spage%3D1131%26epage%3D1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5h"><span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberge, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawerence, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotella, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feyen, J. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, J. K.,  Jr.</span><span> </span><span class="NLM_article-title">Discovery and structure activity relationships of benzylpyrrolidine substituted aryloxypropanols as calcium-sensing receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1225</span><span class="NLM_x">–</span> <span class="NLM_lpage">1228</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1225-1228&author=W.+Yangauthor=Y.+Wangauthor=J.+Y.+Robergeauthor=Z.+Maauthor=Y.+Liuauthor=R.+M.+Lawerenceauthor=D.+P.+Rotellaauthor=R.+Seethalaauthor=J.+H.+M.+Feyenauthor=J.+K.+Dickson&title=Discovery+and+structure+activity+relationships+of+benzylpyrrolidine+substituted+aryloxypropanols+as+calcium-sensing+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DRoberge%26aufirst%3DJ.%2BY.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLawerence%26aufirst%3DR.%2BM.%26aulast%3DRotella%26aufirst%3DD.%2BP.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DFeyen%26aufirst%3DJ.%2BH.%2BM.%26aulast%3DDickson%26aufirst%3DJ.%2BK.%26atitle%3DDiscovery%2520and%2520structure%2520activity%2520relationships%2520of%2520benzylpyrrolidine%2520substituted%2520aryloxypropanols%2520as%2520calcium-sensing%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1225%26epage%3D1228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5i"><span><span class="NLM_contrib-group">Gavai, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaz, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikkilineni, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberge, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corte, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednarz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, J. K.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feyen, J. H. M.</span><span> </span><span class="NLM_article-title">Discovery of novel 1-arylmethyl pyrrolidin-2-yl ethanol amines as calcium-sensing receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">5478</span><span class="NLM_x">–</span> <span class="NLM_lpage">5482</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=5478-5482&author=A.+V.+Gavaiauthor=R.+J.+Vazauthor=A.+B.+Mikkilineniauthor=J.+Y.+Robergeauthor=Y.+Liuauthor=R.+M.+Lawrenceauthor=J.+R.+Corteauthor=W.+Yangauthor=M.+Bednarzauthor=J.+K.+Dicksonauthor=Z.+Maauthor=R.+Seethalaauthor=J.+H.+M.+Feyen&title=Discovery+of+novel+1-arylmethyl+pyrrolidin-2-yl+ethanol+amines+as+calcium-sensing+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGavai%26aufirst%3DA.%2BV.%26aulast%3DVaz%26aufirst%3DR.%2BJ.%26aulast%3DMikkilineni%26aufirst%3DA.%2BB.%26aulast%3DRoberge%26aufirst%3DJ.%2BY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLawrence%26aufirst%3DR.%2BM.%26aulast%3DCorte%26aufirst%3DJ.%2BR.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DBednarz%26aufirst%3DM.%26aulast%3DDickson%26aufirst%3DJ.%2BK.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DFeyen%26aufirst%3DJ.%2BH.%2BM.%26atitle%3DDiscovery%2520of%2520novel%25201-arylmethyl%2520pyrrolidin-2-yl%2520ethanol%2520amines%2520as%2520calcium-sensing%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D5478%26epage%3D5482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5j"><span><span class="NLM_contrib-group">Shcherbakova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balandrin, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghatak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, R. L.</span><span> </span><span class="NLM_article-title">3H-Quinazolin-4-ones as a new calcilytic template for the potential treatment of osteoporosis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1557</span><span class="NLM_x">–</span> <span class="NLM_lpage">1560</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1557-1560&author=I.+Shcherbakovaauthor=M.+F.+Balandrinauthor=J.+Foxauthor=A.+Ghatakauthor=W.+Heatonauthor=R.+L.+Conklin&title=3H-Quinazolin-4-ones+as+a+new+calcilytic+template+for+the+potential+treatment+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShcherbakova%26aufirst%3DI.%26aulast%3DBalandrin%26aufirst%3DM.%2BF.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DGhatak%26aufirst%3DA.%26aulast%3DHeaton%26aufirst%3DW.%26aulast%3DConklin%26aufirst%3DR.%2BL.%26atitle%3D3H-Quinazolin-4-ones%2520as%2520a%2520new%2520calcilytic%2520template%2520for%2520the%2520potential%2520treatment%2520of%2520osteoporosis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1557%26epage%3D1560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5k"><span><span class="NLM_contrib-group">Shcherbakova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoffroy, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swierczek, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balandrin, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, R. L.</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2537</span><span class="NLM_x">–</span> <span class="NLM_lpage">2540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Shcherbakova%2C+I.%3B+Huang%2C+G.%3B+Geoffroy%2C+O.+J.%3B+Nair%2C+S.+K.%3B+Swierczek%2C+K.%3B+Balandrin%2C+M.+F.%3B+Fox%2C+J.%3B+Heaton%2C+W.+L.%3B+Conklin%2C+R.+L.Bioorg.+Med.+Chem.+Lett.+2005%2C+15%2C+2537%E2%80%932540"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5k&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShcherbakova%26aufirst%3DI.%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DGeoffroy%26aufirst%3DO.%2BJ.%26aulast%3DNair%26aufirst%3DS.%2BK.%26aulast%3DSwierczek%26aufirst%3DK.%26aulast%3DBalandrin%26aufirst%3DM.%2BF.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DHeaton%26aufirst%3DW.%2BL.%26aulast%3DConklin%26aufirst%3DR.%2BL.%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2537%26epage%3D2540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_contrib-group">Dobnig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, R. T.</span><span> </span><span class="NLM_article-title">Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">3632</span><span class="NLM_x">–</span> <span class="NLM_lpage">3638</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=1995&pages=3632-3638&author=H.+Dobnigauthor=R.+T.+Turner&title=Evidence+that+intermittent+treatment+with+parathyroid+hormone+increases+bone+formation+in+adult+rats+by+activation+of+bone+lining+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDobnig%26aufirst%3DH.%26aulast%3DTurner%26aufirst%3DR.%2BT.%26atitle%3DEvidence%2520that%2520intermittent%2520treatment%2520with%2520parathyroid%2520hormone%2520increases%2520bone%2520formation%2520in%2520adult%2520rats%2520by%2520activation%2520of%2520bone%2520lining%2520cells%26jtitle%3DEndocrinology%26date%3D1995%26volume%3D136%26spage%3D3632%26epage%3D3638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_contrib-group">Ishizuya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokose, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshiki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, A.</span><span> </span><span class="NLM_article-title">Parathyroid hormone exerts disparate effects on osteoclast differentiation depending on exposure time in rat osteoblastic cells</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">2961</span><span class="NLM_x">–</span> <span class="NLM_lpage">2970</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1997&pages=2961-2970&author=T.+Ishizuyaauthor=S.+Yokoseauthor=M.+Horiauthor=T.+Nodaauthor=T.+Sudaauthor=S.+Yoshikiauthor=A.+Yamaguchi&title=Parathyroid+hormone+exerts+disparate+effects+on+osteoclast+differentiation+depending+on+exposure+time+in+rat+osteoblastic+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIshizuya%26aufirst%3DT.%26aulast%3DYokose%26aufirst%3DS.%26aulast%3DHori%26aufirst%3DM.%26aulast%3DNoda%26aufirst%3DT.%26aulast%3DSuda%26aufirst%3DT.%26aulast%3DYoshiki%26aufirst%3DS.%26aulast%3DYamaguchi%26aufirst%3DA.%26atitle%3DParathyroid%2520hormone%2520exerts%2520disparate%2520effects%2520on%2520osteoclast%2520differentiation%2520depending%2520on%2520exposure%2520time%2520in%2520rat%2520osteoblastic%2520cells%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1997%26volume%3D99%26spage%3D2961%26epage%3D2970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_contrib-group">Frolik, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cain, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satterwhite, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown-Augsburger, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hock, J. M.</span><span> </span><span class="NLM_article-title">Anabolic and catabolic bone effects of human parathyroid hormone (1−34) are predicted by duration of hormone exposure</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">372</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2003&pages=372-379&author=C.+A.+Frolikauthor=E.+C.+Blackauthor=R.+L.+Cainauthor=J.+H.+Satterwhiteauthor=P.+L.+Brown-Augsburgerauthor=M.+Satoauthor=J.+M.+Hock&title=Anabolic+and+catabolic+bone+effects+of+human+parathyroid+hormone+%281%E2%88%9234%29+are+predicted+by+duration+of+hormone+exposure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrolik%26aufirst%3DC.%2BA.%26aulast%3DBlack%26aufirst%3DE.%2BC.%26aulast%3DCain%26aufirst%3DR.%2BL.%26aulast%3DSatterwhite%26aufirst%3DJ.%2BH.%26aulast%3DBrown-Augsburger%26aufirst%3DP.%2BL.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DHock%26aufirst%3DJ.%2BM.%26atitle%3DAnabolic%2520and%2520catabolic%2520bone%2520effects%2520of%2520human%2520parathyroid%2520hormone%2520%25281%25E2%2588%259234%2529%2520are%2520predicted%2520by%2520duration%2520of%2520hormone%2520exposure%26jtitle%3DBone%26date%3D2003%26volume%3D33%26spage%3D372%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6d"><span><span class="NLM_contrib-group">Onyia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helvering, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbert, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dow, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotinun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halladay, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miles, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambrose, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frolik, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, R. T.</span><span> </span><span class="NLM_article-title">Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: an analysis of DNA microarray</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">418</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2005&pages=403-418&author=J.+E.+Onyiaauthor=L.+M.+Helveringauthor=L.+Gelbertauthor=T.+Weiauthor=S.+Huangauthor=P.+Chenauthor=E.+R.+Dowauthor=A.+Maranauthor=M.+Zhangauthor=S.+Lotinunauthor=D.+L.+Halladayauthor=R.+R.+Milesauthor=N.+H.+Kulkarniauthor=E.+M.+Ambroseauthor=Y.+L.+Maauthor=C.+A.+Frolikauthor=M.+Satoauthor=H.+U.+Bryantauthor=R.+T.+Turner&title=Molecular+profile+of+catabolic+versus+anabolic+treatment+regimens+of+parathyroid+hormone+%28PTH%29+in+rat+bone%3A+an+analysis+of+DNA+microarray"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOnyia%26aufirst%3DJ.%2BE.%26aulast%3DHelvering%26aufirst%3DL.%2BM.%26aulast%3DGelbert%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DDow%26aufirst%3DE.%2BR.%26aulast%3DMaran%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DLotinun%26aufirst%3DS.%26aulast%3DHalladay%26aufirst%3DD.%2BL.%26aulast%3DMiles%26aufirst%3DR.%2BR.%26aulast%3DKulkarni%26aufirst%3DN.%2BH.%26aulast%3DAmbrose%26aufirst%3DE.%2BM.%26aulast%3DMa%26aufirst%3DY.%2BL.%26aulast%3DFrolik%26aufirst%3DC.%2BA.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DBryant%26aufirst%3DH.%2BU.%26aulast%3DTurner%26aufirst%3DR.%2BT.%26atitle%3DMolecular%2520profile%2520of%2520catabolic%2520versus%2520anabolic%2520treatment%2520regimens%2520of%2520parathyroid%2520hormone%2520%2528PTH%2529%2520in%2520rat%2520bone%253A%2520an%2520analysis%2520of%2520DNA%2520microarray%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2005%26volume%3D95%26spage%3D403%26epage%3D418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Marquis, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lago, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trout, R. E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DelMar, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Vegnan, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roethke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, P.</span><span> </span><span class="NLM_article-title">Antagonists of the calcium receptor I. Amino alcohol-based parathyroid hormone secretagogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3982</span><span class="NLM_x">–</span> <span class="NLM_lpage">3993</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900364m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvVSgtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3982-3993&author=R.+W.+Marquisauthor=A.+M.+Lagoauthor=J.+F.+Callahanauthor=R.+E.+L.+Troutauthor=M.+Gowenauthor=R.+G.+DelMarauthor=B.+C.+Van+Vegnanauthor=S.+Loganauthor=S.+Shimizuauthor=J.+Foxauthor=E.+F.+Nemethauthor=Z.+Yangauthor=T.+Roethkeauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=J.+Leeauthor=R.+M.+Keenanauthor=P.+Bhatnagar&title=Antagonists+of+the+calcium+receptor+I.+Amino+alcohol-based+parathyroid+hormone+secretagogues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonists of the Calcium Receptor I. Amino Alcohol-Based Parathyroid Hormone Secretagogues</span></div><div class="casAuthors">Marquis, Robert W.; Lago, Amparo M.; Callahan, James F.; Trout, Robert E. Lee; Gowen, Maxine; DelMar, Eric G.; Van Wagenen, Bradford C.; Logan, Sarah; Shimizu, Scott; Fox, John; Nemeth, Edward F.; Yang, Zheng; Roethke, Theresa; Smith, Brian R.; Ward, Keith W.; Lee, John; Keenan, Richard M.; Bhatnagar, Pradip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3982-3993</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Functional screening of the former SmithKline Beecham compd. collection against the human calcium receptor (CaR) resulted in the identification of the amino alc.-based hit 2 (IC50 = 11 μM).  Structure-activity studies of 2 focused on the optimization of the right- and left-hand side arom. moieties as well as the amino alc. linker region.  Crit. to the optimization of this antagonist template was the discovery that the chirality of the C-2 secondary alc. played a key role in enhancing both CaR potency as well as selectivity over the β-adrenergic receptor subtypes.  These SAR studies ultimately led to the identification of 38 (NPS 2143; SB-262470A), a potent and orally active CaR antagonist.  Pharmacokinetic characterization of 38 in the rat revealed that this mol. had a large vol. of distribution (11 L/kg), which resulted in a prolonged systemic exposure, protracted increases in the plasma levels of PTH, and an overall lack of net bone formation effect in a rodent model of osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEH_JHFpGSM7Vg90H21EOLACvtfcHk0liQj_CT3lbasA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvVSgtL0%253D&md5=7737a92f22bb30886f925395753243fd</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm900364m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900364m%26sid%3Dliteratum%253Aachs%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DLago%26aufirst%3DA.%2BM.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DTrout%26aufirst%3DR.%2BE.%2BL.%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DDelMar%26aufirst%3DR.%2BG.%26aulast%3DVan%2BVegnan%26aufirst%3DB.%2BC.%26aulast%3DLogan%26aufirst%3DS.%26aulast%3DShimizu%26aufirst%3DS.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DRoethke%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DKeenan%26aufirst%3DR.%2BM.%26aulast%3DBhatnagar%26aufirst%3DP.%26atitle%3DAntagonists%2520of%2520the%2520calcium%2520receptor%2520I.%2520Amino%2520alcohol-based%2520parathyroid%2520hormone%2520secretagogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3982%26epage%3D3993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_contrib-group">Crivori, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poggesi, I.</span><span> </span><span class="NLM_article-title">Predictive model for identifying potential CYP2D6 Inhibitors</span> <span class="citation_source-journal">Basic Clin. Pharm. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Fjm900563e&amp;key=10.1111%2Fj.1742-7843.2005.pto960320.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Fjm900563e&amp;key=15733226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisFSlsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2005&pages=251-253&author=P.+Crivoriauthor=I.+Poggesi&title=Predictive+model+for+identifying+potential+CYP2D6+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Predictive model for identifying potential CYP2D6 inhibitors</span></div><div class="casAuthors">Crivori, Patrizia; Poggesi, Italo</div><div class="citationInfo"><span class="NLM_cas:title">Basic & Clinical Pharmacology & Toxicology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">251-253</span>CODEN:
                <span class="NLM_cas:coden">BCPTBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-7835</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A model for predicting the cytochrome P 450 2D6 (CYP2D6) inhibition potential based on the mol. structures of drug candidates was developed and evaluated using Almond program.  The QSPR model was developed by correlating the exptl. inhibition consts. with the unscaled descriptors calcd. for all conformers generated for the training set.  GRIND descriptors appear to be a valuable tool for modeling CYP2D6 inhibitors.  Although the exptl. data utilized to train the model comes from different labs, the GRIND-based model appears robust and useful to predict CYP2D6 inhibition consts. of external sets of compds.  The performance of this model is at least as good as that reported for other computational models of CYP2D6 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK2FQqoXFbirVg90H21EOLACvtfcHk0liQj_CT3lbasA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisFSlsrY%253D&md5=0fda143645d8ff0a469957247294c70c</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-7843.2005.pto960320.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-7843.2005.pto960320.x%26sid%3Dliteratum%253Aachs%26aulast%3DCrivori%26aufirst%3DP.%26aulast%3DPoggesi%26aufirst%3DI.%26atitle%3DPredictive%2520model%2520for%2520identifying%2520potential%2520CYP2D6%2520Inhibitors%26jtitle%3DBasic%2520Clin.%2520Pharm.%2520Toxicol.%26date%3D2005%26volume%3D96%26spage%3D251%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_contrib-group">Ekins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gianpaolo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ring, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkel, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrighton, S. A.</span><span> </span><span class="NLM_article-title">Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors</span> <span class="citation_source-journal">Pharmacogenetics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">489</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Fjm900563e&amp;key=10780267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADyaK1MXmtlGjs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=477-489&author=S.+Ekinsauthor=B.+Gianpaoloauthor=S.+Binkleyauthor=J.+S.+Gillespieauthor=B.+J.+Ringauthor=J.+H.+Winkelauthor=S.+A.+Wrighton&title=Three+and+four+dimensional-quantitative+structure+activity+relationship+%283D%2F4D-QSAR%29+analyses+of+CYP2D6+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors</span></div><div class="casAuthors">Ekins, Sean; Bravi, Gianpaolo; Binkley, Shelly; Gillespie, Jennifer S.; Ring, Barbara J.; Wikel, James H.; Wrighton, Steven A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacogenetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">477-489</span>CODEN:
                <span class="NLM_cas:coden">PHMCEE</span>;
        ISSN:<span class="NLM_cas:issn">0960-314X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Three- and four-dimensional quant. structure activity relationship (3D/4D-QSAR) pharmacophore models of competitive inhibitors of CYP2D6 were constructed using data from our lab. or the literature.  The 3D-QSAR pharmacophore models of the common structural features of CYP2D6 inhibitors were built using the program Catalyst (Mol. Simulations, San Diego, CA, USA).  These 3D-QSAR models were compared with 3D and 4D-QSAR partial least squares (PLS) models which were constructed using mol. surface-weighted holistic invariant mol. (MS-WHIM) descriptors of size and shape of inhibitors.  The first Catalyst model was generated from multiple conformers of competitive inhibitors (n = 20) of CYP2D6 mediated bufurolol 1'-hydroxylation.  This model demonstrated a correlation of obsd. and predicted Ki (apparent) values of r = 0.75.  A second Catalyst model was constructed from literature derived Ki (apparent) values (n = 31) for the inhibition of CYP2D6.  This model provided a correlation of obsd. and predicted inhibition for CYP2D6 of r = 0.91.  Both Catalyst Ki pharmacophores were then validated by predicting the Ki (apparent) of a test set of known CYP2D6 inhibitors (n = 15).  Ten out of 15 of these Ki (apparent) values were predicted to be within one log residual of the obsd. value using our CYP2D6 inhibitor model, while the literature model predicted nine out of 15 values.  Similarly, 3D- and 4D-QSARs derived from PLS MS-WHIM for our dataset yielded predictable models as assessed using cross-validation.  The corresponding cross-validated PLS MS-WHIM model for the literature dataset yielded a comparable 3D-QSAR and improved 4D-QSAR value.  Such computational models will aid in future prediction of drug-drug interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcRiE7XUQvY7Vg90H21EOLACvtfcHk0libTCmDmt6FbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtlGjs7w%253D&md5=b714320963218c19c858e31376b9b528</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEkins%26aufirst%3DS.%26aulast%3DGianpaolo%26aufirst%3DB.%26aulast%3DBinkley%26aufirst%3DS.%26aulast%3DGillespie%26aufirst%3DJ.%2BS.%26aulast%3DRing%26aufirst%3DB.%2BJ.%26aulast%3DWinkel%26aufirst%3DJ.%2BH.%26aulast%3DWrighton%26aufirst%3DS.%2BA.%26atitle%3DThree%2520and%2520four%2520dimensional-quantitative%2520structure%2520activity%2520relationship%2520%25283D%252F4D-QSAR%2529%2520analyses%2520of%2520CYP2D6%2520inhibitors%26jtitle%3DPharmacogenetics%26date%3D1999%26volume%3D9%26spage%3D477%26epage%3D489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_contrib-group">De Groot, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackland, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B. C.</span><span> </span><span class="NLM_article-title">Novel approach to predicting P450-mediated drug metabolism: development of a combined protein and pharmacophore model for CYP2D6</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1515</span><span class="NLM_x">–</span> <span class="NLM_lpage">1524</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm981118h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1515-1524&author=M.+J.+De+Grootauthor=M.+J.+Acklandauthor=V.+A.+Horneauthor=A.+A.+Alexauthor=B.+C.+Jones&title=Novel+approach+to+predicting+P450-mediated+drug+metabolism%3A+development+of+a+combined+protein+and+pharmacophore+model+for+CYP2D6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1021%2Fjm981118h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm981118h%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BGroot%26aufirst%3DM.%2BJ.%26aulast%3DAckland%26aufirst%3DM.%2BJ.%26aulast%3DHorne%26aufirst%3DV.%2BA.%26aulast%3DAlex%26aufirst%3DA.%2BA.%26aulast%3DJones%26aufirst%3DB.%2BC.%26atitle%3DNovel%2520approach%2520to%2520predicting%2520P450-mediated%2520drug%2520metabolism%253A%2520development%2520of%2520a%2520combined%2520protein%2520and%2520pharmacophore%2520model%2520for%2520CYP2D6%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1515%26epage%3D1524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8d"><span><span class="NLM_contrib-group">Rowland, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smyth, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leydon, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oxbrow, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tennant, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eggleston, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenery, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, A. M.</span><span> </span><span class="NLM_article-title">Crystal structure of the human cytochrome P450 2D6</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">7614</span><span class="NLM_x">–</span> <span class="NLM_lpage">7622</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=7614-7622&author=P.+Rowlandauthor=F.+E.+Blaneyauthor=M.+G.+Smythauthor=J.+J.+Jonesauthor=V.+R.+Leydonauthor=A.+K.+Oxbrowauthor=C.+J.+Lewisauthor=M.+G.+Tennantauthor=S.+Modiauthor=D.+S.+Egglestonauthor=R.+J.+Cheneryauthor=A.+M.+Bridges&title=Crystal+structure+of+the+human+cytochrome+P450+2D6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DBlaney%26aufirst%3DF.%2BE.%26aulast%3DSmyth%26aufirst%3DM.%2BG.%26aulast%3DJones%26aufirst%3DJ.%2BJ.%26aulast%3DLeydon%26aufirst%3DV.%2BR.%26aulast%3DOxbrow%26aufirst%3DA.%2BK.%26aulast%3DLewis%26aufirst%3DC.%2BJ.%26aulast%3DTennant%26aufirst%3DM.%2BG.%26aulast%3DModi%26aufirst%3DS.%26aulast%3DEggleston%26aufirst%3DD.%2BS.%26aulast%3DChenery%26aufirst%3DR.%2BJ.%26aulast%3DBridges%26aufirst%3DA.%2BM.%26atitle%3DCrystal%2520structure%2520of%2520the%2520human%2520cytochrome%2520P450%25202D6%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D7614%26epage%3D7622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8e"><span><span class="NLM_contrib-group">Mitcheson, J. S.</span><span> </span><span class="NLM_article-title">hERG potassium channels and the structural basis of drug-induced arrhythmias</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx800035b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=1005-1010&author=J.+S.+Mitcheson&title=hERG+potassium+channels+and+the+structural+basis+of+drug-induced+arrhythmias"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8e&amp;dbid=16384&amp;doi=10.1021%2Ftx800035b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx800035b%26sid%3Dliteratum%253Aachs%26aulast%3DMitcheson%26aufirst%3DJ.%2BS.%26atitle%3DhERG%2520potassium%2520channels%2520and%2520the%2520structural%2520basis%2520of%2520drug-induced%2520arrhythmias%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D1005%26epage%3D1010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8f"><span><span class="NLM_contrib-group">Kramer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kriegel, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, T.</span><span> </span><span class="NLM_article-title">A composite model for hERG blockade</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">254</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=254-265&author=C.+Kramerauthor=B.+Beckauthor=J.+M.+Kriegelauthor=T.+Clark&title=A+composite+model+for+hERG+blockade"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DC.%26aulast%3DBeck%26aufirst%3DB.%26aulast%3DKriegel%26aufirst%3DJ.%2BM.%26aulast%3DClark%26aufirst%3DT.%26atitle%3DA%2520composite%2520model%2520for%2520hERG%2520blockade%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D254%26epage%3D265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8g"><span><span class="NLM_contrib-group">Stansfeld, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gedeck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosling, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitcheson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, M. J.</span><span> </span><span class="NLM_article-title">Drug block of the hERG potassium channel: insights from modeling</span> <span class="citation_source-journal">Proteins: Struct., Funct., Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">568</span><span class="NLM_x">–</span> <span class="NLM_lpage">580</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2007&pages=568-580&author=P.+J.+Stansfeldauthor=P.+Gedeckauthor=M.+Goslingauthor=B.+Coxauthor=J.+S.+Mitchesonauthor=M.+J.+Sutcliffe&title=Drug+block+of+the+hERG+potassium+channel%3A+insights+from+modeling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStansfeld%26aufirst%3DP.%2BJ.%26aulast%3DGedeck%26aufirst%3DP.%26aulast%3DGosling%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DB.%26aulast%3DMitcheson%26aufirst%3DJ.%2BS.%26aulast%3DSutcliffe%26aufirst%3DM.%2BJ.%26atitle%3DDrug%2520block%2520of%2520the%2520hERG%2520potassium%2520channel%253A%2520insights%2520from%2520modeling%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Bioinf.%26date%3D2007%26volume%3D68%26spage%3D568%26epage%3D580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8h"><span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tristani-Firouzi, M.</span><span> </span><span class="NLM_article-title">hERG potassium channels and cardiac arrhythmia</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">440</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8h&amp;dbid=16&amp;doi=10.1021%2Fjm900563e&amp;key=10.1038%2Fnature04710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8h&amp;dbid=8&amp;doi=10.1021%2Fjm900563e&amp;key=16554806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8h&amp;dbid=32&amp;doi=10.1021%2Fjm900563e&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1OlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=2006&pages=463-469&author=M.+C.+Sanguinettiauthor=M.+Tristani-Firouzi&title=hERG+potassium+channels+and+cardiac+arrhythmia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8hR"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">hERG potassium channels and cardiac arrhythmia</span></div><div class="casAuthors">Sanguinetti, Michael C.; Tristani-Firouzi, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">440</span>
        (<span class="NLM_cas:issue">7083</span>),
    <span class="NLM_cas:pages">463-469</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  HERG potassium channels are essential for normal elec. activity in the heart.  Inherited mutations in the HERG gene cause long QT syndrome, a disorder that predisposes individuals to life-threatening arrhythmias.  Arrhythmia can also be induced by a blockage of hERG channels by a surprisingly diverse group of drugs.  This side effect is a common reason for drug failure in preclin. safety trials.  Insights gained from the crystal structures of other potassium channels have helped our understanding of the block of hERG channels and the mechanisms of gating.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopS3WBEpuAUrVg90H21EOLACvtfcHk0libTCmDmt6FbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1OlsLs%253D&md5=3f355dcd51da3488d73c7c91cbe8d3b8</span></div><a href="/servlet/linkout?suffix=cit8h&amp;dbid=16384&amp;doi=10.1038%2Fnature04710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04710%26sid%3Dliteratum%253Aachs%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26aulast%3DTristani-Firouzi%26aufirst%3DM.%26atitle%3DhERG%2520potassium%2520channels%2520and%2520cardiac%2520arrhythmia%26jtitle%3DNature%26date%3D2006%26volume%3D440%26spage%3D463%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8i"><span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitcheson, J. S.</span><span> </span><span class="NLM_article-title">Predicting drug-hERG channel interactions that cause acquired long QT syndrome</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=119-124&author=M.+C.+Sanguinettiauthor=J.+S.+Mitcheson&title=Predicting+drug-hERG+channel+interactions+that+cause+acquired+long+QT+syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26aulast%3DMitcheson%26aufirst%3DJ.%2BS.%26atitle%3DPredicting%2520drug-hERG%2520channel%2520interactions%2520that%2520cause%2520acquired%2520long%2520QT%2520syndrome%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2005%26volume%3D26%26spage%3D119%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8j"><span><span class="NLM_contrib-group">Fernandez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghanta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span> </span><span class="NLM_article-title">Physiochemical features of the hERG channel binding site</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">10120</span><span class="NLM_x">–</span> <span class="NLM_lpage">10127</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=10120-10127&author=D.+Fernandezauthor=A.+Ghantaauthor=G.+W.+Kauffmanauthor=M.+C.+Sanguinetti&title=Physiochemical+features+of+the+hERG+channel+binding+site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez%26aufirst%3DD.%26aulast%3DGhanta%26aufirst%3DA.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26atitle%3DPhysiochemical%2520features%2520of%2520the%2520hERG%2520channel%2520binding%2520site%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D10120%26epage%3D10127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8k"><span><span class="NLM_contrib-group">Tonioli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crisma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Formaggio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peggion, C.</span><span> </span><span class="NLM_article-title">Control of peptide conformation by the Thorpe−Ingold effect (C-α tetrasubstitution)</span> <span class="citation_source-journal">Biopolymers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">396</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2001&pages=396-419&author=C.+Tonioliauthor=M.+Crismaauthor=F.+Formaggioauthor=C.+Peggion&title=Control+of+peptide+conformation+by+the+Thorpe%E2%88%92Ingold+effect+%28C-%CE%B1+tetrasubstitution%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8k&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTonioli%26aufirst%3DC.%26aulast%3DCrisma%26aufirst%3DM.%26aulast%3DFormaggio%26aufirst%3DF.%26aulast%3DPeggion%26aufirst%3DC.%26atitle%3DControl%2520of%2520peptide%2520conformation%2520by%2520the%2520Thorpe%25E2%2588%2592Ingold%2520effect%2520%2528C-%25CE%25B1%2520tetrasubstitution%2529%26jtitle%3DBiopolymers%26date%3D2001%26volume%3D60%26spage%3D396%26epage%3D419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span> See first two references of ref <span class="NLM_xref">6</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+See+first+two+references+of+ref+6."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm900563e&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Fjm900563e%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-21%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm900563e" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                842KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67992b092c63d1a3","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
